<table><thead><th colspan="2">Response</th><th>Typical time after infection to start of response</th><th>ee</th></thead><tr><td rowspan="5">MEI immune response Adaptive Cult) response</td><td>Inflammation, complement activation hi ene i raraitng a ee phagocytosis, and destruction of pathogen</td><td>Minutes</td><td>Days</td></tr><tr><td></td><td>Interaction between antigen-presenting dendritic cells and antigen-specific T cells: recognition of antigen, adhesion, co- stimulation, T-cell proliferation and differentiation</td><td>Hours</td><td>Days</td></tr><tr><td></td><td>Activation of antigen-specific B cells</td><td>Hours</td><td>Days</td></tr><tr><td></td><td>Formation of effector and memory T cells</td><td>Days</td><td></td></tr><tr><td rowspan="3"></td><td></td><td>Interaction of T cells with B cells, formation of germinal centers. Formation of effector B cells (plasma cells) and memory B cells. Production of antibody</td><td>D Mp</td><td></td></tr><tr><td></td><td>Emigration of effector lymphocytes from peripheral lymphoid organs</td><td>AVTow)| deys</td><td></td></tr><tr><td></td><td>Elimination of pathogen by effector cells and antibody</td><td>AVTow)| deys</td><td></td></tr><tr><td>i li I i ae ogica</td><td>Maintenance of memory B cells and T cells ° and high serum or mucosal antibody levels. Protection against reinfection</td><td>Days to weeks</td><td></td></tr></table>
======================================
<table><thead><th>The immune</th><th>system protects against four</th><th>classes of pathogens</th></thead><tr><td>Type of pathogen</td><td>Examples</td><td>Diseases</td></tr><tr><td>Viruses (intracellular)</td><td>Variola Influenza Varicella</td><td>Smallpox Flu Chickenpox</td></tr><tr><td>9 Intracellular bacteria, pl i : (EEE</td><td>Mycobacterium leprae Leishmania donovani Plasmodium falciparum Toxoplasma gondii</td><td>Leprosy Leishmaniasis Malaria Toxoplasmosis</td></tr><tr><td>Extracellular bacteria, parasites, fungi</td><td>Streptococcus pneumoniae Clostridium tetani Trypanosoma brucei Pneumocystis jirovecii</td><td>Pneumonia Tetanus Sleeping sickness Pneumocystis pneumonia</td></tr><tr><td>Parasitic worms (extracellular)</td><td>Ascaris Schistosoma</td><td>Ascariasis Schistosomiasis</td></tr></table>
======================================
<table><tr><td rowspan="2">Cytotoxicity</td><td>NK cells, CD8 T cells</td></tr><tr><td></td><td>Elimination of virally infected and metabolically stressed cells</td></tr><tr><td rowspan="2">Intracellular immunity (Type 1)</td><td>ILC1, T,,1 cells</td></tr><tr><td></td><td>Elimination of intracellular pathogens; activation of macrophages</td></tr><tr><td rowspan="2">Mucosal and barrier immunity (Type 2)</td><td>ILC2, T,,2 cells</td></tr><tr><td></td><td>Elimination and expulsion of parasites; recruitment of eosinophils, basophils, and mast cells</td></tr><tr><td rowspan="2">Extracellular immunity (Type 3)</td><td>ILC3, T,,17 cells</td></tr><tr><td></td><td>Elimination of extracellular bacteria and fungi; recruitment and activation of neutrophils</td></tr></table>
======================================
<table><thead><th rowspan="2">Antigen</th><th colspan="2">Effect of response to antigen</th></thead><thead><th></th><th>Normal response</th><th>Deficient response</th></thead><tr><td>Infectious agent</td><td>Protective immunity</td><td></td></tr><tr><td>Innocuous substance</td><td></td><td>No response</td></tr><tr><td>Grafted organ</td><td></td><td>Acceptance</td></tr><tr><td>Self organ</td><td></td><td>Self tolerance</td></tr><tr><td>Tumor</td><td>Tumor immunity</td><td></td></tr></table>
======================================
<table><tr><td rowspan="8">Mouth and respiratory tract</td><td rowspan="7">_ Inhalation or ingestion of infective material (e.g., saliva droplets)</td><td>Measles virus</td><td>Measles</td><td>Paramyxovirus</td></tr><tr><td></td><td></td><td>Influenza virus</td><td>Influenza</td><td>Orthomyxovirus</td></tr><tr><td></td><td></td><td>Varicella-zoster</td><td>Chickenpox</td><td>Herpesvirus</td></tr><tr><td></td><td></td><td>Epstein-Barr virus</td><td>Mononucleosis</td><td>Herpesvirus</td></tr><tr><td></td><td></td><td>Streptococcus pyogenes</td><td>Tonsillitis</td><td>Gram-positive bacterium</td></tr><tr><td></td><td></td><td>Haemophilus influenzae</td><td>Pneumonia, meningitis</td><td>Gram-negative bacterium</td></tr><tr><td></td><td></td><td>Neisseria meningitidis</td><td>Meningococcal meningitis</td><td>Gram-negative bacterium</td></tr><tr><td></td><td>Spores</td><td>Bacillus anthracis</td><td>Inhalation anthrax</td><td>Gram-positive bacterium</td></tr><tr><td rowspan="5">Gastrointestinal tract</td><td rowspan="5">i Contaminated water or food</td><td>Rotavirus</td><td>Diarrhea</td><td>Rotavirus</td></tr><tr><td></td><td></td><td>Salmonella enteritidis, rae 7 S. typhimurium</td><td>anni Food poisoning</td><td>A A Gram-negative bacterium</td></tr><tr><td></td><td></td><td>a Vibrio cholerae</td><td>Cholera</td><td>. . Gram-negative bacterium</td></tr><tr><td></td><td></td><td>Salmonella typhi</td><td>Typhoid fever</td><td>Gram-negative bacterium</td></tr><tr><td></td><td></td><td>Trichuris trichiura</td><td>Trichuriasis</td><td>Helminth</td></tr><tr><td rowspan="4">Reproductive tract and other routes</td><td></td><td rowspan="2">infected blood Sexual transmission/</td><td>Hepatitis B virus</td><td>Hepatitis B</td><td>Hepadnavirus</td></tr><tr><td></td><td></td><td>Human immunodeficiency virus (HIV)</td><td>Acquired immunodeficiency syndrome (AIDS)</td><td>Retrovirus</td></tr><tr><td></td><td rowspan="2">a Sexual transmission</td><td></td><td>Neisseria gonorrhoeae</td><td>Gonorrhea</td><td>Gram-negative bacterium</td></tr><tr><td>Treponema pallidum</td><td>Syphilis</td><td>Bacterium (spirochete)</td></tr><tr><td rowspan="2">Opportunistic infections</td><td>Resident microbiota</td><td>Candida albicans</td><td>Candidiasis, thrush</td><td>Fungus</td></tr><tr><td></td><td>Resident lung microbiota</td><td>Pneumocystis jirovecii</td><td>Pneumonia</td><td>Fungus</td></tr></table>
======================================
<table><thead><th>External surface</th><th>Physical contact</th><th>Trichophyton</th><th>Athlete’s foot</th><th>Fungus</th></thead><tr><td rowspan="3">Wounds and abrasions</td><td>Minor skin abrasions</td><td>Bacillus anthracis</td><td>Cutaneous anthrax</td><td>Gram-positive bacterium</td></tr><tr><td></td><td>Puncture wounds</td><td>Clostridium tetani</td><td>Tetanus</td><td>Gram-positive bacterium</td></tr><tr><td></td><td>Handling infected animals</td><td>Francisella tularensis</td><td>Tularemia</td><td>Gram-negative bacterium</td></tr><tr><td rowspan="3">Insect bites</td><td>Vee sere</td><td>Flavivirus</td><td>Yellow fever</td><td>Virus</td></tr><tr><td></td><td>Deer tick bites</td><td>Borrelia burgdorferi</td><td>Lyme disease</td><td>Bacterium (spirochete)</td></tr><tr><td></td><td>Mosquito bites (Anopheles)</td><td>Plasmodium spp.</td><td>Malaria</td><td>Protozoan</td></tr></table>
======================================
<table><tr><td colspan="7">Pathogenic mechanism 4... @~ 6 Ae © ( 70 “ oO</td></tr><tr><td>. Infectious agent</td><td>Streptococcus pyogenes Staphylococcus aureus Corynebacterium diphtheriae Clostridium tetani Vibrio cholerae</td><td>Escherichia coli Haemophilus influenzae Salmonella typhi Shigella Pseudomonas aeruginosa Yersinia pestis</td><td>Variola Varicella-zoster Hepatitis B virus Polio virus Measles virus Influenza virus Herpes simplex virus Human herpes virus 8 (HHV8)</td><td>Hepatitis B virus Malaria Streptococcus pyogenes Treponema pallidum Most acute infections</td><td>Streptococcus pyogenes Mycoplasma pneumoniae</td><td>Lymphocytic choriomeningitis virus Herpes simplex virus Mycobacterium tuberculosis Mycobacterium leprae Borrelia burgdorferi Schistosoma mansoni</td></tr><tr><td>| Disease</td><td>Tonsillitis, scarlet fever Boils, toxic shock syndrome, food poisoning Diphtheria Tetanus Cholera</td><td>Gram-negative sepsis Meningitis, pneumonia Typhoid fever Bacillary dysentery pou infection</td><td>Smallpox Chickenpox, shingles Hepatitis Poliomyelitis | Measles, subacute sere als Influenza Cold sores Kaposi's sarcoma</td><td>Kidney disease Vascular deposits Glomerulonephritis Kidney damage in secondary syphilis Transient renal deposits</td><td>Rheumatic fever Hemolytic anemia</td><td>Aseptic meningitis Herpes stromal keratitis Tuberculosis Tuberculoid leprosy Lyme arthritis Schistosomiasis</td></tr></table>
======================================
<table><thead><th>Skin</th><th>Gut</th><th>Lungs</th><th>Eyes/nose/oral cavity</th></thead><tr><td colspan="4">Epithelial cells joined by tight junctions</td></tr><tr><td>Longitudinal flow of air or fluid</td><td>| Longitudinal flow of air or fluid</td><td>Movement of mucus by cilia</td><td>Tears Nasal cilia</td></tr><tr><td rowspan="2">Fatty acids</td><td>Low pH</td><td>Pulmonary surfactant</td><td>. PSS Us</td></tr><tr><td></td><td>Enzymes (pepsin)</td><td></td><td>(lysozyme)</td></tr><tr><td>a ee Cathelicidin a</td><td>a-defensins (cryptdins) Reglll (lecticidins) Cathelicidin</td><td>a-defensins Cathelicidin</td><td>Histatins £-defensins</td></tr><tr><td></td><td>Normal</td><td>microbiota</td><td></td></tr></table>
======================================
<table><thead><th>Binding to antigen-antibody complexes and pathogen surfaces</th><th>Cig</th></thead><tr><td>Binding to carbohydrate structures such as mannose or GIcNAc on microbial surfaces</td><td>MBL. Ficolins Properdin (factor P)</td></tr><tr><td>Activating enzymes*</td><td>Cir Cis C2a Bt MASP-1 MASP-2 MASP-3</td></tr><tr><td>Surface-binding proteins and opsonins</td><td>C4b C3b</td></tr><tr><td>Membrane-attack proteins</td><td>C5b C6 C7 c8 cg</td></tr><tr><td>Complement receptors</td><td>CR1 CR2 CR3 CR4 CRig</td></tr><tr><td>Complement-regulatory proteins</td><td>C1INH C4BP CR1/CD35 MCP/CD46 DAFICDSS | Pp CD59</td></tr></table>
======================================
<table><thead><th>C3</th><th>convertase</th></thead><tr><td>Lectin pathway</td><td>C4b2a</td></tr><tr><td>Classical pathway</td><td>C4b2a</td></tr><tr><td>Alternative pathway</td><td>C3bBb</td></tr><tr><td>Fluid phase</td><td>€3(H,0)Bb</td></tr></table>
======================================
<table><thead><th>Lectin pathway</th><th>C4b2a3b</th></thead><tr><td>Classical pathway</td><td>C4b2a3b</td></tr><tr><td>Alternative pathway</td><td>C3b,Bb</td></tr></table>
======================================
<table><thead><th>Native component</th><th>Active form</th><th>i i Function of the active form</th></thead><tr><td rowspan="3">C1 (Cig: Cir,:C1s,)</td><td>ct q</td><td>Binds directly to pathogen surfaces or indirectly to antibody bound to pathogens, thus allowing autoactivation of Cir</td></tr><tr><td></td><td>Cir</td><td>Cleaves Cis to active protease</td></tr><tr><td></td><td>Cis</td><td>Cleaves C4 and C2</td></tr><tr><td rowspan="2">CA</td><td>4b</td><td>Covalently binds to pathogen and opsonizes it. Binds C2 for cleavage by Cis</td></tr><tr><td></td><td>C4a</td><td>Peptide mediator of inflammation (weak activity)</td></tr><tr><td rowspan="2">C2</td><td>c2. a</td><td>Active enzyme of classical pathway C3/C5 convertase: cleaves C3 and C5</td></tr><tr><td></td><td>C2b</td><td>Precursor of vasoactive C2 kinin</td></tr><tr><td rowspan="2">C3</td><td>3b</td><td>Binds to pathogen surface and acts as opsonin. Initiates amplification via the alternative pathway. Binds C5 for cleavage by C2a</td></tr><tr><td></td><td>C3a</td><td>Peptide mediator of inflammation (intermediate activity)</td></tr></table>
======================================
<table><tr><td>Native component</td><td>Active fragments</td><td>Function</td></tr><tr><td>63</td><td>(ep</td><td>Binds to pathogen surface; binds B for cleavage by D; C3bBb is a C3 convertase and C3b,Bb is a C5 convertase</td></tr><tr><td>Factor B (B)</td><td>Ep</td><td>Bb is the active enzyme of the C3 convertase C3bBb and the C5 convertase C3b,Bb</td></tr><tr><td>Factor D (D)</td><td>D</td><td>Plasma serine protease, cleaves B when it is bound to C3b to Ba and Bb</td></tr><tr><td>. Properdin (P)</td><td>P</td><td>Plasma protein that binds to bacterial surfaces and stabilizes the C3bBb convertase</td></tr></table>
======================================
<table><thead><th rowspan="2">Step in pathway</th><th colspan="3">Protein serving function in pathway</th><th rowspan="2">Relationship</th></thead><thead><th></th><th>Alternative</th><th>Lectin</th><th>Classical</th><th></th></thead><tr><td>Initiating serine protease</td><td>D</td><td>MASP</td><td>Cis</td><td>ce re ASP)</td></tr><tr><td>Covalent binding to cell surface</td><td>C3b</td><td></td><td>C4b</td><td>Homologous</td></tr><tr><td>C3/C5 convertase</td><td>Bb</td><td></td><td>C2a</td><td>Homologous</td></tr><tr><td>Control of activation</td><td>a</td><td></td><td>crap</td><td>Homaleeaus</td></tr><tr><td>Opsonization</td><td></td><td>C3b</td><td></td><td>Identical</td></tr><tr><td>Initiation of effector pathway</td><td></td><td>C5b</td><td></td><td>Identical</td></tr><tr><td>Local inflammation</td><td></td><td colspan="2">C5a, C3a</td><td>Identical</td></tr><tr><td>Stabilization</td><td>P</td><td></td><td></td><td>Unique</td></tr></table>
======================================
<table><tr><td>CR1 (CD35)</td><td>C3b, C4bi</td><td>Promotes C3b and C4b decay Stimulates phagocytosis (requires C5a) Erythrocyte transport of immune complexes</td><td>Erythrocytes, macrophages, monocytes, polymorphonuclear leukocytes, B cells, FDC</td></tr><tr><td>cR2 (CD21)</td><td>3d, iC3b, C3dg</td><td>Part of B-cell co-receptor | Enhances B-cell response to antigens bearing C3d, iC3b, or C3dg Epstein-Barr virus receptor</td><td>B cells, FDC</td></tr><tr><td>See (cD11b: CD18)</td><td>iC3b</td><td>Stimulates phagocytosis</td><td>Macrophages, monocytes, polymorphonuclear leukocytes, Foc</td></tr><tr><td>(a 95) (cpt c CD18) °</td><td>iC3b</td><td>Stimulates phagocytosis</td><td>Macrophages, monocytes, polymorphonuclear leukocytes, dendritic cells</td></tr><tr><td>CRI 9</td><td>C3b, iC3b</td><td>Phagocytosis of circulating pathogens</td><td>Tissue-resident macrophages, hepatic sinusoid macrophages</td></tr><tr><td>C5a cow</td><td>C5a</td><td>Binding of C5a activates G protein</td><td>Neutrophils, macrophages, endothelial cells, mast cells</td></tr><tr><td>C5L2 (GPR77)</td><td>C5a</td><td>Decoy receptor, regulates C5a receptor</td><td>Neutrophils, macrophages</td></tr><tr><td>C3a receptor</td><td>C3a</td><td>a Binding of C3a. . . activates G protein</td><td>Macrophages, - endothelial cells, mast cells</td></tr></table>
======================================
<table><thead><th>protein</th><th>me</th><th>Bunction</th></thead><tr><td rowspan="2">“</td><td>C5a</td><td>Small peptide mediator of inflammation (high activity)</td></tr><tr><td></td><td>C5b</td><td>Initiates assembly of the membrane-attack system</td></tr><tr><td>C6</td><td>C6</td><td>Binds C5b; forms acceptor for C7</td></tr><tr><td>C7</td><td>C7</td><td>Binds C5b6; amphiphilic complex inserts into lipid bilayer</td></tr><tr><td>c8</td><td>c8</td><td>Binds C5b67; initiates C9 polymerization</td></tr><tr><td>cg</td><td>C9,</td><td>Polymerizes to C5b678 to form a membrane-spanning channel, lysing the cell</td></tr></table>
======================================
<table><thead><th colspan="4">Soluble factors regulating complement</th></thead><thead><th>Name</th><th>Ligand/ binding factor</th><th>4 Action</th><th>r a Pathology if defective</th></thead><tr><td>ne a uo</td><td>Ctr, Cis (C1q); MASP-2 (MBL)</td><td>| Displaces Cir/s and MASP-2, inhibiting activation of C1q and MBL</td><td>Hereditary angiodema</td></tr><tr><td>| C4-binding protein (C4BP)</td><td>4b</td><td>Displaces C2a; cofactor for C4b cleavage by factor |</td><td></td></tr><tr><td>CPN1 (Carboxypeptidase N)</td><td>C3a, C5a</td><td>Inactivates C3a and C5a</td><td></td></tr><tr><td>Factor H</td><td>C3b</td><td>Displaces Bb, cofactor for factor |</td><td>Age-related macular degeneration, atypical hemolytic uremic syndrome</td></tr><tr><td>Factor!</td><td>C3b, Céb</td><td>Serine protease, cleaves C3b and C4b</td><td>Low C3 levels, hemolytic uremic syndrome</td></tr><tr><td>Protein $</td><td>CSb67 complex</td><td>Inhibits MAC formation</td><td></td></tr></table>
======================================
<table><thead><th></th><th>binding factor</th><th>Action</th><th>Pathology if defective</th></thead><tr><td>CRIg</td><td>C3b, iC3b, C3c</td><td>Inhibits activation of alternative pathway</td><td>Increased susceptibiity to blood-borne infections</td></tr><tr><td>Complement receptor 1 (CR1, CD35)</td><td>C3b, C4b</td><td>Cofactor for factor |; displaces Bb from C3b, and C2a from C4b</td><td></td></tr><tr><td>Decay-accelerating factor (DAF, CD55)</td><td>C3 convertase</td><td>Displaces Bb and C2a from C3b and C4b, respectively</td><td>Paroxysmal nocturnal hemoglobinuria</td></tr><tr><td>Membrane-cofactor protein (MCP, CD46)</td><td>C3b, C4b</td><td>Cofactor for factor |</td><td>5 , Ayplcal hemolytic</td></tr><tr><td>Protectin (CD59)</td><td>68</td><td>Inhibits MAC formation</td><td>Paroxysmal nocturnal hemoglobinuria</td></tr></table>
======================================
<table><thead><th>Pathogen</th><th>Evasion molecule</th><th>Host target</th><th>Mechanism of action</th></thead><tr><td colspan="4">Membrane proteins</td></tr><tr><td>Neisseria meningitidis</td><td>Factor H binding protein (fHbp)</td><td>Factor H</td><td>‘ Inactivates bound C3b</td></tr><tr><td>Borrelia burgdorferi</td><td>Outer surface protein E (OspE)</td><td>Factor H</td><td>Inactivates bound C3b</td></tr><tr><td>Streptococcus pneumoniae</td><td>Pneumococcal surface protein C (PspC)</td><td>Factor H</td><td>Inactivates bound C3b</td></tr><tr><td colspan="4">Secreted proteins</td></tr><tr><td>Neisseria meningitidis</td><td>PorA</td><td>C4BP</td><td>Inactivates bound C3b</td></tr><tr><td>Staphylococcus erotis)</td><td>Clumping factor A (cla)</td><td>Factor |</td><td>Inactivates bound C3b</td></tr><tr><td>Staphylococcus aureus</td><td>Staphylococcus protein A (Spa)</td><td>. Immunoglobulin</td><td>Binds to Fc regions and interferes with C1 activation</td></tr><tr><td>Staphylococcus euros)</td><td>Staphylokinase (SAK)</td><td>: Immunoglobulin</td><td>Cleaves immunoglobulins</td></tr><tr><td>Staphylococcus aureus</td><td>Complement inhibitor (SCIN)</td><td>C3 convertase (C3b2a, C3bBb)</td><td>Inhibition of convertase activity</td></tr></table>
======================================
<table><tr><td></td><td>syndrome</td></tr><tr><td>B. Factor H &amp; factor |</td><td>2. Hereditary angioedema</td></tr><tr><td>C. DAF</td><td>3. Paroxysmal nocturnal hemoglobinuria</td></tr></table>
======================================
<table><tr><td>c2</td></tr><tr><td>C4a</td></tr><tr><td>C4b2a</td></tr><tr><td>C3</td></tr><tr><td>C8b</td></tr></table>
======================================
<table><tr><td>Specificity inherited in the genome</td><td>Yes</td><td>No</td></tr><tr><td>Expressed by all cells of a particular type (e.g., macrophages)</td><td>Variable</td><td>No</td></tr><tr><td>Triggers immediate response</td><td>Yes</td><td>No</td></tr><tr><td>Recognizes broad classes of pathogens</td><td>Yes</td><td>No</td></tr><tr><td>Interacts with a range of molecular structures of a given type</td><td>Yes</td><td>No</td></tr><tr><td>Encoded in multiple gene segments</td><td>No</td><td>Yes</td></tr><tr><td>Requires gene rearrangement</td><td>No</td><td>Yes</td></tr><tr><td>Clonal distribution</td><td>No</td><td>Yes</td></tr><tr><td>Able to discriminate between even closely related molecular structures</td><td>Yes</td><td>Yes</td></tr></table>
======================================
<table><thead><th colspan="3">Antimicrobial mechanisms of phagocytes</th></thead><thead><th>Class of mechanism</th><th>Macrophage products</th><th>Neutrophil products</th></thead><tr><td>Acidification</td><td colspan="2">pH~3.5-4.0, bacteriostatic or bactericidal</td></tr><tr><td>Toxi -derived products i Cis Areas [Ines</td><td colspan="2">Superoxide 0,-, hydrogen peroxide H0&gt;, singlet oxygen '0,°, hydroxyl radical *OH, hypohalite OCI-</td></tr><tr><td>Toxic nitrogen oxides</td><td>Nitric oxide NO</td><td></td></tr><tr><td>Antimicrobial peptides</td><td>Cathelicidin, macrophage elastase-derived peptide</td><td>a-Defensins (HNP1—4), B-defensin | HBD4, cathelicidin, azurocidin, bacterial permeability inducing protein (BPI), lactoferricin</td></tr><tr><td>Enzymes</td><td colspan="2">Lysozyme: digests cell walls of some Gram-positive bacteria Acid hydrolases (e.g., elastase and other proteases): break down ingested microbes</td></tr><tr><td>Competitors</td><td colspan="2">Lactoferrin (sequesters Fe?"), vitamin B,,-binding protein</td></tr></table>
======================================
<table><thead><th>Toll-like receptor</th><th>Ligand</th><th>Hematopoietic cellular distribution</th></thead><tr><td>TLR-1:TLR-2 heterodimer</td><td rowspan="2">Lipomannans (mycobacteria) Lipoproteins (diacyl lipopeptides; triacyl lipopeptides) Lipoteichoic acids (Gram-positive bacteria) Cell-wall B-glucans (bacteria and fungi) Zymosan (fungi)</td><td rowspan="2">Monocytes, dendritic cells, mast cells, eosinophils, basophils</td></tr><tr><td>TLR-2:TLR-6 heterodimer</td><td></td><td></td></tr><tr><td>TLR-3</td><td>Double-stranded RNA (viruses), poly I:C</td><td>Macrophages, dendritic cells, intestinal epithelium</td></tr><tr><td>TLR-4 (plus MD-2 and CD14)</td><td>LPS (Gram-negative bacteria) Lipoteichoic acids (Gram-positive bacteria)</td><td>Macrophages, dendritic cells, mast cells, eosinophils</td></tr><tr><td>TLR-5</td><td>Flagellin (bacteria)</td><td>Intestinal epithelium, macrophages, dendritic cells</td></tr><tr><td>TLR-7</td><td>Single-stranded RNA (viruses)</td><td>Plasmacytoid dendritic cells, macrophages, eosinophils, B cells</td></tr><tr><td>TLR-8</td><td>Single-stranded RNA (viruses)</td><td>Macrophages, neutrophils</td></tr><tr><td>TLR-9</td><td>DNA with unmethylated CpG (bacteria and herpesviruses)</td><td>Plasmacytoid dendritic cells, eosinophils, B cells, basophils</td></tr><tr><td>TLR-10 (human only)</td><td>Unknown</td><td>Plasmacytoid dendritic cells, eosinophils, B cells, basophils</td></tr><tr><td>TLR-11 (mouse only)</td><td>Profilin and profilin-like proteins (Toxoplasma gondii, uropathogenic bacteria)</td><td>Macrophages, dendritic cells (also liver, kidney, and bladder)</td></tr><tr><td>TLR-12 (mouse only)</td><td>Profilin (Toxoplasma gondii)</td><td>Macrophages, dendritic cells (also liver, kidney, bladder)</td></tr><tr><td>TLR-13 (mouse only)</td><td>Single-stranded RNA (bacterial ribosomal RNA)</td><td>Macrophages, dendritic cells</td></tr></table>
======================================
<table><tr><td>TLR-2/1</td><td>MyD88/MAL</td></tr><tr><td>TLR-3</td><td>TRIF</td></tr><tr><td>TLR-4</td><td>MyD88/MAL TRIF/TRAM</td></tr><tr><td>TLR-5</td><td>MyD88</td></tr><tr><td>TLR-2/6</td><td>MyD88/MAL</td></tr><tr><td>TLR-7</td><td>MyD88</td></tr><tr><td>TLR-8</td><td>MyD88</td></tr><tr><td>TLR-9</td><td>MyD88</td></tr><tr><td>TLRIW/12</td><td>MyD88</td></tr><tr><td>TLR-13</td><td>MyD88</td></tr></table>
======================================
<table><thead><th>Domain</th><th>Proteins</th></thead><tr><td>TIR</td><td>MyD88, MAL, TRIF, TRAM, all TLRs</td></tr><tr><td>CARD</td><td>Caspase 1, RIP2, RIG-I, MDA-5, MAVS, NODs, NLRC4, ASC, NLRP1</td></tr><tr><td>Pyrin</td><td>AIM2, IFI16, ASC, NLRP1-14</td></tr><tr><td>DD (death domain)</td><td>MyD88, IRAK1, IRAK4, DR4, DRS, FADD, FAS,</td></tr><tr><td>DED (death effector domain)</td><td>Caspase 8, caspase 10, FADD</td></tr></table>
======================================
<table><tr><td>ae</td><td>i</td><td>Receptors for erythropoietin and growth hormone</td></tr><tr><td rowspan="2">Heterodimeric receptors with a common chain</td><td>Be</td><td>Receptors for IL-3, IL-5, GM-CSF share a common chain, CD131 or B. (common B chain)</td></tr><tr><td></td><td>Y</td><td>Receptors for IL-2, IL-4, IL-7, IL-9, and IL-15 share a common chain, CD132 or y¢ (common y chain). IL-2 receptor also has a third chain, a high-affinity subunit IL-2Ra (CD25)</td></tr><tr><td rowspan="2">Heterodimeric receptors (no common chain)</td><td>LES</td><td>IL-1 family receptors</td></tr><tr><td></td><td></td><td>Receptors for IL-13, IFN-a, IFN-f, IFN-y, IL-10</td></tr><tr><td>TNF ti family</td><td></td><td>Tumor necrosis factor (TNF) receptors | and Il, CD40, Fas (Apot, CD95), CD30, CD27, nerve growth factor receptor</td></tr><tr><td>Chemokine receptor family</td><td>F</td><td>CCRI-10, CXCR1-5, XCR1, CX3CR1</td></tr></table>
======================================
<table><tr><td rowspan="4">CXC</td><td>xcs (IL-8)</td><td>Monocytes Fioobasts | Epithelial cells Endothelial cells</td><td>SxOR1 | CXCR2</td><td>Neutrophils, | Naive T cells</td><td>Mobilizes, Segranulates neutrophils Angiogenesis</td></tr><tr><td></td><td>CXCL7 (PBP, B-TG, NAP-2)</td><td>Platelets</td><td>CXCR2</td><td>Neutrophils</td><td>Activates neutrophils Clot resorption Angiogenesis</td></tr><tr><td></td><td>CXCL1 (GROa) CXCL2 (GROB) CXCL3 (GROy)</td><td>Monocytes Fibroblasts Endothelium</td><td>CXCR2</td><td>Neutrophils Naive T cells Fibroblasts</td><td>Activates neutrophils Fibroplasia Angiogenesis</td></tr><tr><td rowspan="4">He</td><td></td><td>cCLs (MIP-1a)</td><td>Monocytes T cells Mast cells Fibroblasts</td><td>CCRI1, 3, 5</td><td>Monocytes NK and T cells Basophils Dendritic cells</td><td>i 7 | Gompetes with HIV-1 Antiviral defense Promotes Ty1 immunity</td></tr><tr><td></td><td>CCL4 (MIP-1B)</td><td>Monocytes Macrophages | Neutrophils Endothelium</td><td>cori, 3,5 |</td><td>Monocytes NK andT cells Dendritic cells</td><td>| Competes with HIV-1</td></tr><tr><td></td><td>CCL2 (MCP-1)</td><td>Monocytes Macrophages Fibroblasts Keratinocytes</td><td>CCROB</td><td>Monocytes NK and T cells | Basophils Dendritic cells</td><td>Activates macrophages Basophil histamine release ; , Promotes Ty2 immunity</td></tr><tr><td></td><td>CCL5 (RANTES)</td><td>T cells Endothelium Platelets</td><td>CCR1, 3, 5 |</td><td>Monocytes NK and T cells | Basophils Eosinophils Dendritic cells</td><td>Degranulates basophils Activates T cells Chronic inflammation</td></tr><tr><td>on (CXC)</td><td>Gera</td><td>Monocytes Endothelium Microglial cells</td><td>CX,CR1</td><td>poneeyres</td><td>Leukocyte-endothelial adhesion Brain inflammation</td></tr></table>
======================================
<table><thead><th></th><th>P-selectin</th><th>P-selectin (PADGEM, CD62P)</th><th>Activated endothelium and platelets</th><th>. . PSGL-1, sialyl-Lewis*</th></thead><tr><td>Bind carbohydrates. Initiate leukocyte— endothe</td><td></td><td>E-selectin (ELAM-1, CD62E)</td><td>Activated endothelium</td><td>Sialyl-Lewis*</td></tr><tr><td></td><td rowspan="3">. LAT</td><td>aBy : (LFA-1, CD11a:CD18)</td><td>Monocytes, T cells, macrophages, neutrophils, dendrite cells, NK cells</td><td>ICAM-1, ICAM-2</td></tr><tr><td>. Bind to cell-adhesion molecules and</td><td></td><td>. AtyB (CRS, Mac-1, CD11b:CD18)</td><td>Neutrophils, monocytes, macrophages, NK cells</td><td>ICAM-1, iC3b, fibrinogen</td></tr><tr><td rowspan="2">extracellular matrix. . Strong adhesion</td><td rowspan="2"></td><td></td><td>ay:Bo (CR4, p150.95, CD11c:CD18)</td><td>" Dendritic cells, macrophages, neutrophils, NK cells</td><td>icab '</td></tr><tr><td></td><td></td><td>as:B (VLA-5, CD49d:CD29)</td><td>Monocytes, macrophages</td><td>. . Fibronectin</td></tr><tr><td></td><td></td><td>ICAM-1 (CD54)</td><td>Activated endothelium, activated leukocytes</td><td>- LFA-1, Mac</td></tr><tr><td></td><td rowspan="3">\CAM-1</td><td></td><td>ICAM-2 (CD102)</td><td>Resting endothelium, dendritic cells</td><td>- LA</td></tr><tr><td>Various roles in cell adhesion.</td><td>VCAM-1 (CD106)</td><td>- Activated endothelium</td><td>VLA-4</td></tr><tr><td>Ligand for integrins</td><td></td><td>PECAM (CD31)</td><td>Activated leukocytes, endothelial cell-cell junctions</td><td>cD31</td></tr></table>
======================================
<table><tr><td>virus ard</td></tr><tr><td>IFN-a, IFN-B</td></tr><tr><td>XZ Activate STAT1 and STAT2, which combine IRF9 to form ISGF3</td></tr><tr><td>Induce resistance to viral replication in all by inducing Mx proteins, 2'-5'-linked adenosine oligomers, and the kinase PKR</td></tr><tr><td>Induce expression of IFIT proteins, which suppress the translation of viral RNA</td></tr><tr><td>Increase MHC class | expression and antigen presentation in all cells</td></tr><tr><td>Activate dendritic cells and macrophages</td></tr><tr><td>Activate NK cells to kill virus-infected cells</td></tr><tr><td>Induce chemokines to recruit lymphocytes</td></tr></table>
======================================
<table><thead><th>Innate lymphoid subgroup</th><th>Inducing cytokine</th><th>Effector molecules produced</th><th>Function</th></thead><tr><td>NK cells</td><td>IL-12</td><td>IFN-y, perforin, granzyme</td><td>Immunity against viruses, intracellular pathogens</td></tr><tr><td>ILC1</td><td>IL-12</td><td>IFN-y</td><td>Defense against viruses, intracellular pathogens</td></tr><tr><td>ILC2</td><td>IL-25, IL-33, TSLP</td><td>IL-5, IL-13</td><td>Expulsion of extracellular parasites</td></tr><tr><td>ILC3, LTi cells</td><td>IL-23</td><td>IL-22, IL-17</td><td>Immunity to extracellular bacteria and fungi</td></tr></table>
======================================
<table><tr><td>A. TLR-2:TLR-1 or TLR-2:TLR-6</td><td>i. ssRNA</td></tr><tr><td>B. TLR-3</td><td>ii. Lipopolysaccharide</td></tr><tr><td>C. TLR-4</td><td>iii. Lipoteichoic acid and</td></tr><tr><td colspan="2">di-/triacyl lipoproteins</td></tr><tr><td>D. TLR-5</td><td>iv. dsRNA</td></tr><tr><td>E. TLR-7</td><td>v. Flagellin</td></tr><tr><td>F. TLR-9</td><td>vi. Unmethylated CpG DN</td></tr></table>
======================================
<table><tr><td>Electrostatic forces</td><td>Attraction between opposite charges</td></tr><tr><td>Hydrogen bonds</td><td>Hydrogen shared between electronegative atoms (N, 0)</td></tr><tr><td>Van der Waals forces</td><td>Fluctuations in electron clouds around molecules polarize neighboring atoms oppositely</td></tr><tr><td>Hydrophobic forces</td><td>Hydrophobic groups interact unfavorably with water and tend to pack together to exclude water molecules. The attraction also involves van der Waals forces</td></tr><tr><td>Cation-pi interaction</td><td>Non-covalent interaction between a cation and an electron cloud of a nearby aromatic group</td></tr></table>
======================================
<table><thead><th>Tissue</th><th>MHC class |</th><th>MHC | class Il</th></thead><tr><td colspan="3">Lymphoid tissues</td></tr><tr><td>T cells</td><td></td><td></td></tr><tr><td>B cells</td><td></td><td></td></tr><tr><td>Macrophages</td><td></td><td></td></tr><tr><td>Dendritic cells</td><td></td><td></td></tr><tr><td>Epithelial cells of thymus</td><td></td><td></td></tr></table>
======================================
<table><thead><th>Neutrophils</th><th>+++ | -</th></thead><tr><td>Hepatocytes</td><td>ar -</td></tr><tr><td>Kidney</td><td>ae —</td></tr><tr><td>Brain</td><td>oF _t</td></tr></table>
======================================
<table><tr><td>Nonnucleated cells</td></tr><tr><td>Red blood cells</td></tr></table>
======================================
<table><thead><th colspan="4">Number of functional gene segments in human immunoglobulin loci</th></thead><thead><th rowspan="2">Segment</th><th colspan="2">Light chains</th><th>Heavy chain</th></thead><thead><th></th><th>K</th><th>ru</th><th>H</th></thead><tr><td>Diversity (D)</td><td>0</td><td>0</td><td>23</td></tr><tr><td>Joining (J)</td><td>5</td><td>4-5</td><td>6</td></tr><tr><td>Constant (C)</td><td>1</td><td>4-5</td><td>9</td></tr></table>
======================================
<table><tr><td>Number of variable segments (V)</td><td>~40</td><td>~70</td><td>52</td><td>~70</td></tr><tr><td>Number of diversity segments (D)</td><td>23</td><td>0</td><td>2</td><td>0</td></tr><tr><td>Number of D segments read in three frames</td><td>rarely</td><td>-</td><td>often</td><td>-</td></tr><tr><td>Number of joining segments (J)</td><td>6</td><td>5(k) 4(A)</td><td>13</td><td>61</td></tr><tr><td>Number of joints with N- and P-nucleotides</td><td>| 2 (VD and DJ)</td><td>| 50% of joints</td><td>| 2 (VD and DJ)</td><td>1 (WJ)</td></tr><tr><td>Number of V gene pairs</td><td colspan="2">1.9 x 106</td><td colspan="2">5.8 x 106</td></tr><tr><td>Number of junctional diversity</td><td colspan="2">~3x107</td><td colspan="2">~2x10"</td></tr><tr><td>Number of total diversity</td><td colspan="2">~5x 108</td><td colspan="2">~10'8</td></tr></table>
======================================
<table><tr><td>leavy chain</td><td>N</td><td>Yo</td><td>| Ys</td><td>| v4</td><td>H</td><td>Gy</td><td>| a</td><td>8</td><td>&amp;</td></tr><tr><td>Nolecular weight (kDa)</td><td>146</td><td>146</td><td>165</td><td>146</td><td>970</td><td>160</td><td>160</td><td>184</td><td>188</td></tr><tr><td>serum level mean adult mg/ml)</td><td>9</td><td>3</td><td>1</td><td>0.5</td><td>1.5</td><td>3.0</td><td>0.5</td><td>0.03</td><td>5 |5x10</td></tr><tr><td>lalf-life in serum (days)</td><td>21</td><td>20</td><td>7</td><td>21</td><td>10</td><td>6</td><td>6</td><td>3</td><td>2</td></tr><tr><td>‘lassical pathway of complement activation</td><td></td><td>+</td><td></td><td>_</td><td></td><td>_</td><td>_</td><td>_</td><td>_</td></tr><tr><td>ternative pathway of complement activation</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td><td>+</td><td>_</td><td>_</td><td>_</td></tr><tr><td>lacental transfer</td><td>[|</td><td>+</td><td>|</td><td>4</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>sinding to macrophage and hagocyte Fc receptors</td><td>+</td><td>_</td><td>*</td><td>- +</td><td>_</td><td>*</td><td>*</td><td>-</td><td>*</td></tr><tr><td>ligh-affinity binding to nast cells and basophils</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td><td></td></tr><tr><td>teactivity with taphylococcal Protein A</td><td>+</td><td>i</td><td>- +]</td><td>+</td><td>_</td><td>_</td><td>_</td><td>_</td><td>_</td></tr></table>
======================================
<table><tr><td>True or False: A developing T cell may by both an aB heterodimer and a y6 recombine successfully.</td><td>chance express heterodimer if all the loci</td><td></td><td>B. Artemis</td><td>ii. Nuclease activity to open the DNA hairpin and generate P-nucleotides</td></tr><tr><td>Multiple Choice: Which of the following antigen-receptor recombination could be</td><td>factors involved in deleted without</td><td></td><td>Cc. TdT</td><td>iii. Recognize(s) RSS and create(s) single-stranded break</td></tr><tr><td>completing ablating antigen receptor . Artemis</td><td>formation?</td><td></td><td>D. DNA ligase IV and _ XRCC4</td><td>iv. Join(s) DNA ends</td></tr><tr><td>TdT . RAG-2 Ku XRCC4 moowp</td><td></td><td></td><td>E. DNA-PKcs</td><td>Vv. Form(s) a complex with Ku to hold DNA together and phosphorylate Artemis</td></tr><tr><td>. True or False: Both B and T cells can hypermutation of their antigen receptor in</td><td>undergo somatic the context of an</td><td>5.6</td><td colspan="2">Short Answer: What is the 12/23 rule and how does it ensure proper V(D)J segment joining?</td></tr><tr><td>immune response in order to enhance</td><td>antigen affinity.</td><td>5.7</td><td>Matching: Match the</td><td>clinical disorder to the gene defect</td></tr><tr><td>Short Answer: What four processes diversity of antibodies and B-cell</td><td>contribute to the vast receptors?</td><td></td><td>A. Ataxia telangiectasia</td><td>i. RAG-1 or RAG-2 mutations resulting in decreased recombinase activity</td></tr><tr><td>Matching: Match the protein(s) to its A. RAG-1 and RAG-2_ i.</td><td>(their) function: addition of</td><td></td><td>B. Irradiation-sensitive SCID (IR-SCID)</td><td>_ ii. ATM mutations</td></tr><tr><td>Nontemplate N-nucleotides</td><td></td><td></td><td colspan="2">C. Omenn syndrome __ iii. Artemis mutations</td></tr></table>
======================================
<table><tr><td>Ovalbumin (257-264)</td></tr><tr><td>HBV surface antigen (208-215)</td></tr><tr><td>Influenza NS2 (114-121)</td></tr><tr><td>LCMV NP (205-212)</td></tr><tr><td>VSV NP (52-59)</td></tr><tr><td>Sendai virus NP (324-332)</td></tr></table>
======================================
<table><thead><th></th><th>Human</th><th>Mouse</th><th>Expression | pattern</th><th>Associates with Bm |</th><th>Poly- morphism</th><th>F Ligand</th><th>T-cell receptor |</th><th>NK receptor</th><th>Other</th><th>a . Biological function</th></thead><tr><td rowspan="14">et</td><td>HLA-C (class 1a)</td><td></td><td>a Ubiquitous</td><td>Yes</td><td>. High</td><td>. Peptide</td><td>TCR</td><td>KIRs</td><td></td><td>Activate T cells Inhibit NK cells</td></tr><tr><td></td><td></td><td>H2-M3</td><td>— Limited</td><td>Yes</td><td>Low</td><td>fMet peptide</td><td>TCR</td><td></td><td></td><td>Activate CTLs with bacterial peptides</td></tr><tr><td></td><td></td><td>T22 T10</td><td>Splenocytes</td><td>Yes</td><td>Low</td><td></td><td>is y:6 TCR</td><td></td><td></td><td>Regulation of activated splenocytes</td></tr><tr><td></td><td>HLA-E</td><td>Qa-1</td><td>a Ubiquitous</td><td>Yes</td><td>Low</td><td>MHC leader : peptides (Qdm)</td><td></td><td>NKG2A NKG2C</td><td></td><td>NK cell inhibition</td></tr><tr><td></td><td>HLA-F</td><td></td><td>Widely expressed</td><td>Yes</td><td>Low</td><td>: Peptide?</td><td></td><td>LILRB1 LILRB2</td><td></td><td>Unknown</td></tr><tr><td></td><td>HLA-G</td><td></td><td>Maternal/fetal interface</td><td>Yes</td><td>Low</td><td>: Peptide</td><td>TCR</td><td>LILRB1</td><td></td><td>Modulate maternal/ fetal interaction</td></tr><tr><td></td><td>ee</td><td></td><td>i onocced</td><td>No</td><td>Moderate</td><td></td><td></td><td>NKG2D</td><td></td><td>Stress-induced activation of NK cells, y:6 and CD8 T cells</td></tr><tr><td></td><td></td><td></td><td>Small</td><td></td><td></td><td></td><td></td><td></td><td></td><td>. .</td></tr><tr><td></td><td></td><td>TL</td><td>5 - intestine epithelium</td><td>Yes</td><td>Low</td><td></td><td>CD8a:0</td><td></td><td></td><td>Potential modulation eet of T-cell activation</td></tr><tr><td></td><td></td><td>M10 MULT1</td><td>Vomeronasal neurons</td><td>Yes</td><td>Low</td><td>Unknown</td><td></td><td></td><td>Vomeronasal receptor V2R</td><td>Pheromone detection</td></tr><tr><td></td><td>ULBPs</td><td>Hee</td><td>a Limited</td><td>No</td><td>Low</td><td></td><td></td><td>NKG2D</td><td></td><td>Induced NK-cell- activating ligand</td></tr><tr><td rowspan="6">Non- MHC encoded</td><td></td><td></td><td>MR1</td><td>MR1</td><td>Ubiquitous</td><td>Yes</td><td></td><td>Vitamin B9 ! stabolit metabolite</td><td>a:B TCR</td><td></td><td></td><td>Control of inflammatory response</td></tr><tr><td></td><td></td><td>CDia— coie |</td><td>CDtd</td><td>a Limited</td><td>Yes</td><td>|</td><td>Lipids glycolipids |</td><td>. ™B TCR</td><td></td><td></td><td>Activate T cells against bacterial lipids</td></tr><tr><td></td><td></td><td></td><td>Milt) Mill2</td><td>Ubiqui iquitous</td><td>Yes? es?</td><td>Ll ow</td><td>Unk Inknown</td><td>Unk inknown</td><td></td><td></td><td>Unk Inknown</td></tr><tr><td></td><td>HFE</td><td>HFE</td><td>. Liver and gut</td><td>Yes</td><td>Low</td><td></td><td></td><td></td><td>; Transferrin receptor</td><td>. Iron homeostasis</td></tr><tr><td>FeRn</td><td>FeRn.</td><td>Maternaetal</td><td>Yes</td><td>Low</td><td></td><td></td><td></td><td>Fe (IgG)</td><td>Shuttle maternal IgG to fetus (passive immunity)</td></tr><tr><td></td><td>ZAG epcr |</td><td>ZAG epcr |</td><td>Bodily fluid Endothelial</td><td>No No</td><td>Low</td><td>Fatty acid</td><td>v8 TCR</td><td></td><td>Protein C</td><td>Lipid homeostasis Blood coagulation</td></tr></table>
======================================
<table><tr><td>722,710</td><td>Mouse</td><td>Various</td></tr><tr><td>|-E (MHC class Il)</td><td>Mouse</td><td>Clones</td></tr><tr><td>Phycoerythrin (PE)</td><td>Mouse</td><td>Various</td></tr><tr><td>Cardiolipin</td><td>Mouse</td><td>Various</td></tr><tr><td>Keratinocytes</td><td>Mouse</td><td>DETC Vy5V81</td></tr><tr><td>HSV-gl</td><td>Mouse</td><td>Clone</td></tr><tr><td>Skint-1</td><td>Mouse</td><td>Vy5V81</td></tr><tr><td>MICA/MICB</td><td>Human</td><td>Clones</td></tr><tr><td>ULBP4</td><td>Human</td><td>Vy9V52</td></tr><tr><td>CD1-sulfatide</td><td>Human</td><td>Vé1</td></tr><tr><td>EPCR (endothelial protein C receptor)</td><td>Human</td><td>Clones</td></tr><tr><td>Phosphoantigens, amino-bisphosphonates</td><td>Human</td><td>Vy9V52</td></tr><tr><td>Alkylamines</td><td>Human</td><td>Vy9V52</td></tr></table>
======================================
<table><tr><td>SH2</td><td>Lek, ZAP-70, Fyn, Src, Grb2, PLC-y, STAT, Chl, Btk, Itk, SHIP, Vav, SAP, PI3K</td><td>phosphotyrosine</td><td>PpYXXZ</td></tr><tr><td>SH3</td><td>Lek, Fyn, Src, Grb2, Btk, itk, Tec, Fyb, Nek, Gads</td><td>: proline</td><td>PXXP</td></tr><tr><td>PH</td><td>Tec, PLC-y, Akt, Btk, Itk, Sos</td><td>phosphoinositides</td><td>PIP;</td></tr><tr><td>PX</td><td>p4ort, p4z7Phox pip</td><td>phosphoinositides</td><td>PI(3)P</td></tr><tr><td>PDZ</td><td>CARMA1</td><td>C termini of proteins</td><td>IESDV, VETDV</td></tr><tr><td>Ct</td><td>RasGRP, PKC-0</td><td>membrane lipid</td><td>diacylglycerol (DAG) phorbol ester</td></tr><tr><td>NZF</td><td>TAB2</td><td>polyubiquitin (K63-linked)</td><td>polyubiquitinated RIP, TRAF-6, or NEMO</td></tr></table>
======================================
<table><tr><td>&gt;H/PX</td><td></td><td>PLC-y</td></tr><tr><td>SH2</td><td></td><td>ADAP.</td></tr><tr><td colspan="3">vav PI 3-kinase</td></tr><tr><td>_AT:Gads:SLP-76</td><td>Akt</td><td></td></tr></table>
======================================
<table><tr><td>A.</td><td>Ras</td><td>i.. WASp; actin polymerizatior</td></tr><tr><td>B. (Rho</td><td>Cdc42 family)</td><td>ii. mTOR; cellular metabolism</td></tr><tr><td>Cc.</td><td>Rap1</td><td>iii. LFA-1 aggregation;</td></tr><tr><td></td><td></td><td>cellular adhesion</td></tr><tr><td>D.</td><td>Rheb</td><td>iv. MAPK pathway;</td></tr><tr><td></td><td></td><td>cellular proliferation</td></tr></table>
======================================
<table><tr><td>CD8e:CD36:(CD3y)2:(CD3t).</td><td>A.</td><td></td></tr><tr><td colspan="3">B. CD21:CD19:CD8</td></tr><tr><td colspan="3" rowspan="2">CD28 D. Cc. Blk,</td></tr><tr><td colspan="3"></td></tr><tr><td>E.</td><td>Fyn, Syk</td><td>Lyn</td></tr><tr><td>LAT:Gads:SLP-76</td><td>F.</td><td></td></tr></table>
======================================
<table><tr><td colspan="9">pre-B receptor 7” ° ” . \</td></tr><tr><td></td><td>H-chain genes</td><td>. Germline</td><td>D-J rearranging</td><td>V-DJ rearranging</td><td>VDJ rearranged</td><td>VDJ rearranged</td><td>VDJ rearranged</td><td>VDJ rearranged</td></tr><tr><td></td><td>con</td><td>Germline</td><td>Germline</td><td>Germline</td><td>Germline</td><td>reawanging</td><td>W rearranged |</td><td>| VJ rearranged</td></tr><tr><td></td><td>Surface Ig</td><td>Absent</td><td>Absent</td><td>Absent</td><td>chain transiently at surface as part recentor Mainly intracellular</td><td>Intracelar H</td><td>IgM expressed on cell surface</td><td>sieht alternatively spliced H-chain transcripts</td></tr><tr><td></td><td>specific</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tot |</td><td>N-nucleotide _aacton</td><td></td><td>»</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>light-chain</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>ab |</td><td></td><td></td><td></td><td></td><td>—EEEEEEEee</td><td></td><td></td><td></td></tr><tr><td></td><td>signal transduction</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>e019</td><td></td><td></td><td></td><td></td><td>_- ll</td><td></td><td></td><td></td></tr><tr><td colspan="9">factor 7m || eee ee</td></tr><tr><td>e024</td><td>Unknown</td><td></td><td></td><td>_</td><td>EEE</td><td></td><td></td><td></td></tr><tr><td>Bet ||</td><td>Amino- petidase</td><td></td><td></td><td></td><td></td><td>—</td><td></td><td></td></tr></table>
======================================
<table><tr><td>When first produced</td><td>Fetus</td><td>After birth</td><td>After birth</td></tr><tr><td>N regions in VDJ junctions</td><td>Few</td><td>Extensive</td><td>Yes</td></tr><tr><td>\V-region repertoire</td><td>Restricted</td><td>Diverse</td><td>Partly restricted</td></tr><tr><td>P i Erimary)focation</td><td>Body cavities (peritoneal, pleural)</td><td>Secondary lymphoid organs</td><td>Spleen</td></tr><tr><td>Dependence on BAFF</td><td>No</td><td>Yes</td><td>Yes</td></tr><tr><td>Dependence on IL-7</td><td>No</td><td>Yes</td><td>Yes</td></tr><tr><td>Mode of renewal</td><td>Self-renewing</td><td>Replaced from bone marrow</td><td>Long-lived</td></tr><tr><td>Spontaneous production of immunoglobulin</td><td>7 High</td><td>Low</td><td>Low</td></tr><tr><td>lsotypes secreted</td><td>IgM &gt;&gt; IgG</td><td>IgG &gt; IgM</td><td>IgM &gt; IgG</td></tr><tr><td>Response to carbohydrate antigen</td><td>Yes</td><td>Maybe</td><td>Yes</td></tr><tr><td>Response to protein antigen</td><td>Maybe</td><td>Yes</td><td>Yes</td></tr><tr><td>Requirement for T-cell help</td><td>No</td><td>Yes</td><td>Sometimes</td></tr><tr><td>Somatic hypermutation</td><td>Low to none</td><td>High</td><td>?</td></tr><tr><td>Memory development</td><td>Little or none</td><td>Yes</td><td>2</td></tr></table>
======================================
<table><tr><td colspan="2">Loe |</td></tr><tr><td colspan="2">Dto Jp</td></tr><tr><td colspan="2">Vto DJs</td></tr><tr><td colspan="2">VtoJ,</td></tr><tr><td colspan="2">Vto J, and V to DJs,</td></tr><tr><td></td><td>GATA3</td></tr><tr><td></td><td>Bel11b</td></tr><tr><td colspan="2" rowspan="2">KLF2 ThPOK</td><td colspan="2"></td></tr><tr><td></td><td>Runx3</td></tr><tr><td></td><td>SiS</td></tr><tr><td>Kit</td><td>Signaling</td></tr><tr><td>Notch</td><td>Signaling</td></tr><tr><td>pta_||</td><td>Surat</td></tr><tr><td>cD3</td><td>Signaling</td></tr><tr><td>cD4</td><td></td></tr><tr><td>cD8</td><td>Co-receptor</td></tr><tr><td>IL-7R</td><td>Signaling</td></tr><tr><td colspan="2">ZAP-70</td></tr><tr><td colspan="2">Syk</td></tr><tr><td colspan="2">licks trneduation</td></tr><tr><td colspan="2">Fyn</td></tr><tr><td colspan="2">cD2</td></tr><tr><td>RAG-1/2 ||</td><td>LmPhoid specific</td></tr></table>
======================================
<table><thead><th>106</th><th>V6</th><th>W4andV,1 VPM</th><th>Vy1,2,4</th><th>AS and V7</th></thead><thead><th colspan="5">105 104</th></thead><tr><td>108 Days of gestation</td><td></td><td>Birth</td><td colspan="2">1 2 Weeks of age</td></tr><tr><td>Stem cells in fetus Days 14-18 of development</td><td>Vs1Ds2J52 Ca Vy5Jyt Cyl</td><td></td><td colspan="2">y:6 T cells become established in skin epidermis and are programmed to secrete keratinocyte growth factor, and inflammatory cytokines and chemokines</td></tr><tr><td>ZF Stem cells in fetus Days 16-19 of</td><td></td><td>L</td><td></td><td>&lt;7 y:5 T cells become established in mucosal epithelia, including reproductive tract, lung, and skin and are</td></tr><tr><td>development</td><td>a</td><td>7</td><td></td><td>dermis, programmed to secrete IL-17</td></tr><tr><td>7 Stem cells predominant in fetus and newborn, rare in adult Vs</td><td>2-7Ds1Dg2J52 C5 V4 Syl Cyl</td><td></td><td></td><td>Z&amp; y:6 cells home to lymph nodes, spleen, lung, and skin dermis and are programmed to secrete IL-17</td></tr><tr><td>Starting day 17 of development</td><td>Vs6 Dsl Ds2Js2 Cg, q Ll Vl dy Cy</td><td>—</td><td></td><td>y:6 cells home to lymph nodes, spleen, lung, and liver and are programmed to secrete IL-4 and IFN-y</td></tr><tr><td>Stem cells in adult Vs</td><td>2-7Ds1Dg2J52 C5 V4 Syl Cyl</td><td></td><td colspan="2">y:6 cells home to lymph nodes and spleen and are programmed to secrete IFN-y</td></tr><tr><td>Starting during late fetal development Vs</td><td>2-7Ds1Dg2J52 C5 q I Wy? dy Cy</td><td>—</td><td colspan="2">y:6 cells home to intestinal epithelium and are programmed to secrete FN-y</td></tr></table>
======================================
<table><tr><td>A. Early pro-B cell</td><td>i. V-DJ rearranging (heavy chain)</td></tr><tr><td>B. Small pre-B cell</td><td>ii. D-J rearranging (heavy chain)</td></tr><tr><td>C. Immature B cell</td><td>iii. Expressing pre-B-cell receptor</td></tr><tr><td>D. Late pro-B cell</td><td>iv. V-J rearranging (light chain)</td></tr><tr><td>E. Large pre-B cell</td><td>v. Surface IgM</td></tr></table>
======================================
<table><thead><th rowspan="2">Receptor</th><th></th><th colspan="5">Effects seen in knockout (KO) mice</th></thead><thead><th></th><th>a Ligands</th><th>Spleen</th><th>Peripheral fran man</th><th>Mi teri famphTncda</th><th>4 Peyer's patch</th><th>Follicular dendriti | TOucul cai GuiTS</th></thead><tr><td>TNFR-I</td><td>_ 1 3</td><td>. are</td><td>Present in TNF-«. KO Absent in LT-a. KO owing to lack of LT-B signals</td><td>Present</td><td>Reduced</td><td>Absent</td></tr><tr><td>LT-B receptor</td><td>TNF-a. LT-ay:B</td><td>Distorted architecture No marginal zones</td><td>Absent</td><td>Present in LT-B KO Absent in LT-B receptor KO</td><td>Absent</td><td>Absent</td></tr></table>
======================================
<table><thead><th>Immunoglobulin</th><th>superfamily</th><th>Tissue distribution</th><th>Ligand</th></thead><tr><td>IcAM1/3,</td><td></td><td>T cells</td><td>CD58 (LFA-3)</td></tr><tr><td rowspan="5">VCAMI CD58</td><td></td><td>Activated vessels. lymphocytes, dendritic cells</td><td>LFA-1, Mac-1</td></tr><tr><td></td><td>= =cD2</td><td>Resting vessels</td><td>LFA-1</td></tr><tr><td></td><td></td><td>Naive T cells</td><td>LFA-1</td></tr><tr><td></td><td></td><td>Lymphocytes, antigen-presenting cells</td><td>c2</td></tr><tr><td></td><td></td><td>Activated endothelium</td><td>VLA-4</td></tr></table>
======================================
<table><tr><td>Antigen uptake</td><td>+++ Macropinocytosis , and phagocytosis by tissue dendritic cells</td><td>+++ Macropinocytosis - +++ Phagocytosis</td><td>Antigen-specific receptor (Ig) +444</td></tr><tr><td>ths expression</td><td>Low on tissue-resident dendritic cells High on dendritic cells in lymphoid tissues</td><td>- bactera ‘and eytkines —to +44</td><td>an Increases n aethaton to te 0 tet</td></tr><tr><td>Co-stimulation delivery</td><td>Inducible | High on dendritic cells in lymphoid tissues +444</td><td>Inducible —t0 +44</td><td>Inducible — to +44</td></tr><tr><td>Location</td><td>Ubiquitous throughout the body</td><td>Lymphoid tissue Connective tissue Body cavities</td><td>aa Lymphoid vou P</td></tr><tr><td>“fect</td><td>Results in activation of naive T cells</td><td>Results in activation of macrophages</td><td>Results in delivery of help to B cell</td></tr></table>
======================================
<table><thead><th colspan="2">CD8 T cells: peptide + MHC class |</th><th rowspan="3">Cytotoxic (killer) Cytotoxic effector molecules</th><th colspan="8">CD4 T cells: peptide + MHC class II</th></thead><thead><th></th><th>T cells</th><th colspan="2">Ty1 cells</th><th colspan="2">Ty2 cells</th><th colspan="2">Ty17 cells</th><th colspan="2">Treg cells</th></thead><thead><th></th><th>Others</th><th>RECS RHecinte Tialecules</th><th>Others</th><th>Barrier immunity activating effector molecules</th><th>Others</th><th>Barrier immunity activating effector molecules, neutrophil recruitment</th><th>Others</th><th>Suppressive ey Okie</th><th>Others</th></thead><tr><td>Perforin Granzymes Granulysin Fas ligand</td><td>mr . TWF-ce</td><td>Fy one GD40 ligand | ig</td><td>i CXCL2 (GROB) |)</td><td>IL-4 IL-5 IL-13 pad figand</td><td>McsF iL-10 TGF-B | coLt1 (eotaxin) | CCL17 (TARC)</td><td>IL-7A IL-A7E IL-22 | CD40 ligand</td><td>te CcL20</td><td>L-10 TGF-B</td><td>135</td></tr></table>
======================================
<table><tr><td>Interleukin-2 5 (ea)</td><td>Naive, Ty1 * No) some CD8</td><td>Stimulates growth and J-chain synthesis</td><td></td><td></td><td>Stimulates NK sell growth</td><td>-</td><td>Impaired Treg cell development and function</td></tr><tr><td>Gee rl</td><td>Tut, Tey, CTL</td><td>Differentiation IgG2a synthesis (mouse)</td><td>Inhibits Ty2 | and Ty17 cell differentiation</td><td></td><td>. Activates NK cells</td><td>Antiviral TMC class | and class Il</td><td>Susceptible to mycobacteria, some viruses</td></tr><tr><td>Lymphotoxin-c. (LT-a, TNF-B)</td><td>Ti, some CTL</td><td>Inhibit nnubits</td><td>Kil HS</td><td></td><td>Activates neutrophils</td><td>sibroti ees and tumor cells</td><td>imp nodes Disorganized spleen</td></tr><tr><td>Interleukin-4 (IL-4)</td><td>TH2, Tr</td><td></td><td></td><td>Promotes marginal zone macrophage activation</td><td>TGrowth of mast cells</td><td>-</td><td>No Tw?</td></tr><tr><td>ane ia</td><td>TH2</td><td>Mouse: Differentiation IgA synthesis</td><td>-</td><td>-</td><td></td><td>-</td><td>Reduced eosinopnilia</td></tr><tr><td>F ecae</td><td>Tu2</td><td>et Ie</td><td>-</td><td>Promotes marginal zone macrophage</td><td>-</td><td></td><td>Impaired helminth expulsion</td></tr><tr><td>. ne Eman</td><td>Ti17</td><td>Promotes IgG2a, IgG2b, IgG3 (mouse)</td><td>-</td><td>-</td><td></td><td></td><td>Impaired antibacterial defense</td></tr><tr><td>F a</td><td>Til7</td><td>-</td><td>-</td><td>-</td><td>-</td><td></td><td>Impaired antibacterial defense</td></tr><tr><td>— ransforming growth factor-B (TGF-B)</td><td>Treg</td><td></td><td></td><td>a anette</td><td>. pctv P</td><td>Inhibits/ inhibi stimulates cell growth</td><td>Impaired Treg cell levelopmen Multi-organ auto- immunity and death ~10 weeks</td></tr><tr><td>Interleukin-10 ((L-10)</td><td>Treg, some Ty1, Ty2,Ta17, CTL</td><td>| TMHCclassit</td><td>ani | Inhibits Trt</td><td></td><td>Co-stimulates mast cell growth</td><td>_</td><td>(BD</td></tr><tr><td>Interleukin-3 (IL-3)</td><td>Tul, TH2, TH17, some CTL</td><td>_</td><td>_</td><td></td><td></td><td>-</td><td>-</td></tr><tr><td>mf P fo aa a (TNF-a)</td><td>Tul, TH17, some Ty2, some CTL</td><td>-</td><td>-</td><td></td><td></td><td>Activates microvascular endothelium</td><td>Susceptibility to Gram —ve sepsis</td></tr><tr><td>Granulocyte- macrophage clornsuraalatin factor (GM-CSF) ‘</td><td>Tul, Ty17, some Tx2, some CTL</td><td>Differentiation |</td><td>ini Inhibits growth? |</td><td>Activation ii iati Differentiation to dendritic cells</td><td></td><td>-</td><td>-</td></tr></table>
======================================
<table><thead><th>Protein in granules of cytotoxic T cells</th><th>Actions on target cells</th></thead><tr><td>Perforin</td><td>Aids in delivering contents of granules into the cytoplasm of target cell</td></tr><tr><td>Granzymes</td><td>Serine proteases, which activate apoptosis once in the cytoplasm of the target cell</td></tr><tr><td>Granulysin</td><td>Has antimicrobial actions and can induce apoptosis</td></tr></table>
======================================
<table><tr><td>CAD</td><td>necrotic</td><td>caspase 3</td></tr><tr><td>intrinsic</td><td>LT-a</td><td>proton gradient</td></tr><tr><td>apoptotic</td><td>caspase 9</td><td>ICAD</td></tr><tr><td>apoptosome</td><td>extrinsic</td><td>TNF-@</td></tr><tr><td>FasL</td><td>perforins</td><td>BID</td></tr><tr><td>cytochrome c</td><td>hypoxia</td><td></td></tr></table>
======================================
<table><tr><td>Of Resting B cell</td><td>High</td><td>Yes</td><td>No</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>©) Re &lt; Plasmablast</td><td>High</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Unknown</td><td>Yes</td></tr><tr><td>Plasma cell ©) Ww</td><td>Low</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>No</td></tr></table>
======================================
<table><thead><th>Cytokines</th><th>IgM</th><th>IgG3</th><th>IgG1</th><th>IgG2b</th><th>IgG2a</th><th>IgE</th><th>IgA</th></thead><tr><td>IL-4</td><td></td><td></td><td>Induces</td><td></td><td>[ts |</td><td>Induces</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>Augments production</td></tr><tr><td></td><td></td><td>Induces</td><td></td><td></td><td>Induces</td><td>[amas</td><td>|</td></tr><tr><td></td><td></td><td></td><td></td><td>Induces</td><td></td><td></td><td>Induces</td></tr><tr><td>IL-21</td><td></td><td>Induces</td><td>Induces</td><td></td><td></td><td></td><td>Induces</td></tr></table>
======================================
<table><tr><td>Antibody response in infants</td><td>Yes</td><td>Yes</td><td>No</td></tr><tr><td>Antibody production in congenitally athymic individual</td><td>No</td><td>Yes</td><td>Yes</td></tr><tr><td>Antibody response in absence of all T cells</td><td>No</td><td>Yes</td><td>Yes</td></tr><tr><td>Primes T cells</td><td>Yes</td><td>No</td><td>No</td></tr><tr><td>Polyclonal B-cell activation</td><td>No</td><td>Yes</td><td>No</td></tr><tr><td>Requires repeating epitopes</td><td>No</td><td>No</td><td>Yes</td></tr><tr><td>Examples of antigen</td><td>Diphtheria toxin Viral hemagglutinin Purified protein derivative (PPD) of Mycobacterium tuberculosis</td><td>Bacterial lipopoly- saccharide Brucella abortus</td><td>Pneumococcal polysaccharide Salmonella polymerized flagellin Dextran Hapten-conjugated Ficoll (polysucrose)</td></tr></table>
======================================
<table><tr><td>Neutralization</td><td></td></tr><tr><td>Opsonization</td><td></td></tr><tr><td>Sensitization for killing by NK cells</td><td></td></tr><tr><td>Sensitization of mast cells</td><td></td></tr><tr><td>Activates complement system</td><td></td></tr><tr><td>Transport across epithelium</td><td></td></tr><tr><td>Transport across placenta</td><td></td></tr><tr><td>Diffusion into extravascular sites</td><td>+/-</td></tr><tr><td>Mean serum level (mgemt-*)</td><td>1.5</td></tr></table>
======================================
<table><tr><td>crater S</td><td>Clostridium tetani</td><td>Tetanus toxin</td><td>Blocks inhibitory neuron action, leading to chronic muscle contraction</td></tr><tr><td>Diphther: (MUTE)</td><td>Corynebacterium diphtheriae</td><td>Diphtheria toxin</td><td>Inhibits protein synthesis, leading to epithelial cell damage and myocarditis</td></tr><tr><td>Gas gangrene</td><td>Clostridium perfringens</td><td>Clostridial toxin</td><td>Phospholipase activation, leading to cell death</td></tr><tr><td>Cholera</td><td>Vibrio ‘halk cholerae</td><td>Cholera toxi ‘oxin</td><td>Activates adenylate cyclase, elevates cAMP in cells, leading to changes in intestinal epithelial cells that result in loss of water and electrolytes</td></tr><tr><td>‘Anthrax</td><td>Bacillus anthracis</td><td>Anthrax toxic complex</td><td>Increases vascular permeability, leading to edema, hemorrhage, and circulatory collapse</td></tr><tr><td>Botulism</td><td>Clostridium botulinum</td><td>Botulinum toxin</td><td>Blocks release of acetylcholine, leading to paralysis</td></tr><tr><td>Whooping cough</td><td>Bordetella pertussis</td><td>Pertussis toxin Tracheal cytotoxin</td><td>ADP-ribosylation of G proteins, leading to lymphoproliferation Inhibits cilia and causes epithelial cell loss</td></tr><tr><td rowspan="2">Scarlet fever</td><td></td><td rowspan="2">Streptococcus pyogenes</td><td></td><td>Erythrogenic ‘oxin</td><td>Vasodilation, leading to scarlet fever rash</td></tr><tr><td>di sieptanins</td><td>Kill phagocytes, allowing bacterial survival</td></tr><tr><td>Food Poisoning</td><td>Staphylococcus | aureus</td><td>Staphylococcal | enterotoxin</td><td>Acts on intestinal neurons to induce vomiting. Also a potent T-cell mitogen (SE superantigen)</td></tr><tr><td>Toxic-shock syndrome</td><td>| Staphylococcus aureus</td><td>| Toxic-shock syndrome toxin |</td><td>Causes hypotension and skin loss. Also a potent T-cell mitogen (TSST-1 superantigen)</td></tr></table>
======================================
<table><tr><td rowspan="2">Structure</td><td>a. 72kDa Y</td><td>a 40kDa 4</td><td>;</td><td>4</td><td>a. 50-70 kDa or H yors</td><td>a 45 kDa H B 33 kDa y 9kDa</td><td>lectin trimer domain 8 oo</td><td>a. 55-75 kDa ; y 9kDa</td><td>a. 70kDa 0</td></tr><tr><td></td><td>H w</td><td>J y-lke domain</td><td>(mm</td><td>‘i TIM</td><td>i I wo</td><td>fit I HH</td><td>N</td><td>zi w</td><td></td></tr><tr><td>Binding</td><td>IgG1</td><td>IgG</td><td>IgGt</td><td>IgG</td><td>IgG</td><td>IgE</td><td>IgE</td><td>IgAt, IgA2</td><td>IgA, IgM</td></tr><tr><td>Order of affinity</td><td>10° 1) IgG1=I9G3 2) IgG4 3) IgG2</td><td>2x 108M 1) IgG 2)IgG3=IgG2* 3) IgG4</td><td>2x 108M 1)IgGt=IgG3 | 2) IgG4 3) IgG2</td><td>2x 108M" | 1) IgGi=IgG3 2) IgG4 3) IgG2</td><td>5x 105M | IgGt=I1gG3</td><td>10° wt</td><td>2-7 x10’M"} (trimer) 2-7 x 108M! (monomer)</td><td>107M" IgA1=IgA2</td><td>3x 109M" 1) IgM 2) IgA</td></tr><tr><td>Cell type</td><td>Macrophages | Neutrophils Eosinophils</td><td>Macrophages Neutrophils Eosinophils Platelets Langerhans cells</td><td>| Macrophages Neutrophils Eosinophils</td><td>B cells Mast cells</td><td>NK cells Eosinophils Macrophages Neutrophils Mast cells</td><td>Mast cells Basophils</td><td>Eosinophils B cells</td><td>Macrophages | Eosinophilst Neutrophils</td><td>Macrophages B cells</td></tr><tr><td>Effect of ligation</td><td>Uptake Stimulation Activation of respiratory burst] Induction of killing</td><td>Uptake Granule release (eosinophils)</td><td>Uptake Inhibition of stimulation</td><td>No uptake Inhibition of stimulation</td><td>Induction of killing (NK cells)</td><td>Secretion of granules</td><td>Degranulation</td><td>Uptake Induction of killing</td><td>Uptake</td></tr></table>
======================================
<table><thead><th></th><th colspan="2">Source of B cells</th></thead><thead><th></th><th>Unimmunized donor Primary response</th><th>Immunized donor Secondary response</th></thead><tr><td>Frequency of antigen-specific B cells</td><td>-194 “195 1:10" - 1:10</td><td>“1092 “193 1:10° — 1:10</td></tr><tr><td>Isotype of antibody produced</td><td>IgM &gt; IgG</td><td>IgG, IgA</td></tr><tr><td>Affinity of antibody</td><td>Low</td><td>High</td></tr><tr><td>Somatic hypermutation</td><td>Low</td><td>High</td></tr></table>
======================================
<table><tr><td>cD44</td><td></td><td>Cell-adhesion molecule</td></tr><tr><td>CD45RO</td><td></td><td>Modulates T-cell receptor signaling</td></tr><tr><td></td><td></td><td>Modulates T-cell receptor signaling</td></tr><tr><td></td><td></td><td>Receptor for homing to lymph node</td></tr><tr><td></td><td></td><td>Chemokine receptor for homing to lymph node</td></tr><tr><td></td><td></td><td>Early activation antigen</td></tr><tr><td></td><td></td><td>Promotes cell survival</td></tr><tr><td>Interferon-y</td><td></td><td>Effector cytokine; mRNA present and protein made on activation</td></tr><tr><td>Granzyme B</td><td>-</td><td>Effector molecule in cell killing</td></tr><tr><td>FasL</td><td>-</td><td>Effector molecule in cell killing</td></tr><tr><td>cD122</td><td>+/—</td><td>Part of receptor for IL-15 and IL-2</td></tr><tr><td>cD25</td><td></td><td>Part of receptor for IL-2</td></tr><tr><td></td><td></td><td>Part of receptor for IL-7</td></tr><tr><td></td><td></td><td>GPl-linked protein</td></tr><tr><td></td><td></td><td>Receptor for chemokine CXCL12; controls tissue migration</td></tr><tr><td></td><td></td><td>Receptor for chemokines CCL3 and CCL4; tissue migration</td></tr><tr><td></td><td></td><td>Cell surface receptor</td></tr></table>
======================================
<table><tr><td></td><td>Nonspecific Innate No memory No specific T cells</td><td>Nonspecific + specific Inducible No memory No specific T cells</td><td>Specific Inducible Memory Specific T cells</td></tr><tr><td>Barrier functions</td><td>Skin, epithelia, mucins, | acid</td><td>Local inflammation (C5a) Local TNF-o</td><td>IgA antibody in luminal spaces IgE antibody on mast cells Local inflammation</td></tr><tr><td>Response to extracellular pathogens</td><td>Phagocytes Alternative and MBL complement pathway | Lysozyme Lactoferrin Peroxidase Defensins</td><td>Mannan-binding lectin C-reactive protein T-independent B-cell antibody Complement</td><td>IgG antibody and Fe receptor- bearing cells IgG, IgM antibody + classical complement pathway</td></tr><tr><td>Response to intracellular bacteria</td><td>Macrophages</td><td>Activated NK- dependent macrophage activation IL-1, IL-6, TNF-a, IL-12</td><td>T-cell activation of macrophages by IFN-y</td></tr><tr><td>Response to virus-infected cells</td><td>Natural killer (NK) cells</td><td>| IFN-c and IFN-B IL-12-activated NK cells</td><td>Cytotoxic T cells IFN-y</td></tr></table>
======================================
<table><tr><td>A.</td><td>__</td><td>IL-4 and</td><td>IL-13</td><td></td><td>i. STATS</td></tr><tr><td></td><td>B._IL-12</td><td></td><td></td><td></td><td>ii. STAT4</td></tr><tr><td>Cc.</td><td>__IL-23</td><td></td><td></td><td></td><td>iii. STATS</td></tr><tr><td>D.___</td><td></td><td>TSLP,</td><td>IL-2, and</td><td>IL-7</td><td>iv. STAT6</td></tr></table>
======================================
<table><tr><td rowspan="3">Anatomical features</td><td>Intimate interactions between mucosal epithelia and lymphoid tissues</td></tr><tr><td></td><td>Discrete compartments of diffuse lymphoid tissue and more organized structures such as Peyer’s patches, isolated lymphoid follicles, and tonsils</td></tr><tr><td></td><td>Specialized antigen-uptake mechanisms, e.g., M cells in Peyer's patches, adenoids, and tonsils</td></tr><tr><td rowspan="4">Effector mechanisms</td><td>Activated/memory T cells predominate even in the absence of infection</td></tr><tr><td></td><td>Multiple activated ‘natural’ effector/regulatory T cells present</td></tr><tr><td></td><td>Secretory IgA antibodies</td></tr><tr><td></td><td>Presence of distinctive microbiota</td></tr><tr><td rowspan="2">Immunoregulatory environment</td><td></td><td>Active downregulation of immune responses (e.g., to food and other innocuous antigens) predominates</td></tr><tr><td>Inhibitory macrophages and tolerance-inducing dendritic cells</td></tr></table>
======================================
<table><tr><td>. Antigen</td><td>Invasive bacteria, viruses, toxins</td><td>Food proteins; commensal bacteria</td></tr><tr><td>Primary Ig production</td><td>. Seoul an present in serum</td><td>Some local IgA Low or no Ab in serum</td></tr><tr><td>response P Response</td><td>and memory T cells Enhanced</td><td>T-cell response one</td></tr><tr><td>to antigen reexposure</td><td>(memory) response</td><td>cystemi c response</td></tr></table>
======================================
<table><thead><th>Decrease IgE, Ty2 responses</th></thead><tr><td>Increase Treg</td></tr><tr><td>Increase bone remodeling</td></tr><tr><td>Carbohydrate lipid metabolism</td></tr><tr><td>Insulin sensitivity</td></tr><tr><td>Myelopoiesis</td></tr><tr><td>Hypothalamus-pituitary-adrenal axis</td></tr><tr><td>Arthritis</td></tr><tr><td>Experimental autoimmune encephalomyelitis</td></tr><tr><td>Inflammatory bowel disease</td></tr><tr><td>Atopy, asthma</td></tr><tr><td>Metabolic disease</td></tr><tr><td>Cardiovascular disease</td></tr><tr><td>Type | diabetes (reduced by microbiota)</td></tr></table>
======================================
<table><tr><td>Unpurified CD4* T cells</td><td>=</td><td>cP</td><td>No</td></tr><tr><td>Purified CD4*CD45RB" T cells</td><td>ae</td><td>+</td><td>Colitis</td></tr><tr><td>Purified CD4*CD45RB" T cells + (CD25*/FoxP3*) Tog</td><td>_</td><td>+</td><td>No</td></tr><tr><td>CD4*CD45RB""T cells + CD4*CD45RB"T,o,</td><td>_</td><td>+</td><td>No</td></tr><tr><td>CD4*CD45RB""T cells + CD4*CD45RB"° Treg</td><td>+</td><td>+</td><td>Colitis</td></tr><tr><td>CD4*CD45RB""'T cells</td><td>a</td><td>a</td><td>No</td></tr></table>
======================================
<table><tr><td>Severe combined immune deficiency</td><td>See text and</td><td>Fig. 13.2</td><td>General</td></tr><tr><td>DiGeorge's syndrome</td><td>Thymic aplasia</td><td>Variable numers</td><td>General</td></tr><tr><td>ae</td><td>Wisin</td><td>| wocosroas |</td><td>Gren ura ard</td></tr><tr><td>Aber u</td><td>Lack af expression</td><td>No CD4T cells</td><td>General</td></tr><tr><td></td><td>X-linked; defective WASp gene</td><td>polysaccharide antibody, impaired T-cell Defective anti- activation responses, and T,.g dysfunction</td><td>Encapsulated extracellular bacteria ial dst OT</td></tr><tr><td></td><td>Loss of BTK tyrosine kinase</td><td>No B cells</td><td>Extracellular bacteria, enteroviruses</td></tr><tr><td></td><td>a AID deficiency UNG deficiency</td><td>No isotype switching +/- normal somatic hypermutation</td><td>Extracellular bacteria</td></tr><tr><td></td><td>Defective STAT3</td><td>Block in T,17 cell differentiation Elevated IgE</td><td>Extracellular bacteria 4 and fungi</td></tr><tr><td></td><td>Mutations in TACI, ICOS, CD19, etc.</td><td>Defective IgA and IgG production</td><td>Extracellular bacteria</td></tr><tr><td></td><td>Unknown; MHC-linked</td><td>No IgA synthesis</td><td>Respiratory infections</td></tr><tr><td>Phagocyte deficiencies</td><td>i Many different</td><td>Loss of phagocyte function</td><td>Extracellular bacteria and fungi</td></tr><tr><td>Complement deficiencies</td><td>. Many different</td><td>Loss of specific complement components |</td><td>Extracellular bacteria especially Neisseria spp.</td></tr><tr><td>X-linked Iympho- proliferative syndrome</td><td>Mutations in SAP or XIAP</td><td>Inability to control | B-cell growth</td><td>EBV-crWven B-cell tumors mononucleosis</td></tr><tr><td>Ataxia telangiectasia</td><td>Fane i Mutations in ATM</td><td>T cells reduced</td><td>Respiratory infections</td></tr><tr><td>1 Bloom's syndrome</td><td>Defective DNA helicase</td><td>T cells reduced Reduced antibody levels</td><td>Respiratory infections</td></tr></table>
======================================
<table><tr><td>STAT3 deficiency; hyper-IgE syndrome (Job's disease)</td><td>STAT3</td><td>Autosomal dominant</td><td>Deficit of IL-17 producing Ty17 and ILC3 cells; hyper-IgE</td><td>CMC, Staph. aureus, Aspergillus</td></tr><tr><td>WL-12p40 deficiency</td><td>W128</td><td>Autosomal recessive</td><td>| Tty'ang LCS cals"</td><td>exaceldar bacteria, OMC</td></tr><tr><td>i IL-12Rp deficiency</td><td>IL12RB1</td><td>a Autosomal recessive</td><td>Deficit of IL-17 producin Tyl7 and ILC3 Oise 9</td><td>Intracellular and extracellular bacteria, CMC</td></tr><tr><td>IL-17RA deficiency</td><td>IL17RA</td><td>Autosomal recessive</td><td>No IL-17 response</td><td>CMC, pyogenic bacteria</td></tr><tr><td>J acl 4 IL-17F deficiency (partial)</td><td>IL17F</td><td>i Autosomal recessive</td><td>Impaired IL-17F and IL-174/F function</td><td>cmc. ic bacteri , pyogenic bacteria</td></tr><tr><td>=F CARDO deficiency</td><td>CARDO</td><td>i Autosomal recessive</td><td>Deficit of IL-17 producing 7,17 and ILC3 cells</td><td>CMC and severe Candida/ dermatophyte infections</td></tr><tr><td>STAT1 gain-of-function (GOF) mutation</td><td>STATI</td><td>7 Autosomal dominant</td><td>Deficit of IL-17 producing T,17 and ILC3 cells**</td><td>A ‘ CMC, pyogenic bacteria</td></tr><tr><td>APECED syndrome</td><td>AIRE</td><td>Autosomal recessive</td><td>IL-17A, IL-17F +/— IL-22 Neutralizing antibodies:</td><td>cmc</td></tr></table>
======================================
<table><tr><td>Ghee</td><td>Immune-complex disease</td></tr><tr><td>C3</td><td>Susceptibility to encapsulated bacteria</td></tr><tr><td>Cw</td><td>Susceptibility to Neisseria</td></tr><tr><td>ee tractor P)</td><td>Susceptibility to encapsulated bacteria and Neisseria but no immune-complex disease</td></tr><tr><td>Factor |</td><td>Similar effects to deficency of C3</td></tr><tr><td>MCP, factor | or factor H</td><td>Atypical hemolytic- uremic syndrome</td></tr><tr><td>Polymorphisms in factor H</td><td>Age-related macular degeneration</td></tr><tr><td>WDNs, ae)</td><td>Autoimmune-like conditions, including paroxysmal nocturnal hemoglobinuria</td></tr><tr><td>C1INH</td><td>Herditary angiodema (HAE)</td></tr></table>
======================================
<table><tr><td>Congenital neutropenias (e.g., elastase 2 deficiency)</td><td>Widespread pyogenic bacterial infections</td></tr><tr><td>Leukocyte adhesion deficiency</td><td>Widespread pyogenic bacterial infections</td></tr><tr><td>TLR signaling defects (e.g., MyD88 or IRAK4)</td><td>Severe cold pyogenic bacterial infections</td></tr><tr><td>Chronic granulomatous disease</td><td>Intracellular and extracellular infection, granulomas</td></tr><tr><td>G6PD deficiency</td><td>Defective respiratory burst, chronic infection</td></tr><tr><td>Myeloperoxidase deficiency</td><td>Defective intracellular killing, chronic infection</td></tr><tr><td>Chediak—Higashi syndrome</td><td>Intracellular and extracellular infection, granulomas</td></tr></table>
======================================
<table><tr><td>Familial Mediterranean fever (FMF)</td><td>Periodic fever, serositis (inflammation of the pleural and/or peritoneal cavity), arthritis, acute-phase response</td><td>‘Autosomal recessive</td><td>MEFV</td><td>Pyrin</td></tr><tr><td>TNF-receptor associated periodic syndrome (TRAPS) (also known as familial Hibernian fever)</td><td rowspan="2">Periodic fever, myalgia, rash, acute-phase response</td><td>Autosomal dominant</td><td>TNFRSF1A</td><td>TNF-a 55 kDa receptor (TNFR-I)</td></tr><tr><td>Pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA)</td><td></td><td>Autosomal dominant</td><td>PSTPIP1</td><td>CD2-binding protein 1</td></tr><tr><td>Muckle-Wells syndrome</td><td>Periodic fever _ irticarial rash, joint pains, conjunctivitis, progressive deafness</td><td rowspan="3">. Autosomal dominant</td><td rowspan="3">NLRP3</td><td rowspan="3">. Cryopyrin</td></tr><tr><td>Familial cold autoinflammatory syndrome (FCAS) (familial cold urticaria)</td><td>Cold-induced ji iar periodic fever, urticarial rash, joint pains, conjunctivitis °</td><td></td><td></td><td></td></tr><tr><td>Gre heres syndrome (CINCA)</td><td>Neonatal onset recurrent fever, urticarial rash, chronic arthropathy, facial dysmorphia, neurologic involvement pany, ysmorpnia, 3</td><td></td><td></td><td></td></tr><tr><td>Hyper-IgD syndrome (HIDS)</td><td>Periodic fever, elevated IgD levels, lymphadenopathy</td><td>Autosomal recessive</td><td>MVK</td><td>Mevalonate synthase</td></tr><tr><td>Blau syndrome</td><td>Granulomatous inflammation of skin, eye, and joints</td><td>Autosomal dominant</td><td>NOD2</td><td>NOD2</td></tr></table>
======================================
<table><thead><th>Extracellular bacteria</th><th></th><th></th><th></th></thead><tr><td rowspan="3">sil iding oy inhibition of MAMPs</td><td>Capsular polysaccharide</td><td>Block detection of lipopolysaccharide (LPS)</td><td>5 S. pneumoniae</td></tr><tr><td></td><td>Hypoacylation of lipid A ypoacy' P</td><td>| Antagonism of TLR-4 o</td><td>P gingivalis “ging</td></tr><tr><td></td><td>Coating of bacterium by self proteins (e.g., fibrin)</td><td>Block detection of peptidoglycan</td><td>S. aureus</td></tr><tr><td>Antigenic variation</td><td>5 Modulator of expressed pl,</td><td>Antibodies that block bacterial attachment become ineffective</td><td>N. gt nominee, :</td></tr><tr><td rowspan="3">aoe Inhibition of opsonization</td><td>Secretion of complement- degrading factors</td><td>Cleavage of complement components |</td><td>N. meningitidis, P aeruginosa, S. aureus</td></tr><tr><td></td><td>Capsular polysaccharide</td><td>ae Block fixation of complement</td><td>S. pneumoniae, ’ H. influenzae, K. pneumoniae</td></tr><tr><td></td><td>Expression of Fc-binding surface moleclues (e.g., Protein A)</td><td>Prevents binding of antibody to Fe receptors of phagocytes</td><td>S. aureus</td></tr><tr><td>Inhibition/scavenging A of reactive oxygen species (ROS)</td><td>Secretion of catalase and superoxide dismutase</td><td>Neutralize ROS produced by NADPH and myeloperoxidase (MPO)</td><td>S. aureus, B. abortus .</td></tr><tr><td rowspan="2">Resistance to antimicrobial - peptides (AMES)</td><td>Secretion of AMP- : : degrading peptidases</td><td>Cleavage of AMPS</td><td>Fl E. coli</td></tr><tr><td></td><td>. Modulation of cell membrane phospholipids</td><td>a Prevents bindin functional insertion of AMPs in cell membrane</td><td>S. aureus</td></tr><tr><td colspan="4">Intracellular bacteria</td></tr><tr><td>Antigenic variation</td><td>pili, fimbriae . Modulation of expressed</td><td>become ineffective Antibodies that block bacterial attachment</td><td>Salmonella spp.</td></tr><tr><td rowspan="2">Inhibition of MAMP recognition/ signaling</td><td>Production of peptidoglycan hydrolase</td><td>Block detection of peptidoglycan by NODs</td><td>L. monocytogenes</td></tr><tr><td></td><td>. __ Secretion of intracellular toxins</td><td>Block NF«B and MAP kinase signaling pathways</td><td>¥. pestis</td></tr><tr><td rowspan="2">Resistance to anti- “ne Imicrobial peptides</td><td></td><td>Secretion of AMP- degrading peptidases</td><td>Cleavage of AMPS</td><td>. Y. pestis</td></tr><tr><td>membrane phospholipids . Modulation of cell</td><td>AMPs in cell membrane adi Prevents binding, functional insertion of</td><td>Salmonella spp.</td></tr><tr><td>Inhibition of fusion of phagosome with lysosome</td><td>Release of bacterial cell wall components</td><td>Inhibits phago- lysosomal fusion</td><td>M. tuberculosis, M. leprae, L. pneumophila</td></tr><tr><td>Survival within phagolysosome</td><td>Waxy, hydrophobic cell wall containing mycolic acids and other lipids</td><td>Resistance against lysosomal enzymes</td><td>M. tuberculosis, M. leprae</td></tr><tr><td>Escape from phagosome</td><td>Production of hemolysins (e.g., listeriolysin 0)</td><td>Lysis of phagosome; escape into cytosol</td><td>L. monocytogenes, Shigella spp.</td></tr></table>
======================================
<table><tr><td rowspan="3">Inhibition of humoral immunity</td><td>Virally encoded Fe receptor</td><td>Blocks effector functions Shi of artodies bound to</td><td>Herpes simplex Cytomegalovirus</td></tr><tr><td></td><td>Virally encoded complement receptor</td><td>Blocks complement- mediated effector pathways</td><td>Herpes simplex p P</td></tr><tr><td></td><td>Virally encoded complement control protein</td><td>Inhibits complement activation by infected cell</td><td>Vaccinia</td></tr><tr><td rowspan="4">Inhibition of inflammatory response</td><td>Virally encoded chemokine receptor homolog, €.9., B-chemokine receptor</td><td>Sensitizes infected cells to effects of B-chemokine; advantage to virus unknown</td><td>. Cytomegalovirus</td></tr><tr><td></td><td>interferon-y receptor homolog Virally encoded soluble cytokine receptor, e.g., IL-1 receptor homolog, TNF receptor homolog,</td><td>host receptors Blocks effects of cytokines by inhibiting their interaction with</td><td>Vaccinia Rabbit myxoma virus</td></tr><tr><td></td><td>Viral inhibition of adhesion molecule expression, e.g., LFA-3 ICAM-1</td><td>Blocks adhesion of lymphocytes to infected cells</td><td>Epstein-Barr virus</td></tr><tr><td></td><td>Protection from NF«B activation by short sequences that mimic LRs</td><td>Blocks inflammatory responses elicited by IL-1 or bacterial pathogens</td><td>Vaccinia</td></tr><tr><td rowspan="2">Blocking of antigen processing and presentation</td><td></td><td>Inhibition of MHC class | expression</td><td>ree deals op of cytotoxic T cells</td><td>Herpes simplex Cytomegalovirus</td></tr><tr><td>ae . Inhibition of peptide transport by TAP</td><td>Blocks peptide association with MHC class |</td><td>Herpes simplex</td></tr><tr><td>\ . Sa</td><td>Virally encoded cytokine homolog of</td><td>production Inhibits T41 lymphocytes Reduces interferon-y</td><td>Epstein-Barr virus</td></tr></table>
======================================
<table><tr><td>Herpes simplex virus 1</td><td>ICP47</td><td></td><td>an Blocks peptide binding to TAP</td></tr><tr><td>7 Human cytomegalovirus (HCMV)</td><td>uS6</td><td>Blocks peptide entry to endoplasmic reticulum</td><td>_ _ Inhibits TAP ATPase activity and blocks peptide release into endoplasmic reticulum</td></tr><tr><td>Bovine herpes virus</td><td>UL49.5</td><td></td><td>Inhibits TAP peptide transport</td></tr><tr><td>Adenovirus</td><td>E19</td><td></td><td>Competitive inhibitor of tapasin</td></tr><tr><td>HCMV</td><td>US3</td><td>Retention of . MHC class 1 in endoplasmic</td><td>Blocks tapasin function</td></tr><tr><td>ea cytomegalovirus</td><td>m152</td><td>reticulum</td><td>Downregulation of host MHC class |</td></tr><tr><td>RCN</td><td>us2</td><td>Degradation of</td><td>Transports some newly synthesized MHC class | molecules into cytosol</td></tr><tr><td>ran " urine gamma herpes virus 68</td><td>mK3</td><td>MHC class | (dislocation)</td><td>“i iauitin Ii - E3-ubiquitin ligase activity</td></tr><tr><td>. Murine) Guy</td><td>m4</td><td>Binds MHC class | at cell surface</td><td>Interferes with recognition by cytotoxic lymphocytes by an unknown mechanism</td></tr></table>
======================================
<table><tr><td></td><td>Group-specific antigen</td><td>Core proteins</td><td>and matrix</td><td>proteins</td><td></td><td></td></tr><tr><td></td><td>Polymerase</td><td>Reverse : integrase</td><td>transcriptase, enzymes</td><td>protease,</td><td>and</td><td></td></tr><tr><td></td><td>Envelope</td><td>Transmembrane CD4 and fusion and</td><td>CCR5; gp41 internalization</td><td>glycoproteins. is required</td><td>gp120 for</td><td>binds virus</td></tr><tr><td></td><td>Transactivator</td><td>Positive</td><td>regulator of</td><td>transcription</td><td></td><td></td></tr><tr><td></td><td>Regulator of viral expression</td><td>Allows export transcripts</td><td>of unspliced from nucleus</td><td>and</td><td>partially</td><td>spliced</td></tr><tr><td></td><td>Viral infectivity</td><td>Affects</td><td>particle infectivity</td><td></td><td></td><td></td></tr><tr><td></td><td>Viral protein R</td><td>Transport of virion</td><td>DNA to production.</td><td>nucleus. Cell-cycle arrest</td><td>Augments</td><td></td></tr><tr><td></td><td>Viral protein U</td><td>Promotes enhances</td><td>intracellular release of</td><td>degradation virus from</td><td>of cell</td><td>CD4 and membrane</td></tr><tr><td>nef</td><td>Negative-regulation factor</td><td colspan="5">Augments viral replication in vivo and in vitro. Decreases CD4, MHC class | and Il expression</td></tr></table>
======================================
<table><tr><td colspan="5">HIV entry</td></tr><tr><td rowspan="4">CCRS</td><td rowspan="3">A32</td><td rowspan="3">Recessive Dominant</td><td>Prevents infection</td><td>Knockout of CCR5 expression</td></tr><tr><td></td><td></td><td></td><td>Prevents lymphoma (L)</td><td rowspan="2">Decreases available CCRS</td></tr><tr><td></td><td></td><td></td><td>Delays AIDS</td><td></td></tr><tr><td></td><td>Pi</td><td>Recessive</td><td>Accelerates AIDS (E)</td><td>Increases CCR5 expression</td></tr><tr><td>CCR2</td><td>164</td><td>Dominant</td><td>Delays AIDS</td><td>Interacts with and reduces CXCR4</td></tr><tr><td>CCL5</td><td>Int.ic</td><td>Dominant</td><td>Accelerates AIDS</td><td>Decreases CCL5 expression</td></tr><tr><td>CXCL12</td><td>3A</td><td>Recessive</td><td>Delays AIDS (L)</td><td>Impedes CCR5-CXCR4 transition (?)</td></tr><tr><td>CXCR6</td><td>E3K</td><td>Dominant</td><td>Accelerates P jirovecii pneumonia (L)}</td><td>Alters T-cell activations (?)</td></tr><tr><td>CCL2-CCL7-CCL11</td><td>H7</td><td>Dominant</td><td>Enhances infection</td><td>Stimulates immune response (?)</td></tr><tr><td>Cytokine anti-HIV</td><td></td><td></td><td></td><td></td></tr></table>
======================================
<table><thead><th rowspan="2">1L10</th><th rowspan="2">5A</th><th rowspan="2">Dominant</th><th rowspan="2">Limits infection Accelerates AIDS</th><th rowspan="2">Decreases IL-10 expression</th></thead><thead><th></th><th></th><th></th><th></th><th></th></thead><tr><td>IFNG</td><td>-179T</td><td>Dominant</td><td>Accelerates AIDS (E)</td><td></td></tr></table>
======================================
<table><tr><td rowspan="4">HLA</td><td>A,B,C</td><td>Homozygous</td><td>Accelerates AIDS</td><td>Decreases breadth of HLA class | epitope recognition</td></tr><tr><td></td><td>B*27</td><td rowspan="3">Codominant</td><td rowspan="2">Delays AIDS</td><td rowspan="2">Delays HIV-1 escape</td></tr><tr><td></td><td>BYS7</td><td></td><td></td><td></td></tr><tr><td></td><td>B*35-Px</td><td></td><td>Accelerates AIDS</td><td>Deflects CD8-mediated T-cell clearance of HIV-1</td></tr><tr><td>KIR3DS1</td><td>3DS1</td><td>Epistatic with HLA-Bw4</td><td>Delays AIDS</td><td>Clears HIV*, HLAT cells (2)</td></tr></table>
======================================
<table><tr><td>Infections</td><td></td></tr><tr><td>Parasites</td><td>Toxoplasma spp. Cryptosporidium spp. Leishmania spp. Microsporidium spp.</td></tr><tr><td>Intracellular bacteria</td><td>Mycobacterium tuberculosis Mycobacterium avium intracellulare Salmonella spp.</td></tr><tr><td>Fungi Viruses</td><td>Pneumocystis jirovecii Cryptococcus neoformans Candida spp. Histoplasma capsulatum Coccidioides immitis Herpes simplex</td></tr><tr><td></td><td>Cytomegalovirus Herpes zoster</td></tr><tr><td>Malignancies</td><td>—</td></tr><tr><td>Kaposi sarcoma Non-Hodgkin's EBV-positive Primary lymphoma</td><td>(HHV8) lymphoma, including Burkitt's lymphoma of the brain</td></tr></table>
======================================
<table><tr><td>A. Kindlin-3</td><td>i.</td><td></td><td>Production</td></tr><tr><td>B. Neutrophil elastase</td><td>ii.</td><td></td><td>Adhesion</td></tr><tr><td>C. Myeloperoxidase</td><td></td><td>iii.</td><td>Activation</td></tr><tr><td>D. MyD88s</td><td>iv.</td><td></td><td>Microbial killir</td></tr></table>
======================================
<table><tr><td>Systemic anaphylaxis</td><td>Drugs Venoms Food, e.g., peanuts Serum</td><td>Intravenous (either i i Greely oF Following the Dod after oral intake)</td><td>Edema Increased vascular permeability Laryngeal edema Circulatory collapse Death</td></tr><tr><td>Acute urticaria (wheal-and-flare)</td><td>Post-viral Animal hair Bee stings Allergy testing</td><td>Through skin Systemic</td><td>Local increase in blood flow and vascular permeability Edema</td></tr><tr><td>Seasonal rhinoconjunctivitis (hay fever)</td><td>Pollens (ragweed, trees, grasses) Dust-mite feces</td><td>Contact with conjunctiva of eye and nasal mucosa</td><td>Edema of conjunctiva and nasal mucosa Sneezing</td></tr><tr><td>Asthma</td><td>Dander (cat) Pollens Dust-mite feces</td><td>Inhalation leading to contact with mucosal lining of lower airways</td><td>Bronchial constriction Increased mucus production Airway inflammation Bronchial hyperreactivity</td></tr><tr><td>Food allergy</td><td>Peanuts Tree nuts is ee Milk Eggs Soy Wheat</td><td>Oral</td><td>oa Vomiting Diarrhea Pruritus (itching) Urticaria (hives) Anaphylaxis (rarely)</td></tr></table>
======================================
<table><tr><td>Protein, often with carbohydrate side chains</td><td>Protein antigens induce T-cell responses</td></tr><tr><td>Low dose</td><td>Favors activation of IL-4- producing CD4 T cells</td></tr><tr><td>Low molecular weight</td><td>Allergen can diffuse out of particles into the mucosa</td></tr><tr><td>Highly soluble</td><td>Allergen can be readily eluted from particle</td></tr><tr><td>Stable</td><td>Allergen can survive in desiccated particle</td></tr><tr><td>Contains peptides that bind host MHC class II</td><td>Required for T-cell priming</td></tr></table>
======================================
<table><thead><th>Genes expressed in airway epithelial cells</th></thead><tr><td>Chemokines: CCL5, CCL11, CCL24, CCL26</td></tr><tr><td>Antimicrobial peptides: DEFB1</td></tr><tr><td>Secretoglobin family: SCGB1A1</td></tr><tr><td>Epithelial barrier protein: FLG</td></tr><tr><td>Genes regulating CD4 T-cell and ILC2 differentiation and function</td></tr><tr><td>Transcription factors: GATA3, TBX21, RORA, STAT3, PHF11, IKZF4</td></tr><tr><td>Cytokines: /L4, IL5, IL10, IL13, 1L25, 1L33, TGFB1</td></tr><tr><td>Cytokine receptors: IL2RB, IL4RA, IL5RA, IL6R, IL18R, IL1RL1, FCER1B</td></tr><tr><td>Pattern recognition receptors: CD14, TLR2, TLR4, TLR6, TLR10, NOD1, NOD2</td></tr><tr><td>Antigen presentation: HLA-DRB1, HLA-DRB3, HLA-DOQA, HLA-DQB, HLA-DPA, HLA-DPB, HLA-G</td></tr><tr><td>Prostaglandin receptors: PDFER2, PTGDR</td></tr><tr><td>Genes with other functions</td></tr><tr><td>Proteinase or proteinase inhibitor: ADAM33, USP38, SPINK5S</td></tr><tr><td>Signaling proteins: IRAKM, SMAD3, PYHINT, NOTCH4, GAB1, TNIP1</td></tr><tr><td>Receptors: ADRB2, P2X7</td></tr><tr><td>Other: DPP70, GPRA, COL29A1, ORMDL3, GSDMB, WDR36, DENND1B, RAD50, PBX2, LRRC32, AGER, CDK2</td></tr></table>
======================================
<table><tr><td>Enzyme</td><td>Tryptase, chymase, cathepsin G, carboxypeptidase</td><td>Remodel connective tissue matrix</td></tr><tr><td>Toxic mediator</td><td>Histamine, heparin</td><td>Toxic to parasites Increase vascular permeability Cause smooth muscle contraction Anticoagulation</td></tr><tr><td rowspan="3">Cytokine</td><td>IL-4, IL-13, IL-33</td><td>Stimulate and amplify T,2-cell response</td></tr><tr><td></td><td>IL-3, IL-5, GM-CSF</td><td>Promote eosinophil production and activation</td></tr><tr><td></td><td>TNF-a (some stored Iefornen in granules)</td><td>Promotes inflammation, stimulates cytokine S production by many cell types, activates endothelium</td></tr><tr><td>Chemokine</td><td>CCL3</td><td>Attracts monocytes, macrophages, and neutrophils</td></tr><tr><td rowspan="2">Lipid mediator</td><td>Prostaglandins D,, E, Leukotrienes C4, D4, E4</td><td>Smooth muscle contraction Chemotaxis of eosinophils, basophils, and T,,2 cells Increase vascular permeability Stimulate mucus secretion Bronchoconstriction</td></tr><tr><td></td><td>Platelet-activating factor</td><td>Attracts leukocytes Amplifies production of lipid mediators Activates neutrophils, eosinophils, and platelets</td></tr></table>
======================================
<table><tr><td rowspan="3">Enzyme</td><td>Eosinophil peroxidase</td><td>Toxic to targets by catalyzing halogenation Triggers histamine release from mast cells</td></tr><tr><td></td><td>Eosinophil collagenase</td><td>Remodels connective tissue matrix</td></tr><tr><td></td><td>Matrix metalloproteinase-9</td><td>Matrix protein degradation</td></tr><tr><td rowspan="3">Toxic protein</td><td>Major basic protein</td><td>Toxic to parasites and mammalian cells Triggers histamine release from mast cells</td></tr><tr><td></td><td>Eosinophil cationic protein</td><td>Ribonuclease _ Toxic to parasites Neurotoxin</td></tr><tr><td></td><td>Eosinophil-derived neurotoxin</td><td>Neurotoxin</td></tr><tr><td rowspan="2">Cytokine</td><td>IL-3, IL-5, GM-CSF</td><td>Amplify eosinophil production by bone marrow Eosinophil activation</td></tr><tr><td></td><td>7 7 TGF-a, TEF-B</td><td>Epithelial proliferation, myofibroblast formation</td></tr><tr><td>Chemokine</td><td>CXCL8 (IL-8)</td><td>Promotes influx of leukocytes</td></tr><tr><td rowspan="2">Lipid mediator</td><td>Leukotrienes C4, D4, E4</td><td>Smooth muscle contraction Increase vascular permeability Increase mucus secretion Bronchoconstriction</td></tr><tr><td></td><td>Platelet-activating factor</td><td>Attracts leukocytes Amplifies production of lipid mediators Activates neutrophils, eosinophils, and platelets</td></tr></table>
======================================
<table><tr><td>Immature mucosal immune system</td></tr><tr><td>Early introduction of solid food</td></tr><tr><td>Hereditary increase in mucosal permeability</td></tr><tr><td>IgA deficiency or delayed IgA production</td></tr><tr><td>Inadequate colonization of the intestinal immune system by commensal flora</td></tr><tr><td>Birth by cesarean section</td></tr><tr><td>Genetically determined bias toward a Ty2 environment</td></tr><tr><td>Polymorphisms of Ty2 cytokine or IgE receptor genes</td></tr><tr><td>Impaired enteric nervous system</td></tr><tr><td>Immune alterations (e.g., low levels of TGF-p)</td></tr><tr><td>Gastrointestinal infections</td></tr></table>
======================================
<table><thead><th>Target</th><th>Mechanism of treatment</th><th>Specific approach</th></thead><tr><td colspan="3">In clinical use</td></tr><tr><td rowspan="2">Mediator action</td><td>Inhibit effects of mediators on specific receptors</td><td>Antihistamines, B-agonists Leukotriene receptor blockers</td></tr><tr><td></td><td>Inhibit synthesis of specific mediators</td><td>Lipoxygenase inhibitors</td></tr><tr><td>Chronic inflammatory reactions</td><td>General anti-inflammatory effects</td><td>Corticosteroids</td></tr><tr><td>Ty2 response</td><td>Induction of regulatory T cells</td><td>Desensitization therapy by injections of specific antigen</td></tr><tr><td>IgE binding to mast cell</td><td>Bind to IgE Fe region and prevent IgE binding to Fc receptors on mast cells</td><td>Anti-IgE antibodies (omalizumab)</td></tr><tr><td colspan="3">Proposed or under investigation</td></tr><tr><td rowspan="3">Ty2 activation</td><td rowspan="3">Induction of regulatory T cells</td><td>Injection of specific antigen peptides</td></tr><tr><td></td><td></td><td>Administration of cytokines, e.g., IFN~y, IL-10, IL-12, TGF-B</td></tr><tr><td></td><td></td><td>Use of adjuvants such as CpG oligodeoxynucleotides to stimulate T1 response</td></tr><tr><td>Activation of B cell to produce IgE</td><td>Block co-stimulation Inhibit Ty2 cytokines</td><td>Inhibit CD40L Inhibit IL-4 or IL-13</td></tr><tr><td>Mast-cell activation</td><td>Inhibit effects of IgE binding to mast cell</td><td>Blockade of IgE receptor</td></tr><tr><td>Eosinophil-dependent inflammation</td><td>Block cytokine and chemokine receptors that mediate eosinophil recruitment and activation</td><td>Inhibit IL-5 Block CCR3</td></tr></table>
======================================
<table><tr><td>Delayed-type hypersensitivity</td><td>Proteins: Insect venom Mycobacterial proteins (tuberculin, lepromin)</td><td>Local skin swelling: pythema Cellular infiltrate Dermatitis</td></tr><tr><td>Contact hypersensitivity</td><td>Haptens: Pentadecacatechol (poison ivy) DNFB ; Small metal ions: Nickel Chromate</td><td>Local epidermal reaction: Erythema . ang Cellular infiltrate Vesicles Intraepidermal abscesses</td></tr><tr><td>Gluten-sensitive enteropathy (celiac disease)</td><td>Gliadin</td><td>Villous atrophy in small bowel Malabsorption</td></tr></table>
======================================
<table><tr><td>Psoriasis</td><td>Autoreactive T cells against skin-associated antigens</td><td>Inflammation of skin with formation of scaly patches or plaques</td><td>1 in 50</td></tr><tr><td>5 on Rheumatoid arthritis</td><td>Autoreactive T cells and autoantibodies against antigens localized to joint synovium</td><td>fran ‘ 5 a ae Joint inflammation and destruction causing arthritis</td><td>A 1 in 100</td></tr><tr><td>oh Graves' disease</td><td>Autoantibodies against the thyroid-stimulating- hormone receptor</td><td>a . . Hyperthyroidism: overproduction of thyroid hormones</td><td>. 1 in 100</td></tr><tr><td>. 1 ae Bashimicty ShiiyToiuits</td><td>Autoantibodies and autoreactive T cells against thyroid antigens</td><td>Destruction of thyroid tissue leading to hypothyroidism: underproduction of thyroid hormones</td><td>A 1 in 200</td></tr><tr><td>. Se</td><td>Autoantibodies and autoreactive T cells against DNA, chromatin proteins, and ubiquitous ribonucleoprotein antigens</td><td>Glomerulonephritis, vasculitis, rash</td><td>1 in 200</td></tr><tr><td>Sjégren's syndrome</td><td>ae . ‘ Autoantibodies and autoreactive T calls against P 9</td><td>Lymphocyte infiltration of exocrine glands, leading to dry eyes and/or dry mouth; other organs may be involved, leading to systemic disease</td><td>1 in 300</td></tr><tr><td>Crohn’s disease</td><td>Autoreactive T cells against intestinal flora antigens</td><td>Intestinal inflammation and scarring</td><td>1 in 500</td></tr><tr><td>q q Multiple sclerosis</td><td>Autoreactive T cells against brain and spinal cord antigens</td><td>Formation of sclerotic plaques in brain and spinal cord with destruction of myelin sheaths surrounding nerve cell axons, leading to muscle weakness, ataxia, and other symptoms</td><td>A 1 in 700</td></tr><tr><td>Type 1 diabetes (insulin-dependent diabetes mellitus, IDDM)</td><td>. 5 a Autoreactive T cells against pancreatic islet cell antigens</td><td>. ae Destruction of pancreatic islet B cells leading to nonproduction of insulin</td><td>1 in 800</td></tr></table>
======================================
<table><thead><th colspan="3">Layers of self-tolerance</th></thead><thead><th>Type of tolerance</th><th>Mechanism</th><th>Site of action</th></thead><tr><td>Central tolerance</td><td>Deletion Editing</td><td>Thymus (T cells) Bone marrow (B cells)</td></tr><tr><td>Antigen segregation</td><td>Physical barrier to self-antigen access to lymphoid system</td><td>Peripheral organs (e.g., thyroid, pancreas)</td></tr><tr><td>Peripheral anergy</td><td>Cellular inactivation by weak signaling without co-stimulus</td><td>Secondary lymphoid tissue</td></tr><tr><td>Regulatory T cells</td><td>Suppression by cytokines, intercellular signals</td><td>Secondary lymphoid tissue and sites of inflammation; multiple tissues in steady state</td></tr><tr><td>Functional deviation</td><td>Differentiation of regulatory T cells that limit inflammatory cytokine secretion</td><td>Secondary lymphoid tissue and sites of inflammation</td></tr><tr><td>Activation-induced cell death</td><td>Apoptosis</td><td>Secondary lymphoid tissue and sites of inflammation</td></tr></table>
======================================
<table><tr><td>Eye</td><td></td></tr><tr><td></td><td>Testis</td></tr><tr><td>Uterus</td><td>(fetus)</td></tr></table>
======================================
<table><tr><td>Type 1 diabetes mellitus</td></tr><tr><td>Goodpasture’s syndrome</td></tr><tr><td>Multiple sclerosis Crohn’s disease Psoriasis</td></tr><tr><td>Hashimoto's thyroiditis Autoimmune hemolytic anemia Autoimmune Addison's disease Vitiligo Myasthenia gravis</td></tr><tr><td>Rheumatoid arthritis</td></tr><tr><td>Scleroderma</td></tr><tr><td>Systemic lupus erythematosus Primary Sjogren’s syndrome Polymyositis</td></tr></table>
======================================
<table><tr><td>Myasthenia gravis</td><td>Anti-acetylcholine receptor</td><td>Muscle weakness</td></tr><tr><td>Graves' disease</td><td>Anti-thyroid-stimulating- hormone (TSH) receptor</td><td>Hyperthyroidism</td></tr><tr><td>Thrombocytopenic purpura</td><td>Anti-platelet antibodies</td><td>Bruising and hemorrhage</td></tr><tr><td>Neonatal lupus rash and/or congenital heart block</td><td>Anti-Ro antibodies Anti-La antibodies</td><td>Photosensitive rash and/or bradycardia</td></tr><tr><td>Pemphigus vulgaris</td><td>Anti-desmoglein-3</td><td>Blistering rash</td></tr></table>
======================================
<table><thead><th>Disease</th><th>T cells</th><th>B cells</th><th>Antibody</th></thead><tr><td>Systemic lupus erythematosus</td><td>Pathogenic Help for antibody</td><td>Present antigen to T cells</td><td>Pathogenic</td></tr><tr><td>Type 1 diabetes</td><td>Pathogenic</td><td>Present antigen to T cells</td><td>Present, but role unclear</td></tr><tr><td>Myasthenia gravis</td><td>Help for antibody</td><td>Antibody secretion</td><td>Pathogenic</td></tr><tr><td>Multiple sclerosis</td><td>Pathogenic</td><td>Present antigen to T cells</td><td>Present, but role unclear</td></tr></table>
======================================
<table><thead><th>Autoimmune hemolytic anemia</th><th>Rh blood group antigens, | antigen</th><th>Destruction of red blood cells by complement and FcR* phagocytes, anemia</th></thead><tr><td>Autoimmune thrombocytopenic purpura</td><td>Platelet integrin Gpllb:Illa</td><td>Abnormal bleeding</td></tr><tr><td>Goodpasture’s syndrome</td><td>Noncollagenous domain of basement membrane collagen type IV</td><td>Glomerulonephritis, pulmonary hemorrhage</td></tr><tr><td>Pemphigus vulgaris</td><td>Epidermal cadherin</td><td>Blistering of skin</td></tr><tr><td>Acute rheumatic fever</td><td>Streptococcal cell-wall antigens. Antibodies cross-react with cardiac muscle</td><td>Arthritis, myocarditis, late scarring of heart valves</td></tr><tr><td>Mixed essential cryoglobulinemia</td><td>Rheumatoid factor IgG complexes (with or without hepatitis C antigens)</td><td>Systemic vasculitis</td></tr><tr><td>Rheumatoid arthritis</td><td>Rheumatoid factor IgG complexes</td><td>Arthritis</td></tr><tr><td>Type 1 diabetes</td><td>Pancreatic B-cell antigen</td><td>B-cell destruction</td></tr><tr><td>Rheumatoid arthritis</td><td>Unknown synovial joint antigen</td><td>Joint inflammation and destruction</td></tr><tr><td>Multiple sclerosis</td><td>Myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein</td><td>Brain and spinal cord invasion by CD4 T cells, muscle weakness, and other neurological symptoms</td></tr><tr><td>Crohn's disease</td><td>Antigens of intestinal microbiota</td><td>Regional intestinal inflammation and scarring</td></tr><tr><td>Psoriasis</td><td>Unknown skin antigens</td><td>Inflammation of skin with formation of plaques</td></tr></table>
======================================
<table><thead><th>Diseases</th><th rowspan="2">mediated by antibodies Antigen</th><th rowspan="2">against Antibody</th><th colspan="3">cell-surface receptors</th></thead><thead><th>Syndrome</th><th></th><th></th><th>Consequence</th><th>Target cell</th></thead><tr><td>Oh Graves) disease</td><td>Thyroid-stimulating hormone receptor</td><td>Agonist gon's</td><td>Hyperthyroid Yyperthyroidism</td><td>Thyroid epithelial cell</td></tr><tr><td>Myasthenia gravis</td><td>Acetylcholine receptor</td><td>Antagonist</td><td>Progressive muscle weakness</td><td>Muscle</td></tr><tr><td>Insulin-resistant diabetes</td><td>| Insulin receptor</td><td>Antagonist</td><td>Hyperglycemia, ketoacidosis</td><td>All cells</td></tr><tr><td>Hypoglycemia</td><td>Insulin receptor</td><td>Agonist</td><td>Hypoglycemia</td><td>All cells</td></tr><tr><td>re Chronic urticaria</td><td>Receptor-bound IgE or IgE receptor</td><td>Agonist</td><td>Persistant itehy rash</td><td>Mast cells</td></tr></table>
======================================
<table><tr><td rowspan="6">Overexpression</td><td>TNF-a.</td><td>Inflammatory bowel disease, arthritis, vasculitis</td></tr><tr><td></td><td>IL-2, IL-7, IL-2R</td><td>Inflammatory bowel disease</td></tr><tr><td></td><td>IL-3</td><td>Demyelinating syndrome</td></tr><tr><td></td><td>IFN- v</td><td>Overexpression in skin leads to SLE</td></tr><tr><td></td><td>IL-23R</td><td>Inflammatory bowel disease, psoriasis</td></tr><tr><td></td><td>STAT4</td><td>Inflammatory bowel disease</td></tr><tr><td rowspan="4">Underexpression</td><td></td><td>TNF-a.</td><td>SLE</td></tr><tr><td></td><td>IL-1 receptor agonist</td><td>Arthritis</td></tr><tr><td>IL-10, IL-10R, STAT3</td><td>Inflammatory bowel disease</td></tr><tr><td></td><td>TGF-p</td><td>Ubiquitous underexpression leads to inflammatory bowel disease. Underexpression specifically in T cells leads to SLE</td></tr></table>
======================================
<table><tr><td rowspan="5">Antigen clearance and presentation</td><td rowspan="2">C1q knockout C4 knockout</td><td rowspan="2">Lupus-like</td><td rowspan="2">C10A C2, 04</td><td rowspan="2">Lupus-like</td></tr><tr><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>AIRE knockout</td><td></td><td>Mannose-binding lectin AIRE</td><td rowspan="2">APECED</td></tr><tr><td></td><td></td><td>Multi-organ autoimmunity resembling APECED</td><td></td><td></td></tr><tr><td rowspan="6">Signaling</td><td></td><td>Mer knockout</td><td rowspan="5">Lupus-like Lupus-like</td><td rowspan="5"></td><td rowspan="5"></td></tr><tr><td></td><td>SHP-1 knockout</td><td></td><td></td><td></td></tr><tr><td></td><td>Lyn knockout</td><td></td><td></td><td></td></tr><tr><td></td><td>CD22 knockout</td><td></td><td></td><td></td></tr><tr><td></td><td>CD45 E613R point mutation B cells deficient</td><td></td><td></td><td></td></tr><tr><td></td><td>FcyRIIB knockout (inhibitory signaling molecule)</td><td></td><td>FCGR2A</td><td>Lupus</td></tr><tr><td rowspan="3">Co-stimulatory molecules</td><td>CTLA-4 knockout (blocks inhibitory signal)</td><td>Lymphocyte infiltration into organs</td><td></td><td></td></tr><tr><td></td><td>PD-1 knockout (blocks inhibitory signal)</td><td rowspan="2">Lupus-like</td><td></td><td></td></tr><tr><td></td><td>BAFF overexpression (transgenic mouse)</td><td></td><td></td><td></td></tr><tr><td rowspan="5">Apoptosis Treg development/ function</td><td></td><td>Fas knockout (Ipn</td><td>Lupus-like with lymphocyte infiltrates</td><td>FAS and FASL mutations (ALPS)</td><td>Lupus-like with lymphocyte infiltrates</td></tr><tr><td></td><td>FasL knockout (gid)</td><td></td><td></td><td></td></tr><tr><td></td><td>Bel-2 overexpression (transgenic mouse)</td><td>Lupus-like</td><td></td><td></td></tr><tr><td>Pten heterozygous deficiency</td><td></td><td></td><td></td></tr><tr><td></td><td>scurfy mouse</td><td>Multi-organ autoimmunity</td><td>FOXP3</td><td>IPEX</td></tr></table>
======================================
<table><tr><td>elit</td><td>APECED (APS-1)</td><td>Knockout</td><td>Decreased expression of self antigens in the thymus, resulting in defective negative selection of self-reactive T cells</td></tr><tr><td>CTLA4</td><td>Association with Graves’ disease, type 1 diabetes, and others</td><td>Knockout</td><td>Failure of T-cell anergy and reduced activation threshold of self-reactive T cells</td></tr><tr><td>FOXP3</td><td>IPEX</td><td>Knock rutin</td><td>Decreased function of CD4 CD25 regulatory T cells</td></tr><tr><td>FAS</td><td>ALPS</td><td>Ipr/Ipr; gid/gid mutants</td><td>Failure of apoptotic death of self-reactive B and T cells</td></tr><tr><td>C1q</td><td>SLE</td><td>Knockout</td><td>Defective clearance of immune complexes and apoptotic cells</td></tr><tr><td>ATGT6L1</td><td>BD</td><td>Hypomorph</td><td>Defective autophagy/clearance of bacteria by innate Cells in intestines</td></tr><tr><td>IL10RA, IL10RB</td><td>IBD</td><td>Knockout</td><td>Defective IL-10 signaling; impaired anti-inflammatory response</td></tr><tr><td>INS</td><td>Type 1 diabetes</td><td></td><td>Decreased expression of insulin in thymus; impaired negative selection</td></tr></table>
======================================
<table><thead><th>Disease</th><th>HLA allele</th><th>Relative risk</th><th>Sex ratio (9:0)</th></thead><tr><td>Ankylosing spondylitis</td><td>B27</td><td>87.4</td><td>0.3</td></tr><tr><td>Type 1 diabetes</td><td>DQ2 and DQ8</td><td>~25</td><td>~1</td></tr><tr><td>Goodpasture’s syndrome</td><td>DR2</td><td>15.9</td><td>~1</td></tr><tr><td>Pemphigus vulgaris</td><td>DR4</td><td>14.4</td><td>~1</td></tr><tr><td>Autoimmune uveitis</td><td>B27</td><td>10</td><td>&lt;0.5</td></tr><tr><td>Psoriasis vulgaris</td><td>CW6</td><td>7</td><td>~1</td></tr><tr><td>Systemic lupus erythematosus</td><td>DR3</td><td>5.8</td><td>10-20</td></tr><tr><td>Addison's disease</td><td>DR3</td><td>5</td><td>~13</td></tr><tr><td>Multiple sclerosis</td><td>DR2</td><td>48</td><td>10</td></tr><tr><td>Rheumatoid arthritis</td><td>DR4</td><td>4.2</td><td>3</td></tr><tr><td>Graves’ disease</td><td>DR3</td><td>3.7</td><td>4-5</td></tr><tr><td>Hashimoto’s thyroiditis</td><td>DR5</td><td>3.2</td><td>4-5</td></tr><tr><td>Myasthenia gravis</td><td>DR3</td><td>2.5</td><td>~1</td></tr><tr><td>Type | diabetes</td><td>DQ6</td><td>0.02</td><td>~1</td></tr></table>
======================================
<table><thead><th>Disruption of cell or tissue barrier</th><th>Molecular mimicry</th></thead><tr><td>Release of sequestered self antigen; activation of nontolerized cells</td><td>Production of cross-reactive antibodies orT cells</td></tr><tr><td>. ial</td><td>Rheumatic fever Reactive arthritis Lyme arthritis</td></tr><tr><td></td><td></td></tr><tr><td></td><td>ap</td></tr><tr><td></td><td>[oloTo</td></tr></table>
======================================
<table><tr><td>Kidney</td><td>17,815</td><td>81.4%"</td></tr><tr><td>Liver</td><td>6729</td><td>68.3%</td></tr><tr><td>Heart</td><td>2679</td><td>74.0%</td></tr><tr><td>Pancreas</td><td>954</td><td>53.4%t</td></tr><tr><td>Lung</td><td>1949</td><td>50.6%</td></tr><tr><td>Intestine</td><td>139</td><td>~48.4%</td></tr><tr><td>Cornea</td><td>~45,000</td><td>~70%</td></tr><tr><td>ae</td><td>~20,000"*</td><td>&gt;80%t</td></tr></table>
======================================
<table><thead><th>Type</th><th>Example</th></thead><tr><td colspan="2">Radiation</td></tr><tr><td colspan="2">Small molecules</td></tr><tr><td>Drugs</td><td>Sirolimus (rapamycin)</td></tr><tr><td>Adjuvants</td><td>Alum</td></tr><tr><td colspan="2">Macromolecules</td></tr><tr><td>Hormones</td><td>Cortisol</td></tr><tr><td>Cytokines</td><td>Interferon a</td></tr><tr><td>Antibodies</td><td>Rituximab (anti-CD20 antibody)</td></tr><tr><td>Fusion proteins |</td><td>Abatacept (CTLA-4—Ig)</td></tr><tr><td>DNA vaccines</td><td>(Experimental)</td></tr><tr><td>Subunit vaccines</td><td>a . Hepatitis B vaccine</td></tr><tr><td>Conjugate vaccines</td><td>Hib (Haemophilus influenzae type B) vaccine</td></tr><tr><td colspan="2">Cells and organisms</td></tr><tr><td>Inactivated vaccines</td><td>IPV (inactivated poliovirus vaccine)</td></tr><tr><td>ate auated vaccines</td><td>MMR (measles, mumps, rubella) vaccine</td></tr><tr><td>Adoptive cell transfer</td><td>CAR (chimeric antigen receptor) T cells</td></tr><tr><td>Heterologous bone</td><td>marrow transplant</td></tr></table>
======================================
<table><thead><th>Conventional</th><th>immunosuppressive drugs in clinical use</th></thead><thead><th>Immunosuppressive drug</th><th>Mechanism of action</th></thead><tr><td>Corticosteroids</td><td>Inhibit inflammation; inhibit many targets including cytokine production by macrophages</td></tr><tr><td>Azathioprine, cyclophosphamide, mycophenolate</td><td>Inhibit proliferation of lymphocytes by interfering with DNA synthesis</td></tr><tr><td>Cyclosporin A, tacrolimus (FK506)</td><td>Inhibit the calcineurin-dependent activation of NFAT; block IL-2 production by T cells and proliferation by T cells</td></tr><tr><td>Rapamycin (sirolimus)</td><td>Inhibits proliferation of effector T cells by blocking Rictor-dependent mTOR activation</td></tr><tr><td>Fingolimod (FTY270)</td><td>Blocks lymphocyte trafficking out of lymphoid tissues by interfering with signaling by the sphingosine 1-phosphate receptor</td></tr></table>
======================================
<table><thead><th colspan="2">Corticosteroid therapy</th></thead><thead><th>Effect on</th><th>Physiological effects</th></thead><tr><td>| IL-1, TNF-a, GM-CSF IL-3, IL-4, IL-5, CXCL8</td><td>Inflammation | caused by cytokines</td></tr><tr><td>{Nos</td><td>{NO</td></tr><tr><td>} Phospholipase A, 4 Cyclooxygenase type 2 + Annexin-1</td><td>+ Prostaglandins + Leukotrienes</td></tr><tr><td>{ Adhesion molecules</td><td>Reduced emigration of leukocytes from vessels</td></tr><tr><td>t Endonucleases</td><td>Induction of apoptosis in lymphocytes and eosinophils</td></tr></table>
======================================
<table><thead><th></th><th>Immunological effects of cyclosporin A and tacrolimus</th></thead><tr><td>Cell type</td><td>Effects</td></tr><tr><td>T lymphocyte</td><td>Reduced expression of IL-2, IL-3, IL-4, GM-CSF, TNF-a Reduced proliferation following decreased IL-2 production Reduced Ca°*-dependent exocytosis of granule-associated serine esterases Inhibition of antigen-driven apoptosis</td></tr><tr><td>B lymphocyte</td><td>Inhibition of proliferation secondary to reduced cytokine production by T lymphocytes Inhibition of proliferation following ligation of surface immunoglobulin Induction of apoptosis following B-cell activation</td></tr><tr><td>Granulocyte</td><td>Reduced Ca?*-dependent exocytosis of granule-associated serine esterases</td></tr></table>
======================================
<table><thead><th>Generic name</th><th>Specificity</th><th>Mechanism of action</th><th>Approved indication</th></thead><tr><td></td><td>Anti-CD20</td><td>Eliminates B cells</td><td>Non-Hodgkin's lymphoma</td></tr><tr><td></td><td>Anti-CD52</td><td>Eliminates lymphocytes</td><td>Chronic myeloid leukemia</td></tr><tr><td></td><td>Anti-CD3</td><td>Inhibits T-cell activation</td><td rowspan="3">Kidney transplantation</td></tr><tr><td></td><td>Anti-IL-2R</td><td>Reduces T-cell activation</td><td></td></tr><tr><td></td><td>Anti-IL-2R</td><td>Reduces T-cell activation</td><td></td></tr><tr><td></td><td>Anti-TNF-o.</td><td></td><td>Crohn's disease</td></tr><tr><td></td><td>Anti-TNF-o.</td><td>Inhibit inflammation</td><td rowspan="3">Rheumatoid arthritis</td><td></td></tr><tr><td></td><td>Anti-TNF-o.</td><td>induced by TNF-a</td></tr><tr><td></td><td>Anti-TNF-o.</td><td></td><td></td></tr><tr><td></td><td>: Anti-IL-GR</td><td>Blocks inflammation induced by IL-6 signaling</td><td></td></tr><tr><td></td><td>i Anti-IL-1p</td><td>Blocks inflammation caused by IL-1</td><td>Muckle—Wells syndrome</td></tr><tr><td></td><td>a a Anti-RANK-L</td><td>Inhibits activation of osteoclasts by RANK-L</td><td>Bone loss</td></tr><tr><td></td><td>i-IL- Anti-IL-12/23</td><td>Inhibits inflammation caused by IL-12 and IL-23</td><td>Jaci Psoriasis</td></tr><tr><td></td><td>Anti-CD11a (a, integrin subunit)</td><td rowspan="2">Block lymphocyte trafficking</td><td>Psoriasis (withdrawn from use in United States and European Union)</td></tr><tr><td></td><td>Anti-a, integrin</td><td></td><td>Multiple sclerosis</td></tr><tr><td></td><td>Anti-IgE</td><td>Removes IgE antibody</td><td>Chronic asthma</td></tr><tr><td></td><td>Anti-BLyS</td><td>Reduces B-cell responses</td><td>Systemic lupus erythematosus (pending approval)</td></tr><tr><td></td><td>Anti-CTLA-4</td><td>Increases CD4 T-cell responses</td><td>Metastatic melanoma</td></tr><tr><td></td><td>Anti-Bacillus anthracis protective antigen (the cell-binding moiety of anthrax toxin)</td><td>Prevents action of anthrax toxins</td><td>Anthrax infection (pending approval)</td></tr></table>
======================================
<table><thead><th>Target</th><th>Therapeutic agent</th><th>Disease</th><th>Disease outcome</th><th>Disadvantages</th></thead><tr><td>integrins</td><td>4:8, integrin-specific monoclonal antibody (mAb)</td><td>Relapsing/ remitting multiple sclerosis (MS) Rheumatoid arthritis (RA) Inflammatory bowel disease</td><td>Reduction in | relapse rate; delay | in disease progression</td><td>Increased risk of infection; progressive multifocal encephalopathy</td></tr><tr><td>B cells</td><td>CD20-specific mAb</td><td>RA Systemic lupus erythematosus (SLE) MS</td><td>Improvement in arthritis, possibly in SLE</td><td>Increased risk of infection</td></tr><tr><td>HMG-coenzyme A</td><td>Statins</td><td>MS</td><td>Reduction in</td><td>Hepatotoxicity;</td></tr><tr><td rowspan="2">reductase T cells</td><td>CD3-specific mAb |</td><td>Type 1 diabetes mellitus</td><td>disease activity Reduced insulin use</td><td>rhabdomyolysis Increased risk of infection</td></tr><tr><td></td><td>CTLA-4-immuno- globulin fusion protein</td><td>RA Psoriasis Ms</td><td>Improvement in arthritis</td><td></td></tr><tr><td rowspan="5">Cytokines</td><td>TNF-specific mAb | and soluble TNFR | fusion protein</td><td>RA Crohn's disease Psoriatic arthritis Ankylosing spondylitis</td><td>Improvement in disability; joint repair in arthritis</td><td>Increased risk of tuberculosis and other infections; slight increase in tisk of lymphoma</td></tr><tr><td></td><td>IL-1 receptor antagonist</td><td>RA</td><td>Improves disability</td><td>Low efficacy</td></tr><tr><td></td><td>IL-15-specific mAb</td><td>RA</td><td>May improve disability</td><td>Increased risk of opportunistic infection</td></tr><tr><td></td><td>IL-6 receptor- specific mAb</td><td>RA</td><td>Decreased disease activity</td><td>Increased risk of opportunistic infection</td></tr><tr><td></td><td>Type l interferons |</td><td>Relapsing/ remitting MS</td><td>Reduction in relapse rate</td><td>Liver toxicity; influenza-like syndrome is common</td></tr></table>
======================================
<table><tr><td rowspan="4">TmORspentiC iutated oncogene r tumor uppressor gene</td><td>Cyclin- dependent kinase 4</td><td>Cell-cycle regulator</td><td>Melanoma</td></tr><tr><td></td><td>B-Catenin</td><td>Relay in signal transduction pathway</td><td>Melanoma</td></tr><tr><td></td><td>Caspase 8</td><td>‘ Regulator of apoptosis</td><td>Squamous cell carcinoma</td></tr><tr><td></td><td>ove a P</td><td>Specific antibody after gene rearrangements in B-cell clone</td><td>Lymphoma</td></tr><tr><td>4 acer testis wy</td><td>MAGE-1 MAGE-3 NY-ESO-1</td><td>Normal testicular proteins</td><td>Melanoma Breast Glioma</td></tr><tr><td>. -— ifferentiation</td><td>a Tyrosinase</td><td>Enzyme in pathway of melanin synthesis</td><td>Melanoma</td></tr><tr><td rowspan="2">prone ene expression</td><td>HER-2/neu</td><td>ae Receptor tyrosine kinase</td><td>Breast Ovary</td></tr><tr><td></td><td>WT1</td><td>_ Transcription factor</td><td>A Leukemia</td></tr><tr><td>bnormal post- anslational aaa 1odification</td><td>MUC-1</td><td>Underglycosylated mucin</td><td>peast ancreas</td></tr><tr><td>bnormal post- anscriptional 1odification</td><td>NA17</td><td>Retention of introns in the mRNA</td><td>Melanoma</td></tr><tr><td>ncoviral protein</td><td>HPV type 16, E6 and E7 proteins</td><td>, . Mira ansormnd 9 Pl</td><td>Cervical carcinoma</td></tr></table>
======================================
<table><tr><td rowspan="2">Lymphoma/ leukemia</td><td>Differentiation antigen</td><td>CDS Idiotype CD52 (Campath-1H)</td><td>T-cell lymphoma B-cell lymphoma T- and B-cell lymphoma/ leukemia</td></tr><tr><td></td><td>B-cell signaling receptor</td><td>cD20</td><td>Non-Hodgkin's B-cell lymphoma</td></tr><tr><td rowspan="4">Solid tumors</td><td>Cell-surface antigens Glycoprotein</td><td>CEA, mucin-1</td><td>Epithelial tumors</td></tr><tr><td></td><td>Carbohydrate</td><td>Lewis CA-125</td><td>(breast, colon, lung) Epithelial tumors Ovarian carcinoma</td></tr><tr><td></td><td>Growth factor receptors</td><td>Epidermal growth factor receptor HER-2/neu IL-2 receptor Vascular endothelial growth factor (VEGF)</td><td>Lung, breast, and head and neck tumors Breast, ovarian tumors T- and B-cell tumors Colon cancer Lung, prostate, breast</td></tr><tr><td></td><td>Stromal extracellular antigen</td><td>FAP-o Tenascin Metalloproteinases</td><td>Epithelial tumors Glioblastoma multiforme Epithelial tumors</td></tr></table>
======================================
<table><thead><th>Di ISease</th><th>Estimated annual mortality</th></thead><tr><td>Malaria</td><td>618,248</td></tr><tr><td>Schistosomiasis</td><td>21,797</td></tr><tr><td>Intestinal worm infestation</td><td>3304</td></tr><tr><td>Tuberculosis</td><td>934,879</td></tr><tr><td>Diarrheal disease</td><td>1,497,724</td></tr><tr><td>Respiratory infections</td><td>3,060,837</td></tr><tr><td>HIV/AIDS</td><td>1,533,760</td></tr><tr><td>Measles”</td><td>130,461</td></tr></table>
======================================
<table><thead><th>Safe</th><th>Vaccine must not itself cause illness or death</th></thead><tr><td>. Protective</td><td>Vaccine must protect against illness resulting from exposure to live pathogen</td></tr><tr><td>Gives. sustained protection</td><td>Protection against illness must last for several years</td></tr><tr><td>Induces neutralizing antibody</td><td>Some pathogens (such as polio virus) infect cells that cannot be replaced (e.g., neurons). Neutralizing antibody is essential to prevent infection of such cells</td></tr><tr><td>mouces ate jl Ive cells</td><td>Some pathogens, particularly intracellular, are more effectively dealt with by cell-mediated responses</td></tr><tr><td>Practical considerations |</td><td>Low cost per dose Biological stability Ease of administration Few side-effects</td></tr></table>
======================================
<table><tr><td></td><td>——_———</td><td></td></tr><tr><td>om . Lipopolysaccharide</td><td></td><td>iii.</td></tr><tr><td>DNA</td><td></td><td>iv.</td></tr><tr><td>1</td><td></td><td></td></tr></table>
======================================
<table><thead><th>Adjuvant name</th><th>Composition</th><th>Mechanism of action</th></thead><tr><td>Incomplete Freund’s adjuvant</td><td>Oil-in-water emulsion</td><td>Delayed release of antigen; enhanced uptake by macrophages</td></tr><tr><td>Complete Freund’s adjuvant</td><td>Oil-in-water emulsion with dead mycobacteria that stimulate C-type lectin receptors</td><td>Delayed release of antigen; enhanced uptake by macrophages; induction of co-stimulators in macrophages</td></tr><tr><td>Freund’s adjuvant with MDP</td><td>Oil-in-water emulsion with muramyl dipeptide (MDP), a constituent of mycobacteria that stimulates NOD-like receptors</td><td>Similar to complete Freund’s adjuvant</td></tr><tr><td>Alum (aluminum hydroxide)</td><td>Aluminum hydroxide gel</td><td>Delayed release of antigen; enhanced macrophage uptake</td></tr><tr><td>Alum plus Bordetella pertussis</td><td>Aluminum hydroxide gel with killed B. pertussis</td><td>Delayed release of antigen; enhanced uptake by macrophages; induction of co-stimulators</td></tr><tr><td>Immune stimulatory complexes (ISCOMs)</td><td>Matrix of Quil A containing viral proteins</td><td>Delivers antigen to cytosol; allows induction of cytotoxic T cells</td></tr><tr><td>TLR agonists</td><td>Lipopolysaccharide, flagellin, lipopeptides, ds-RNA, unmethylated DNA</td><td>Inflammatory cytokine production, induction of co-stimulators, enhanced antigen presentation to T cells</td></tr><tr><td>NOD-like receptor (NLR) agonists</td><td>Muramyl dipeptide (bacterial cell wall constituent)</td><td>Inflammatory cytokine production, induction of co-stimulators, enhanced antigen presentation to T cells</td></tr><tr><td>C-type lectin receptor agonists</td><td>Mycobacterial cell wall component trehalose-6,6’-dimycolate</td><td>Inflammatory cytokine production</td></tr></table>
======================================
<table><thead><th>Probe</th><th>ea</th><th>Emission (nm)</th></thead><tr><td>pees</td><td>480; 565</td><td></td></tr><tr><td>Fluorescein</td><td>495</td><td></td></tr><tr><td>PerCP</td><td>490</td><td></td></tr><tr><td>Texas Red</td><td>589</td><td></td></tr><tr><td>Rhodamine</td><td>550</td><td></td></tr></table>
======================================
<table><tr><td rowspan="4">sample {</td><td>MS1 spectra</td><td>MS2 spectra</td><td></td><td></td><td>MS2</td></tr><tr><td></td><td></td><td></td><td>Ly Tly[RJ1[1]k|s[s[D/P[v</td><td>PT YRIIKSSDPVPT RIIKSSDPVPT</td><td>spectra</td></tr><tr><td></td><td>fragmentation</td><td></td><td></td><td>ITIKSSDPVPT IKSSDPVPT</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td></tr></table>
======================================
<table><thead><th></th><th colspan="5">Evaluation of the cellular components of the human immune system</th></thead><thead><th></th><th>B cells</th><th></th><th>T cells</th><th></th><th>Phagocytes</th></thead><tr><td>Normal numbers (x10° per liter of blood)</td><td>Approximately</td><td>0.3</td><td>Total 1.0-2.5 CD4 0.5-1.6 CD8 0.3-0.9</td><td>Monocytes Polymorphonuclear Neutrophils Eosinophils</td><td>0.15-0.6 leukocytes: 3.00-5.5 0.05-0.25 Basophils 0.02</td></tr><tr><td>Measurement of function in vivo</td><td>Serum lg Specific antibody levels</td><td>levels</td><td>Skin test</td><td></td><td>_</td></tr><tr><td>Measurement fo) a an) cats</td><td>Induced antibody in response pokeweed</td><td>production to mitogen or</td><td>T-cell proliferation in response to phytohemagglutinin to tetanus toxoid</td><td>Nitroblue of</td><td>Phagocytosis tetrazolium uptake Intracellular killing bacteria</td></tr><tr><td></td><td>Evaluation</td><td>of the humoral</td><td>components of</td><td>the human</td><td>immune system</td></tr><tr><td></td><td></td><td></td><td>Immunoglobulins</td><td></td><td>Complement</td></tr><tr><td>Component</td><td>IgG</td><td>IgM</td><td>IgA</td><td>IgE</td><td></td></tr><tr><td>Normal levels</td><td>edt? 600-1400 mgedi"'|</td><td>edt 40-345 mgedI"*</td><td>edi | 60-380 mgedI</td><td>emt! 0-200 IUemf</td><td>CHeo of 125-300 Uemi</td></tr></table>
======================================
<table><thead><th>Mitogen</th><th>Responding cells</th></thead><tr><td>Phytohemagglutinin (PHA) (red kidney bean)</td><td>T cells</td></tr><tr><td>Concanavalin (ConA) (jack bean)</td><td>T cells</td></tr><tr><td>Pokeweed mitogen (PWM) (pokeweed)</td><td>T and B cells</td></tr><tr><td>Lipopolysaccharide (LPS) (Escherichia coli)</td><td>B cells (mouse)</td></tr></table>
======================================
<table><tr><td>CD1a, b,c, d</td><td>Cortical thymocytes, Langerhans cells, dendritic cells, B cells (CD1c), intestinal epithelium, smooth muscle, blood vessels (CD1d)</td><td>43-49</td><td>MHC class |-like molecule, associated with B2-microglobulin. Has specialized role in presentation of lipid antigens</td><td></td><td>Immunoglobulin</td></tr><tr><td>cD2</td><td>T cells, thymocytes, NK cells</td><td>45-58</td><td>Adhesion molecule, binding CD58 (LFA-3). Binds Lck intracellularly and activates T cells</td><td>711, LFA-2</td><td>Immunoglobulin</td></tr><tr><td>CD3</td><td>Thymocytes, T cells</td><td>y: 25-28 6:20 «20</td><td>Associated with the T-cell antigen receptor (TCR). Required for cell-surface expression of and signal transduction by the TCR</td><td>13</td><td>Immunoglobulin</td></tr><tr><td>CD4</td><td>Thymocyte subsets, helper T cells and Treg cells, some ILC3 cells (LTi cells), some NKT cells, some monocytes and macrophages</td><td>55</td><td>Co-receptor for MHC class II molecules. Binds Lek on cytoplasmic face of membrane. Receptor for HIV-1 and HIV-2 gp120</td><td>74, L3T4</td><td>Immunoglobulin</td></tr><tr><td>CDS</td><td>Thymocytes, T cells, subset of B cells</td><td>67</td><td>Attenuates TCR signaling. Enhances Akt signaling in T cells. Required for optimal T,42 and 1,17 differentiation</td><td>Ti Lyl</td><td>Scavenger receptor</td></tr><tr><td>CD6</td><td>Thymocytes, T cells, B cells in chronic lymphatic leukemia</td><td>100-130</td><td>Binds CD166</td><td>112</td><td>Scavenger receptor</td></tr><tr><td>CD8</td><td>Thymocyte subsets, cytotoxic T cells (about one third of peripheral T cells), a chain homodimer is expressed on a subset of dendritic cells and intestinal lymphocytes</td><td></td><td>pluripotential stem cell leukemias Co-receptor for MHC class | molecules Binds Lck on cytoplasmic face of membrane</td><td>18, Lyt2,3</td><td>Immunoglobulin</td></tr><tr><td>cD9</td><td>Pre-B cells, monocytes, eosinophils, basophils, platelets, activated T cells, brain and peripheral nerves, vascular smooth muscle</td><td>24</td><td>Mediates platelet aggregation and activation via FcyRlla, may play a role in cell migration</td><td>MIC3, MRP-1, BICC-1, DRAP-27, TSPAN29</td><td>Tetraspanning membrane protein, also called transmembrane 4 (TM)</td></tr><tr><td>CD10</td><td>B- and T-cell precursors, bone marrow stromal cells, and some endothelial cells</td><td></td><td>Zinc metalloproteinase, marker for pre-B acute lymphatic leukemia (ALL)</td><td>Neutral endopeptidase, common acute lymphocytic leukemia antigen (CALLA)</td><td></td></tr><tr><td>CDila</td><td>Lymphocytes, granulocytes, monocytes, and macrophages</td><td>180</td><td>aL subunit of integrin LFA-1 (associated with CD18); binds to CD54 (ICAM-1), CD102 (ICAM-2), and CD50 (ICAM-3)</td><td>LFA-1</td><td>Integrin a</td></tr><tr><td>CD11b</td><td>Myeloid and NK cells</td><td>170</td><td>aM subunit of integrin CR3 (associated with CD18): binds CD54, complement component iC3b, and extracellular matrix proteins</td><td>Mac-1, Mac-1a, CR3, CR3A, Ly40</td><td>Integrin a</td></tr><tr><td>CD11c</td><td>Myeloid cells</td><td>150</td><td>aX subunit of integrin CR4 (associated with CD18); binds fibrinogen</td><td>CR4, p150, 95</td><td>Integrin a</td></tr></table>
======================================
<table><tr><td></td><td>Leukocytes</td><td>125</td><td>aD subunits of integrin; associated with CD18; binds to CD50</td><td rowspan="2">ADB2</td><td>Integrin a</td></tr><tr><td></td><td>Monocytes, granulocytes, platelets</td><td>90-120</td><td>Unknown</td><td></td><td></td></tr><tr><td></td><td>Myelomonocytic cells</td><td>150-170</td><td>Zinc metalloproteinase</td><td>Aminopeptidase N</td><td></td></tr><tr><td></td><td>Myelomonocytic cells</td><td>53-55</td><td>Receptor for complex of lipopoly- saccharide and lipopolysaccharide binding protein (LBP)</td><td></td><td></td></tr><tr><td>CD15</td><td>Neutrophils, eosinophils, monocytes</td><td>59</td><td>Terminal trisaccharide expressed on glycolipids and many cell-surface glycoproteins</td><td>Lewis* (Le*)</td><td></td></tr><tr><td>CD15s</td><td>Leukocytes, endothelium</td><td>43</td><td>Ligand for CD62E, P</td><td>Sialyl-Lewis* (sLe*)</td><td>poly-NV-acetyl- lactosamine</td></tr><tr><td>CD15u</td><td>Subset of memory T cells, NK cells</td><td>41</td><td>Sulfated CD15</td><td></td><td>Carbohydrate structures</td></tr><tr><td>CD16a</td><td>NK cells</td><td>50-80</td><td>Contributes to phagocytosis and antibody- dependent cell-mediated cytotoxicity as component of low affinity Fc receptor, FcyRIll, expressed by NK cells. Highly similar to CD16b</td><td>FeyRilla</td><td>Immunoglobulin</td></tr><tr><td>CD17</td><td>Neutrophils, monocytes, platelets</td><td></td><td>macrophages. Highly similar to CD16a Lactosyl ceramide, a cell-surface glycosphingolipid</td><td></td><td></td></tr><tr><td>CD18</td><td>Leukocytes</td><td>95</td><td>Integrin B2 subunit, associates with CD11a, b,c, andd</td><td>LAD, MF17, MFI7, LCAMB, LFA-1, Mac-1</td><td>Integrin B</td></tr><tr><td>CD19</td><td>B cells</td><td>95</td><td>Forms complex with CD21 (CR2) and CD81 (TAPA-1); co-receptor for B cells— cytoplasmic domain binds cytoplasmic tyrosine kinases and PI 3-kinase</td><td></td><td>Immunoglobulin</td></tr><tr><td>CD20</td><td>B cells</td><td>33-37</td><td>Oligomers of CD20 may form a Ca channel; possible role in regulating B-cell activation; involved in B-cell development and plasma B-cell differentiation</td><td></td><td>Contains 4 transmembrane segments</td></tr><tr><td>CD21</td><td>Mature B cells, follicular dendritic cells</td><td>145</td><td>Receptor for complement component C3d, Epstein-Barr virus. With CD19 and CD81, CD21 forms co-receptor for B cells</td><td>CR2</td><td>Complement control protein (CCP)</td></tr><tr><td>CD22</td><td>Mature B cells</td><td>a: 130 B: 140</td><td>Binds sialoconjugates</td><td>BL-CAM, SIGLEC-2, Lyb8</td><td>Immunoglobulin</td></tr><tr><td>CD23</td><td>Mature B cells, activated macrophages, eosinophils, follicular dendritic cells, platelets</td><td>45</td><td>Low-affinity receptor for IgE, regulates IgE synthesis; ligand for CD19:CD21:CD81 co-receptor</td><td>FceRIl, FCE2, CD23A, CLEC4J, BLAST-2</td><td rowspan="2">C-type lectin</td></tr><tr><td>CD24</td><td>B cells, granulocytes</td><td>35-45</td><td>Sialoglycoprotein, anchored to cell surface via glycosylphosphatidylinositol (GPI) link</td><td>Possible human homolog of mouse heat stable antigen (HSA)</td><td></td></tr></table>
======================================
<table><tr><td></td><td>Leukocytes</td><td></td><td>Integrin B1 subunit, associates with CD49a in VLA-1 integrin</td><td></td><td>Integrin B</td></tr><tr><td></td><td>Activated T, B, and NK cells, monocytes</td><td></td><td>Binds CD30L (CD153); cross-linking CD30 enhances proliferation of B and T cells</td><td>Ki-1</td><td>TNF receptor</td></tr><tr><td></td><td>Monocytes, platelets, granulocytes, T-cell subsets, endothelial cells</td><td>130-140</td><td>Adhesion molecule, mediating both leukocyte—endothelial and endothelial— endothelial interactions</td><td>PECAM-1</td><td>Immunoglobulin</td></tr><tr><td></td><td>Monocytes, granulocytes, B cells, eosinophils</td><td>40</td><td>Low affinity Fe receptor for aggregated immunoglobulin:immune complexes</td><td>FoyRil</td><td>Immunoglobulin</td></tr><tr><td></td><td>Myeloid progenitor cells, monocytes</td><td>67</td><td>Binds sialoconjugates</td><td>SIGLEC-3</td><td>Immunoglobulin</td></tr><tr><td></td><td>Hematopoietic precursors, capillary endothelium</td><td>105-120</td><td>Ligand for CD62L (L-selectin), attaches bone marrow stem cells to stromal cell extracellular matrix</td><td></td><td>Mucin</td></tr><tr><td>CD35</td><td>Erythrocytes, B cells, monocytes, neutrophils, eosinophils, follicular dendritic cells</td><td>250</td><td>Complement receptor 1, binds C3b and C4b, mediates phagocytosis</td><td>CRI</td><td>CcP</td></tr><tr><td>CD36</td><td>Platelets, monocytes, endothelial cells</td><td></td><td>Platelet adhesion molecule; involved in recognition and phagocytosis of apoptosed cells</td><td>Platelet GPIV, GPIllb</td><td></td></tr><tr><td>CD37</td><td>Mature B cells, mature T cells, myeloid cells</td><td>40-52</td><td>Unknown, may be involved in signal transduction; may play a role in T-cell/ B-cell interactions; forms complexes with CD53, CD81, CD82, and MHC class II</td><td>TSPAN26</td><td>Transmembrane 4</td></tr><tr><td>CD38</td><td>Early B and T cells, activated T cells, germinal center B cells, plasma cells</td><td>45</td><td>NAD glycohydrolase, augments B-cell proliferation</td><td>710</td><td></td></tr><tr><td>CD39</td><td>Activated B cells, activated NK cells, macrophages, dendritic cells</td><td>78</td><td>Involved in suppressive functions of CD4* Treg Cells; may mediate adhesion of B cells</td><td>ENTPD1; ATPDase; NTPDase-1</td><td></td></tr><tr><td>CD40</td><td>B cells, macrophages, dendritic cells, basal epithelial cells</td><td>48</td><td>Binds CD154 (CD40L); receptor for co-stimulatory signal for B cells, promotes growth, differentiation, and isotype switching of B cells, and promotes germinal center formation and memory B-cell development; promotes cytokine production by macrophages and dendritic cells</td><td>TNFRSFS</td><td>TNF receptor</td></tr><tr><td>CD41</td><td>Platelets, megakaryocytes</td><td>Dimer: GPllba: 125 GPllbb: 22</td><td>allb integrin, associates with CD61 to form GPllb, binds fibrinogen, fibronectin, von Willebrand factor, and thrombospondin</td><td>GPllb</td><td>Integrin a</td></tr><tr><td>CD42a, b,c, d</td><td>Platelets, megakaryocytes</td><td>a: 23 b: 135, 23 c: 22 d: 85</td><td>Binds von Willebrand factor, thrombin; essential for platelet adhesion at sites of injury</td><td>a: GPIX b: GPlba. c: GPIbB d: GPV</td><td>Leucine-rich repeat</td></tr><tr><td>CD43</td><td>Leukocytes, except resting B cells</td><td>115-135 (neutrophils) 95-115 (T cells)</td><td>Has extended structure approx. 45 nm long and may be anti-adhesive</td><td>Leukosialin, sialophorin</td><td>Mucin</td></tr><tr><td>CD44</td><td>Leukocytes, erythrocytes</td><td>80-95</td><td>Binds hyaluronic acid, mediates adhesion of leukocytes</td><td>Hermes antigen, Pgp-1</td><td>Link protein</td></tr><tr><td>CD45</td><td>All hematopoietic cells</td><td>180-240 (multiple isoforms)</td><td>Tyrosine phosphatase, augments signaling through antigen receptor of B and T cells, multiple isoforms result from alternative splicing (see below)</td><td>Leukocyte common antigen (LCA), 1200, B220</td>
======================================
<td>Protein tyrosine phosphatase (PTP); fibronectin type III</td></tr></table>
======================================
<table><tr><td></td><td>Hematopoietic and non-hematopoietic nucleated cells</td><td>56/66 (splice variants)</td><td>Membrane co-factor protein, binds to C3b and C4b to permit their degradation by Factor |</td><td>MCP</td><td>CcP</td></tr><tr><td></td><td>Allcells</td><td>47-52</td><td>Adhesion molecule, thrombospondin receptor</td><td>IAP, MER6, OA3</td><td>Immunoglobulin</td></tr><tr><td></td><td>Leukocytes</td><td>40-47</td><td>Putative ligand for CD244</td><td>Blast-1</td><td>Immunoglobulin</td></tr><tr><td></td><td>Activated T cells, monocytes, neuronal cells, smooth muscle</td><td>200</td><td>1 integrin, associates with CD29, binds collagen, laminin-1</td><td>VLA-1</td><td>Integrin a</td></tr><tr><td></td><td>B cells, monocytes, platelets, megakaryocytes, neuronal, epithelial and endothelial cells, osteoclasts</td><td>160</td><td>a2 integrin, associates with CD29, binds collagen, laminin</td><td>VLA-2, platelet GPla</td><td>Integrin a</td></tr><tr><td>CD49c</td><td>B cells, many adherent cells</td><td>125, 30</td><td>a3 integrin, associates with CD29, binds laminin-5, fibronectin, collagen, entactin, invasin</td><td>VLA-3</td><td>Integrin a</td></tr><tr><td>CD49d</td><td>Broad distribution includes B cells, thymocytes, monocytes, granulocytes, dendritic cells</td><td>150</td><td>a4 integrin, associates with CD29, binds fibronectin, MAdCAM-1, VCAM-1</td><td>VLA-4</td><td>Integrin a</td></tr><tr><td>CD49e</td><td>Broad distribution includes memory T cells, monocytes, platelets</td><td>135, 25</td><td>a5 integrin, associates with CD29, binds fibronectin, invasin</td><td>VLA-5</td><td>Integrin a</td></tr><tr><td>CD49f</td><td>T lymphocytes, monocytes, platelets, megakaryocytes, trophoblasts</td><td>125, 25</td><td>a6 integrin, associates with CD29, binds laminin, invasin, merosine</td><td>VLA-6</td><td>Integrin a</td></tr><tr><td>CD50</td><td>Thymocytes, T cells, B cells, monocytes, granulocytes</td><td>130</td><td>Binds integrin CD11a/CD18</td><td>ICAM-3</td><td>Immunoglobulin</td></tr><tr><td>CD51</td><td>Platelets, megakaryocytes</td><td>125, 24</td><td>aV integrin, associates with CD61, binds vitronectin, von Willebrand factor, fibrinogen, and thrombospondin; may be receptor for apoptotic cells</td><td>Vitronectin receptor</td><td>Integrin a</td></tr><tr><td>CD52</td><td>Thymocytes, T cells, B cells (not plasma cells), monocytes, granulocytes, spermatozoa</td><td>25</td><td>Unknown, target for antibodies used therapeutically to deplete T cells from bone marrow</td><td>CAMPATH-1, HES</td><td></td></tr><tr><td>CD53</td><td>Leukocytes</td><td>35-42</td><td>Contributes to transduction of CD2- generated signals in T cells and NK cells; may play a role in regulation of growth</td><td>MRC 0x44</td><td>Transmembrane 4</td></tr><tr><td>CD54</td><td>Hematopoietic and non-hematopoietic cells</td><td>75-115</td><td>Intercellular adhesion molecule (ICAM)-1 binds CD11a/CD18 integrin (LFA-1) and CD11b/CD18 integrin (Mac-1), receptor for rhinovirus</td><td>ICAM-1</td><td>Immunoglobulin</td></tr><tr><td>CD55</td><td>Hematopoietic and non-hematopoietic cells</td><td>60-70</td><td>Decay accelerating factor (DAF), binds C3b, disassembles C3/C5 convertase</td><td>DAF</td><td>CcP</td></tr><tr><td>CD56</td><td>NK cells, some activated T cells</td><td>135-220</td><td>|soform of neural cell-adhesion molecule (NCAM), adhesion molecule</td><td>NKH-1</td><td>Immunoglobulin</td></tr><tr><td>CD57</td><td>NK cells, subsets of T cells, B cells, and monocytes</td><td></td><td>Oligosaccharide, found on many cell-surface glycoproteins</td><td>HNK-1, Leu-7</td><td></td></tr><tr><td>CD58</td><td>Hematopoietic and non-hematopoietic cells</td><td>55-70</td><td>Leukocyte function-associated antigen-3 (LFA-3), binds CD2, adhesion molecule</td><td>LFA-3</td><td>Immunoglobulin</td></tr><tr><td>CD59</td><td>Hematopoietic and non-hematopoietic cells</td><td></td><td>Binds complement components C8 and C9, blocks assembly of membrane-attack complex</td><td>Protectin, 
======================================
Mac inhibitor</td><td>Ly-6</td></tr><tr><td>CD60a</td><td>T cells, platelets, keratinocytes, smooth muscle cells</td><td>70</td><td>Disialyl ganglioside D3 (GD3)</td><td></td><td>Carbohydrate structures</td></tr></table>
======================================
<table><tr><td></td><td>Endothelium</td><td></td><td>Endothelium leukocyte adhesion molecule (ELAM), binds sialyl-Lewis*, mediates rolling interaction of neutrophils on endothelium</td><td>ELAM-1, E-selectin</td><td>C-type lectin, EGF, and CCP</td></tr><tr><td>CD62L</td><td>B cells, T cells, monocytes, NK cells</td><td>150</td><td>Leukocyte adhesion molecule (LAM), binds CD34, GlyCAM, mediates rolling interactions with endothelium</td><td>LAM-1, L-selectin, LECAM-1</td><td>C-type lectin, EGF, and CCP</td></tr><tr><td>CD62P</td><td>Platelets, megakaryocytes, endothelium</td><td>140</td><td>Adhesion molecule, binds CD162 (PSGL-1), mediates interaction of platelets with endothelial cells, monocytes and rolling leukocytes on endothelium</td><td>P-selectin, PADGEM</td><td>C-type lectin, EGF, and CCP</td></tr><tr><td>CD63</td><td>Activated platelets, monocytes, macrophages</td><td>53</td><td>Unknown, is lysosomal membrane protein translocated to cell surface after activation</td><td>Platelet activation antigen</td><td>Transmembrane 4</td></tr><tr><td>CD64</td><td>Monocytes, macrophages</td><td>72</td><td>High-affinity receptor for IgG, binds IgG3&gt;IgG1&gt;IgG4&gt;&gt;&gt;IlgG2, mediates phagocytosis, antigen capture, ADCC</td><td>FeyRI</td><td rowspan="2">Immunoglobulin</td></tr><tr><td>CD65</td><td>Myeloid cells</td><td>47</td><td>Oligosaccharide component of a ceramide dodecasaccharide</td><td></td><td></td></tr><tr><td>CD66a</td><td>Neutrophils, NK cells</td><td>160-180</td><td>Inhibits NKG2D-mediated cytolytic function and signaling in activated NK cells</td><td>C-CAM, BGP1, CEA-1, CEA-7, MHVR1</td><td>Immunoglobulin</td></tr><tr><td>CD66b</td><td>Granulocytes</td><td>95-100</td><td>Regulates adhesion and activation of human eosinophils</td><td>CEACAMB, CD67, CGM6, NCA-95 (previously called CD67)</td><td>Immunoglobulin</td></tr><tr><td>CD66c</td><td>Neutrophils, colon carcinoma</td><td>90</td><td>Regulation of CD8* T-cell responses against multiple myeloma</td><td>CEACAMB, NCA</td><td>Immunoglobulin</td></tr><tr><td>CD66d</td><td>Neutrophils</td><td>30</td><td>Directs phagocytosis of several bacterial species, thought to regulate innate immune response</td><td>CEACAMS, CEA, CGM1, W264, W282</td><td>Immunoglobulin</td></tr><tr><td>CD66e</td><td>Adult colon epithelium, colon carcinoma</td><td>180-200</td><td>Resistance to bacterial and viral infections of the respiratory tract</td><td>CEACAMS</td><td>Immunoglobulin</td></tr><tr><td>CD66f</td><td>Macrophages</td><td></td><td>Upregulates arginase activity and inhibits nitric oxide production in macrophages, induces alternative activation in monocytes, suppresses accessory cell-dependent T-cell proliferation</td><td>Pregnancy specific beta-1- glycoprotein 1 (PSG1), SP1, B1G1, DHFRP2</td><td>Immunoglobulin</td></tr><tr><td>CD68</td><td>Monocytes, macrophages, neutrophils, basophils, large lymphocytes</td><td>110</td><td>Unknown</td><td>Macrosialin, GP110, LAMP4, SCARD1</td><td>Lysosomal/ endosomal- associated membrane glycoprotein (LAMP), scavenger receptor</td></tr><tr><td>CD69</td><td>Activated T and B cells, activated macrophages and NK cells</td><td>28, 32 homodimer</td><td>Downregulates S1PR1 to promote retention in secondary lymphoid tissues, may play a role in regulating proliferation, may act to transmit signals in natural killer cells and platelets</td><td>Activation inducer molecule (AIM)</td><td>C-type lectin</td></tr><tr><td></td><td>Activated T and B cells, and macrophages</td><td>75, 95, 170</td><td>Ligand for CD27, may function in co- stimulation of B and T cells</td><td>Ki-24</td><td>TNF</td></tr><tr><td></td><td>All proliferating cells, hence activated leukocytes</td><td>95 homodimer</td><td>Transferrin receptor</td><td>19</td><td></td></tr></table>
======================================
<table><tr><td></td><td rowspan="2">Mature B cells, T-cell subsets</td><td>47</td><td>Lactosamines, ligand for CD22, mediates B-cell-B-cell adhesion</td><td>CD76</td><td></td></tr><tr><td></td><td></td><td></td><td>a-2,6-sialylated lactosamines</td><td></td><td>Carbohydrate structures</td></tr><tr><td></td><td>Germinal center B cells</td><td>71</td><td>Neutral glycosphingolipid (Gala1—4GalB1—4GlcB1—ceramide), binds Shiga toxin, cross-linking induces apoptosis</td><td>Globotriaosyl- ceramide (Gb3) Pk blood group</td><td></td></tr><tr><td></td><td>B cells</td><td>a: 40-45 B: 37</td><td>Components of B-cell antigen receptor analogous to CD3, required for cell-surface expression and signal transduction</td><td>Iga, IgB</td><td>Immunoglobulin</td></tr><tr><td></td><td>B-cell subset</td><td>60</td><td>Co-stimulator, ligand for CD28 and CTLA-4</td><td>B7 (now B7.1), BB1</td><td>Immunoglobulin</td></tr><tr><td></td><td>Lymphocytes</td><td>26</td><td>Associates with CD19, CD21 to form B cell co-receptor</td><td>Target of anti- proliferative antibody (TAPA-1)</td><td>Transmembrane 4</td></tr><tr><td></td><td>Leukocytes</td><td>50-53</td><td>Unknown</td><td>R2</td><td>Transmembrane 4</td></tr><tr><td></td><td>Dendritic cells, B cells, Langerhans cells</td><td>43</td><td>Regulation of antigen presentation; a soluble form of this protein can bind to dendritic cells and inhibit their maturation</td><td>HB15</td><td>Immunoglobulin</td></tr><tr><td>CD84</td><td>Monocytes, platelets, circulating B cells</td><td>73</td><td>Interacts with SAP (SH2D1A) and FYN, regulates platelet function and LPS-induced cytokine secretion by</td><td>CDw84, SLAMES, Ly9b</td><td>Immunoglobulin</td></tr><tr><td>CD85</td><td>Dendritic cells, monocytes, macrophages, and lymphocytes</td><td></td><td>macrophages Binds to MHC class | molecules on antigen-presenting cells, inhibits activation</td><td>LILR1-9, ILT2, LIR1, MIR?</td><td>Immunoglobulin</td></tr><tr><td>CD86</td><td>Monocytes, activated B cells, dendritic cells</td><td>80</td><td>Ligand for CD28 and CTLA4</td><td>B7.2</td><td>Immunoglobulin</td></tr><tr><td>CD87</td><td>Granulocytes, monocytes, macrophages, T cells, NK cells, wide variety of non-hematopoietic cell types</td><td>35-59</td><td>Receptor for urokinase plasminogen activator</td><td>uPAR</td><td>Ly-6</td></tr><tr><td>CD88</td><td>Polymorphonuclear leukocytes, macrophages, mast cells</td><td>43</td><td>Receptor for complement component C5a</td><td>C5aR</td><td>G protein-coupled receptor</td></tr><tr><td>CD89</td><td>Monocytes, macrophages, granulocytes, neutrophils, B-cell subsets, T-cell subsets</td><td>50-70</td><td>IgA receptor</td><td>FeaR</td><td>Immunoglobulin</td></tr><tr><td>CD30</td><td>CD34* prothymocytes (human), thymocytes, T cells (mouse), ILCs, some NK cells</td><td></td><td>Adhesion and trafficking of leukocytes at sites of inflammation</td><td>Thy-1</td><td>Immunoglobulin</td></tr><tr><td>CD91</td><td>Monocytes, many non-hematopoietic cells</td><td></td><td>a2-macroglobulin receptor</td><td></td><td>EGF, LDL receptor</td></tr><tr><td>CD92</td><td>Neutrophils, monocytes, platelets, endothelium</td><td></td><td>Choline transporter</td><td></td><td></td></tr><tr><td>CD93</td><td>Neutrophils, monocytes, endothelium</td><td></td><td>Intercellular adhesion and clearance of apoptotic cells/debris</td><td>C10R1</td><td></td></tr><tr><td>CD94</td><td>T-cell subsets, NK cells</td><td></td><td>Regulation of NK-cell function</td><td>KLRD1</td><td>C-type lectin</td></tr><tr><td>CD95</td><td>Wide variety of cell lines, in vivo distribution uncertain</td><td></td><td>Binds TNF-like Fas ligand, induces apoptosis</td><td>Apo-1, Fas</td><td>TNF receptor</td></tr><tr><td>CD96</td><td>Activated T cells, NK cells</td><td></td><td>Adhesive interactions of activated T and NK cells, may influence antigen presentation</td><td>T-cell activation increased late expression (TACTILE)</td><td>Immunoglobulin</td></tr></table>
======================================
<table><tr><td></td><td>Hematopoietic cells</td><td>150 homodimer</td><td>Ligand for Plexin B1, interacts with calmodulin</td><td>SEMA4D</td><td>Immunoglobulin, semaphorin</td></tr><tr><td></td><td>Monocytes, granulocytes, dendritic cells, activated T cells</td><td>120 homodimer</td><td>Inhibits TCR/CD3-dependent IL-2 production by T cells, induces production of IL-10 by dendritic cells</td><td>BPC#4</td><td>Immunoglobulin</td></tr><tr><td></td><td>Resting lymphocytes, monocytes, vascular endothelium cells (strongest)</td><td>55-65</td><td>Binds CD11a/CD18 (LFA-1) but not CD11b/CD18 (Mac-1)</td><td>ICAM-2</td><td>Immunoglobulin</td></tr><tr><td></td><td>Intraepithelial lymphocytes, 2-6% peri- pheral blood lymphocytes</td><td>150, 25</td><td>aE integrin</td><td>HML-1, a6, a integrin</td><td>Integrin a</td></tr><tr><td></td><td>CD4- CD8" thymocytes, neuronal, epithelial, and some endothelial cells, Schwann cells, trophoblasts</td><td>220</td><td>Integrin B4 associates with CD49f, binds laminins</td><td>4 integrin</td><td>Integrin B</td></tr><tr><td>CD105</td><td>Endothelial cells, activated monocytes and macrophages, bone marrow cell subsets</td><td>90 homodimer</td><td>Binds TGF-B</td><td>Endoglin</td><td></td></tr><tr><td>CD106</td><td>Endothelial cells</td><td>100-110</td><td>Adhesion molecule, ligand for VLA-4 (a1gB, integrin)</td><td>VCAM-1</td><td rowspan="3">Immunoglobulin</td><td></td></tr><tr><td>CD107a</td><td>Activated platelets, activated T cells, activated neutrophils, activated endothelium, NK cells</td><td>110</td><td>Influences endosome/vesicle sorting, protects NK cells from degranulation- associated damage</td><td>Lysosomal associated membrane protein-1 (LAMP-1)</td><td></td></tr><tr><td>CD107b</td><td>Activated platelets, activated T cells, NK cells, activated neutrophils, activated endothelium</td><td>120</td><td>Influences endosome/vesicle sorting, protects NK cells from degranulation- associated damage</td><td>LAMP-2</td></tr><tr><td>CD108</td><td>Erythrocytes, circulating lymphocytes, lymphoblasts</td><td>80</td><td>Receptor for PlexinC1, influences both monocyte and CD4 activation/ differentiation</td><td>GR2, John Milton- Hagen blood group antigen, SEMA7A</td><td>Semaphorin</td></tr><tr><td>cD109</td><td>Activated T cells, activated platelets, vascular endothelium</td><td>170</td><td>Binds to and negatively regulates signaling of transforming growth factor-B (TGF-B)</td><td>Platelet activation factor, GR56</td><td>2-macroglobulin/ complement</td></tr><tr><td>CD110</td><td>Platelets</td><td>71</td><td>Receptor for thrombopoietin</td><td>MPL, TPO R</td><td>Hematopoietic receptor</td></tr><tr><td>cD111</td><td>Myeloid cells</td><td>57</td><td>Plays a role in organization of adherens. and tight junctions in epithelial and endothelial cells</td><td>PPR1/Nectin1</td><td>Immunoglobulin</td></tr><tr><td>CD112</td><td>Myeloid cells</td><td>58</td><td>Component of adherens junctions</td><td>PRR2</td><td></td></tr><tr><td>CD113</td><td>Neurons</td><td></td><td>May be involved in cell adhesion and neural synapse formation; component of adherens junctions</td><td>NECTIN3, PVRL3</td><td>Immunoglobulin</td></tr><tr><td>cD114</td><td>Granulocytes, monocytes</td><td>150</td><td>Granulocyte colony-stimulating factor (G-CSF) receptor</td><td>CSF3R, GCSFR</td><td>Immunoglobulin, fibronectin type III</td></tr><tr><td>CD115</td><td>Monocytes, macrophages</td><td>150</td><td>Macrophage colony-stimulating factor (M-CSF) receptor</td><td>M-CSFR, CSFIR, C-FMS</td><td>Immunoglobulin, tyrosine kinase</td></tr><tr><td>CD116</td><td>Monocytes, neutrophils, eosinophils, endothelium</td><td>70-85</td><td>Granulocyte-macrophage colony-stimulat- ing factor (GM-CSF) receptor a chain</td><td>GM-CSFRa.</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD117</td><td>Hematopoietic progenitors</td><td>145</td><td>Stem-cell factor (SCF) receptor</td><td>c-Kit</td><td>Immunoglobulin, tyrosine kinase</td></tr><tr><td>CD118</td><td>
======================================
Broad cellular expression</td><td></td><td>Interferon-a, B receptor</td><td>IFN-o,, BR</td><td></td></tr><tr><td>CD119</td><td>Macrophages, monocytes, B cells, endothelium</td><td>90-100</td><td>Interferon-y receptor</td><td>IFN-yR, IFNGR1</td><td>Fibronectin type Ill</td></tr></table>
======================================
<table><tr><td>CD121b</td><td>B cells, macrophages, monocytes</td><td>60-70</td><td>Type Il interleukin-1 receptor, binds IL-1a. and IL-1B</td><td>IL-1R type Il</td><td>Immunoglobulin</td></tr><tr><td>CD122</td><td>NK cells, resting T-cell subsets, some B-cell lines</td><td>75</td><td>IL-2 receptor B chain</td><td>IL-2RB</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD123</td><td>Bone marrow stem cells, granulocytes, monocytes, megakaryocytes</td><td>70</td><td>IL-3 receptor a chain</td><td>IL-3Ra.</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD124</td><td>Mature B and T cells, hematopoietic precursor cells</td><td>130-150</td><td>IL-4 receptor</td><td>IL-4R</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD125</td><td>Eosinophils, basophils, activated B cells</td><td>55-60</td><td>IL-5 receptor</td><td>IL-SR</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD126</td><td>Activated B cells and plasma cells (strong), most leukocytes (weak)</td><td>80</td><td>IL-6 receptor a subunit</td><td>IL-6Ra.</td><td>Immunoglobulin, cytokine receptor, fibronectin type III</td></tr><tr><td>CD127</td><td>Bone marrow lymphoid precursors, pro-B cells, mature T cells, ILCs, monocytes</td><td>68-79, possibly forms homodimers</td><td>IL-7 receptor</td><td>IL-7R</td><td>Fibronectin type III</td></tr><tr><td>CD128a, b</td><td>Neutrophils, basophils, T-cell subsets</td><td>58-67</td><td>IL-8 receptor</td><td>IL-8R, CXCR1</td><td>G protein-coupled receptor</td></tr><tr><td>CD129</td><td>Eosinophils, thymocytes, neutrophils</td><td>57</td><td>IL-9 receptor</td><td>IL-9R</td><td>IL2RG</td></tr><tr><td>CD130</td><td>Most cell types, strong on activated B cells and plasma cells</td><td>130</td><td>Common subunit of IL-6, IL-11, oncostatin-M (OSM) and leukemia inhibitory factor (LIF) receptors</td><td>IL-GRB, IL-11RB, OSMRP, LIFRB, IFRB</td><td>Immunoglobulin, cytokine receptor, fibronectin type III</td></tr><tr><td>CD131</td><td>Myeloid progenitors, granulocytes</td><td>140</td><td>Common B subunit of IL-3, IL-5, and GM-CSF receptors</td><td>IL-3RB, IL-5RB, GM-CSFRB</td><td>Cytokine receptor, fibronectin type III</td></tr><tr><td>CD132</td><td>B cells, T cells, NK cells, mast cells, neutrophils</td><td>64</td><td>IL-2 receptor y chain, common subunit of IL-2, IL-4, IL-7, IL-9, and IL-15 receptors</td><td>IL-2RG, SCIDX</td><td>Cytokine receptor</td></tr><tr><td>CD133</td><td>Stem/progenitor cells</td><td>97</td><td>Unknown</td><td>Prominin-1, AC133</td><td></td></tr><tr><td>CD134</td><td>Activated T cells</td><td>50</td><td>Receptor for OX40L, provides co-stimulation to CD4 T cells</td><td>0x40</td><td>TNF receptor</td></tr><tr><td>CD135</td><td>Multipotential precursors, myelomonocytic and B-cell progenitors</td><td>130, 155</td><td>Receptor for FLT-3L, important for development of hematopoietic stem cells and leukocyte progenitors</td><td>FLT3, FLK2, STK-1</td><td>Immunoglobulin, tyrosine kinase</td></tr><tr><td>CD136</td><td>Monocytes, epithelial cells, central and peripheral nervous system</td><td>180</td><td>Chemotaxis, phagocytosis, cell growth, and differentiation</td><td>MSP-R, RON</td><td>Tyrosine kinase</td></tr><tr><td>CD137</td><td>T and B lymphocytes, monocytes, some epithelial cells</td><td>28</td><td>Co-stimulator of T-cell proliferation</td><td>4-1BB, TNFRSF9</td><td>TNF receptor</td></tr><tr><td>CD138</td><td>B cells</td><td>32</td><td>Heparan sulfate proteoglycan binds collagen type |</td><td>Syndecan-1</td><td></td></tr><tr><td>CD139</td><td>B cells</td><td>209, 228</td><td>Unknown</td><td></td><td></td></tr><tr><td>CD140a, b</td><td>Stromal cells, some endothelial cells</td><td>a: 180 b: 180</td><td>Platelet-derived growth factor (PDGF) receptor a and B chains</td><td></td><td></td></tr><tr><td>CD141</td><td>Vascular endothelial cells</td><td>105</td><td>Anticoagulant, binds thrombin, the complex then activates protein C</td><td>Thrombomodulin fetomodulin</td><td>C-
======================================
type lectin, EGF</td></tr><tr><td>cD142</td><td>Epidermal keratinocytes, various epithelial cells, astrocytes, Schwann cells. Absent from cells in direct contact with plasma unless induced by inflammatory mediators</td><td>45-47</td><td>Major initiating factor of clotting. Binds Factor Vila; this complex activates Factors VIL, IX, and X</td><td>Tissue factor, thromboplastin</td><td>Fibronectin type III</td></tr></table>
======================================
<table><tr><td></td><td>Endothelial cells, some stromal cells</td><td>25, 90, 110</td><td>Unknown</td><td></td><td></td></tr><tr><td></td><td>Endothelium, T cells, mesenchymal stromal cells (MSCs)</td><td>130</td><td>Maintenance of hematopoietic stem and progenitor cells, may regulate vasculogenesis</td><td>MCAM, MUC18, S-ENDO</td><td>Immunoglobulin</td></tr><tr><td>cD147</td><td>Leukocytes, red blood cells, platelets, endothelial cells</td><td>55-65</td><td>Activates some MMPs, receptor for CyPA, CypB, and some integrins</td><td>M6, neurothelin, EMMPRIN, basigin, OX-47</td><td>Immunoglobulin</td></tr><tr><td>CD148</td><td>Granulocytes, monocytes, dendritic cells, T cells, fibroblasts, nerve cells</td><td>240-260</td><td>Contact inhibition of cell growth</td><td>HPTPH</td><td>Fibronectin type III, protein tyrosine phosphatase</td></tr><tr><td>CD150</td><td>Thymocytes, activated lymphocytes</td><td>75-95</td><td>Important in signaling in T and B cells, interacts with FYN, PTPN11, SH2D1A (SAP), and SH2D1B</td><td>SLAMF1</td><td>Immunoglobulin, SLAM</td></tr><tr><td>CD151</td><td>Platelets, megakaryocytes, epithelial cells, endothelial cells</td><td>32</td><td>Associates with B1 integrins</td><td>PETA-3, SFA-1</td><td>Transmembrane 4</td></tr><tr><td>CD152</td><td>Activated T cells</td><td>33</td><td>Receptor for B7.1 (CD80), B7.2 (CD86); negative regulator of T-cell activation</td><td>CTLA-4</td><td>Immunoglobulin</td></tr><tr><td>CD153</td><td>Activated T cells, activated macrophages, neutrophils, B cells</td><td>38-40</td><td>Ligand for CD30, inhibits Ig class switching in germinal center B cells</td><td>CD30L, TNFSF8L</td><td>TNF</td></tr><tr><td>CD154</td><td>Activated CD4 T cells</td><td>30 trimer</td><td>Ligand for CD40, inducer of B-cell proliferation and activation</td><td>CD4OL, TRAP, T-BAM, gp39</td><td>TNF receptor</td></tr><tr><td>CD155</td><td>Monocytes, macrophages, thymocytes, CNS neurons</td><td>80-90</td><td>Normal function unknown; receptor for poliovirus</td><td>Poliovirus receptor</td><td>Immunoglobulin</td></tr><tr><td>CD156a</td><td>Neutrophils, monocytes</td><td>69</td><td>Metalloprotinease, cleaves TNFaR1</td><td>ADAMB, MS2</td><td></td></tr><tr><td>CD156b</td><td></td><td></td><td>TNFa. converting enzyme (TACE), cleaves pro-TNFo. to produce mature TNFa</td><td>ADAM17</td><td></td></tr><tr><td>CD156¢</td><td>Neurons</td><td></td><td>Potential adhesion molecule and known processing amyloid-precursor protein</td><td>ADAM10</td><td></td></tr><tr><td>CD157</td><td>Granulocytes, monocytes, bone marrow stromal cells, vascular endothelial cells, follicular dendritic cells</td><td>42-45 (50 on monocytes)</td><td>ADP-ribosyl cyclase, cyclic ADP-ribose hydrolase</td><td>BST-1</td><td></td></tr><tr><td>CD158</td><td>NK cells</td><td></td><td>KIR family</td><td></td><td></td></tr><tr><td>CD158a</td><td>Nk-cell subsets</td><td>50 or 58</td><td>Inhibits NK-cell cytotoxicity on binding MHC class | molecules</td><td>50.1, p58.1</td><td>Immunoglobulin</td></tr><tr><td>CD158b</td><td>Nk-cell subsets</td><td>50 or 58</td><td>Inhibits NK-cell cytotoxicity on binding HLA-Cw3 and related alleles</td><td>50.2, p58.2</td><td>Immunoglobulin</td></tr><tr><td>CD159a</td><td>NK cells</td><td>26</td><td>Binds CD94 to form NK receptor; inhibits Nk-cell cytotoxicity on binding MHC. class | molecules</td><td>NKG2A</td><td></td></tr><tr><td>CD160</td><td>T cells, NK cells, intraepithelial lymphochytes</td><td>27</td><td>Binds classical and non-classical MHC-I molecules, activates phosphoinositide-3 kinase to trigger cytotoxicity and cytokine secretion</td><td>NK1</td><td></td></tr><tr><td>CD161</td><td>NK cells, T cells, ILCs</td><td>44</td><td>Regulates NK cytotoxicity</td><td>NKRP1</td><td>C-type lectin</td></tr></table>
======================================
<table><tr><td>CD165</td><td>Thymocytes, thymic epithelial cells, CNS neurons, pancreatic islets, Bowman's capsule</td><td></td><td>Adhesion between thymocytes and thymic epithelium</td><td>6p37, AD2</td><td></td></tr><tr><td>CD166</td><td>Activated T cells, thymic epithelium, fibroblasts, neurons</td><td>100-105</td><td>Ligand for CD6, involved integrin neurite extension</td><td>ALCAM, BEN, DM-GRASP, SC-1</td><td>Immunoglobulin</td></tr><tr><td>CD167a</td><td>Normal and transformed epithelial cells</td><td>63, 64 dimer</td><td>Binds collagen</td><td>DDR1, trkE, cak, eddr1</td><td>Receptor tyrosine kinase, discoidin- related</td></tr><tr><td>CD168</td><td>Breast cancer cells</td><td>Five isoforms: 58, 60, 64, 70, 84</td><td>Adhesion molecule. Receptor for hyaluronic acid-mediated motility— mediated cell migration</td><td>RHAMM</td><td></td></tr><tr><td>CD169</td><td>Subsets of macrophages</td><td>185</td><td>Adhesion molecule. Binds sialylated carbohydrates. May mediate macrophage binding to granulocytes and lymphocytes</td><td>Sialoadhesin</td><td>Immunoglobulin, sialoadhesin</td></tr><tr><td>CD170</td><td>Neutrophils</td><td>67 homodimer</td><td>Adhesion molecule. Sialic acid-binding Ig-like lectin (Siglec). Cytoplasmic tail contains ITIM motifs</td><td>Siglec-5, OBBP2, CD33L2</td><td>Immunoglobulin, sialoadhesin</td></tr><tr><td>CD171</td><td>Neurons, Schwann cells, lymphoid and myelomonocytic cells, B cells, CD4 T cells (not CD8 T cells)</td><td>200-220, exact MW varies with cell type</td><td>Adhesion molecule, binds CD9, CD24, CD56, also homophilic binding</td><td>L1, NCAM-L1</td><td>Immunoglobulin</td></tr><tr><td>CD172a</td><td></td><td>115-120</td><td>Adhesion molecule; the transmembrane protein is a substrate of activated receptor tyrosine kinases (RTKs) and binds to SH2 domains</td><td>SIRP, SHPS1, MYD-1, SIRP-a-1, protein tyrosine phosphatase, nonreceptor type substrate 1 (PTPNS1)</td><td>Immunoglobulin</td></tr><tr><td>CD173</td><td>Allcells</td><td>41</td><td>Blood group H type 2. Carbohydrate moiety</td><td></td><td></td></tr><tr><td>CD174</td><td>Allcells</td><td>42</td><td>Lewis y blood group. Carbohydrate moiety</td><td></td><td></td></tr><tr><td>CD175</td><td>Allcells</td><td></td><td>Tn blood group. Carbohydrate moiety</td><td></td><td></td></tr><tr><td>CD175s</td><td>Allcells</td><td></td><td>Sialyl-Tn blood group. Carbohydrate moiety</td><td></td><td></td></tr><tr><td>CD176</td><td>Allcells</td><td></td><td>TF blood group. Carbohydrate moiety</td><td></td><td></td></tr><tr><td>CD177</td><td>Myeloid cells</td><td>56-64</td><td>NB1 is a GPl-linked neutrophil-specific antigen, found on only a subpopulation of neutrophils present in NB1-positive adults (97% of healthy donors) NB1 is first expressed at the myelocyte stage of myeloid differentiation</td><td>NB1</td><td></td></tr><tr><td>CD178</td><td>Activated T cells</td><td>38-42</td><td>Fas ligand; binds to Fas to induce apoptosis</td><td>FasL</td><td>TNF</td></tr><tr><td>CD179a</td><td>Early B cells</td><td>16-18</td><td>Immunoglobulin iota chain associates noncovalently with CD179b to form a surrogate light chain which is a component of the pre-B-cell receptor that plays a critical role in early B-cell differentiation</td><td>VpreB, IGVPB, IGu</td><td>Immunoglobulin</td></tr><tr><td>CD179b</td><td>B cells</td><td>22</td><td>Immunoglobulin 4-like polypeptide 1 associates noncovalently with CD179a to form a surrogate light chain that is selectively expressed at the early stages</td><td>IGLL1, A5 (IGL5), IGVPB, 14.</td><td>Immunoglobulin</td></tr></table>
======================================
<table><tr><td></td><td>Neutrophils, monocytes, NK cells, mast cells, basophils, some T cells</td><td></td><td>Receptor for CXCL6, CXCL8 (IL-8). Important for neutrophil trafficking</td><td>CXCR1, IL8Ra</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>CD182</td><td>Neutrophils, monocytes, NK cells, mast cells, basophils, some T cells</td><td></td><td>Receptor for CXCL1, CXCL2, CXCL3, CXCLS5, CXCL6, and CXCL8 (IL-8). Neutrophil trafficking and egress from bone marrow</td><td>CXCR2, ILRB</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>CD183</td><td>Particularly on malignant B cells from chronic lymphoproliferative disorders</td><td>46-52</td><td>CXC chemokine receptor involved in chemotaxis of malignant B lymphocytes. Binds INP10 and MIG?</td><td>CXCR3, G protein- coupled receptor 9 (GPR 9)</td><td>Chemokine receptors, G protein coupled receptor</td></tr><tr><td>CD184</td><td>Preferentially expressed on the more immature CD34* hematopoietic stem cells</td><td>46-52</td><td>Binding to SDF-1 (LESTR/fusin); acts as a cofactor for fusion and entry of T-cell line; trophic strains of HIV-1</td><td>CXCR4, NPY3R, LESTR, fusin, HM89</td><td>Chemokine receptors, G protein coupled receptor</td></tr><tr><td>CD185</td><td>B cells, T,,, cells, and some CD8 T cells</td><td></td><td>Receptor for CXCL13. B- and T-cell trafficking into B-cell zones in lympoid tissue</td><td>CXCRS</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>CD186</td><td>T,17 cells, some NK cells, some NKT cells. Some ILC3s</td><td></td><td>Receptor for CXCL16 and HIV co-receptor</td><td>CXCRE</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>cD191</td><td>Monocytes, macrophages, neutrophils, T,1 cells, dendritic cells</td><td></td><td>Receptor for CCL3, CCL5, CCL8, CCL14, and CCL16. Involved in various processes of innate and adaptive immune-cell trafficking</td><td>CCRI</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>¢D192</td><td>Monocytes, macrophages, Tj1 cells, basophils, NK cells</td><td></td><td>Receptor for CCL2, CCL7, CCL8, CCL12, CCL13, and CCL16. Important for monocyte trafficking and T,,1 responses</td><td>CCR2</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>CD193</td><td>Eosinophils, basophils, mast cells</td><td></td><td>Receptor for CCL5, CCL7, CCL8, CCL11, CCL13, CCL15, CCL24 and CCL28, involved in eosinophil trafficking</td><td>CCR3</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>cD194</td><td>T,2 cells, T,., cells, 117 cells, CD8 T cells, monocytes, B cells</td><td>4</td><td>Receptor for CCL17, CCL22, T-cell homing to the skin and T,2 response</td><td>CCR4</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>CD195</td><td>Promyelocytic cells</td><td>40</td><td>Receptor for a CC-type chemokine. Binds to MIP-1a, MIP-1B, and RANTES. May play a role in the control of granulocytic lineage proliferation or differentiation. Acts as co-receptor with CD4 for primary macrophage-tropic isolates of HIV-1</td><td>CMKBR5, CCR5, CKR-5, CC-CKR-5, CKRS</td><td>Chemokine receptors, G protein-coupled receptor</td></tr><tr><td>CD196</td><td>Ty17 cells, y:6 T cells, NKT cells, NK Cells, Treg Cells, Ty cells, ILCs</td><td></td><td>Receptor for CCL20 and CCL21, necessary for gut association lymphoid tissue development and T,,17 responses</td><td>CCR6</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>cD197</td><td>Activated B and T lymphocytes, strongly upregulated in B cells infected with EBV and T cells infected with HHV6 or 7</td><td>46-52</td><td>Receptor for the MIP-3B chemokine; probable mediator of EBV effects on B lymphocytes or of normal lymphocyte functions</td><td>CCR7, EBI1 (Epstein-Barr virus induced gene 1), CMKBR7, BLR2</td><td>Chemokine receptors, G protein-coupled receptor</td></tr><tr><td>CDw198</td><td>Th2 cells, T,., Cells, y:8 T cells, Monocytes, macrophages</td><td></td><td>Receptor for CCL1, CCL8, and CCL18, necessary for T,2 immunity and thymopoiesis</td><td>CCR8</td><td>Chemokin
======================================
e receptor, GPCR class A</td></tr><tr><td>CDw199</td><td>Intestinal T cells, thymocytes, B cells, dendritic cells</td><td></td><td>Receptor for CCL25, necessary for gut associated lymphoid tissue development and thymopoiesis</td><td>CCR</td><td>Chemokine receptor, GPCR class A</td></tr><tr><td>¢D200</td><td>Normal brain and B-cell lines</td><td>Al (rat thymocytes) 47 (rat brain)</td><td>Antigen identified by MoAb MRCOX-2. Nonlineage molecules. Function unknown</td><td>MOx-2, MOX-1</td><td>Immunoglobulin</td></tr></table>
======================================
<table><tr><td>CD203c</td><td>Myeloid cells (uterus, basophils, and mast cells)</td><td></td><td>Belongs to a series of ectoenzymes that are involved in hydrolysis of extracellular nucleotides. They catalyze the cleavage of phosphodiester and phosphosulfate bonds of a variety of molecules, including deoxynucleotides, NAD, and nucleotide sugars</td><td>NPP3, B10, PONP3, PD-IB, gp130RB13-6</td><td>Type Il transmembrane proteins, Ecto-nucleotide pyrophosphatase/ phosphodiesterase (E-NPP)</td></tr><tr><td>CD204</td><td>Myeloid cells</td><td>220</td><td>Mediate the binding, internalization, and processing of a wide range of negatively charged macromolecules. Implicated in the pathologic deposition of cholesterol in arterial walls during atherogenesis</td><td>Macrophage scavenger R (MSR1)</td><td>Scavenger receptor, collagen-like</td></tr><tr><td>CD205</td><td>Dendritic cells</td><td>205</td><td>Lymphocyte antigen 75; putative antigen- uptake receptor on dendritic cells</td><td>LY75, DEC-205, GP200-MR6</td><td>Type | transmembrane protein</td></tr><tr><td>CD206</td><td>Macrophages, endothelial cells</td><td>175-190</td><td>Type | membrane glycoprotein; only known example of a C-type lectin that contains multiple C-type CRDs (carbohydrate-recognition domains); it binds high-mannose structures on the surface of potentially pathogenic viruses, bacteria, and fungi</td><td>Macrophage Mannose receptor (MMR), MRC1</td><td>C-type lectin</td></tr><tr><td>CD207</td><td>Langerhans cells</td><td>40</td><td>Type Il transmembrane protein; Langerhans cell specific C-type lectin; potent inducer of membrane superimposition and zippering leading to BG (Birbeck granule) formation</td><td>Langerin</td><td>C-type lectin</td></tr><tr><td>CD208</td><td>Interdigitating dendritic cells in lymphoid organs</td><td>70-90</td><td>Homologous to CD68, DC-LAMP is a lysosomal protein involved in remodeling of specialized antigen- processing compartments and in MHC class Il-restricted antigen presentation. Up-regulated in mature DCs induced by CD4OL, TNF-a. and LPS</td><td>D lysosome- associated membrane protein, DC-LAMP</td><td>Major histocompatibility complex</td></tr><tr><td>cD209</td><td>Dendritic cells</td><td>44</td><td>C-type lectin; binds ICAM3 and HIV-1 envelope glycoprotein gp120 enables T-cell receptor engagement by stabilization of the DC/T-cell contact zone, promotes efficient infection in trans cells that express CD4 and chemokine receptors; type Il transmembrane protein</td><td>DC-SIGN (dendritic cell-specific ICAM3-grabbing non-integrin)</td><td>C-type lectin</td></tr><tr><td>CD210</td><td>B cells, T helper cells, and cells of the monocyte/macrophage lineage</td><td>90-110</td><td>Interleukin 10 receptor a and B</td><td>IL-10Rar, IL-10RA, HIL-10R, IL-10RB, IL-10RB, CRF2-4, CRFB4</td><td>Class II cytokine receptor</td></tr><tr><td>CD212</td><td>Activated CD4, CD8, and NK cells</td><td>130</td><td>IL-12 receptor B chain; a type | transmembrane protein involved in IL-12 signal transduction</td><td>IL-12R, IL-12RB</td><td>Hemopoietin cytokine receptor</td></tr><tr><td>CD213a1</td><td>B cells, monocytes, fibroblasts, endothelial cells</td><td>60-70</td><td>Receptor which binds II-13 with a low affinity; together with IL-4Ra can form a functional receptor for IL-13, also serves as an alternate accessory protein to the common cytokine receptor y chain for IL-4 signaling</td><td>IL-13Ra. 1, NR4, IL-13Ra</td><td>Hemopoietic cytokine receptor</td></tr><tr><td>CD213a2</td><td>B cells, monocytes, fibroblasts, endothelial cells</td><td></td><td>IL-13 receptor which binds as a monomer with high affinity to interleukin-13 (IL-13), but not to IL-4; human cells expressing IL-13RA2 show specific IL-13 binding with</td><td>IL-13Ra 2, IL-13BP</td><td>Hemopoietic cytokine receptor</td></tr></table>
======================================
<table><tr><td>CD218b</td><td>Macrophages, neutrophils, NK cells, T cells</td><td></td><td>Signaling induces cytotoxic response</td><td>IL-18Rb</td><td>Immunoglobulin</td></tr><tr><td>¢D220</td><td>Nonlineage molecules</td><td></td><td>Insulin receptor; integral transmembrane glycoprotein comprising two a and two B subunits; this receptor binds insulin and has a tyrosine-protein kinase activity— autophosphorylation activates the kinase activity</td><td>Insulin receptor</td><td>Insulin receptor family of tyrosine- protein kinases</td></tr><tr><td>¢D221</td><td>Nonlineage molecules</td><td>a:135 6:90</td><td>Insulin-like growth factor | receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity and plays a critical role in transformation events. Cleavage of the precursor generates a and B subunits</td><td>IGF1R, JTK13</td><td>Insulin receptor family of tyrosine- protein kinases</td></tr><tr><td>¢D222</td><td>Nonlineage molecules</td><td>250</td><td>Cleaves and activates membrane- bound TGFB. Other functions include internalization of IGF-II, internalization or sorting of lysosomal enzymes and other M6P-containing proteins</td><td>IGF2R, CIMPR, CI-MPR, IGF2R, M6P-R (mannose-6- phosphate receptor)</td><td>Mammalian lectins</td></tr><tr><td>¢D223</td><td>Activated T and NK cells</td><td>70</td><td>Involved in lymphocyte activation; binds to HLA class Il antigens; role in down- regulating antigen specific response; close relationship of LAG3 to CD4</td><td>Lymphocyte- activation gene 3 LAG-3</td><td>Immunoglobulin</td></tr><tr><td>¢D224</td><td>Nonlineage molecules</td><td>62 (unprocessed precursor)</td><td>Predominantly a membrane-bound enzyme; plays a key role in the y-glutamyl cycle, a pathway for the synthesis and degradation of glutathione. This enzyme consists of two polypeptide chains, which are synthesized in precursor form from a single polypeptide</td><td>y-glutamy! transferase, GGT1, 0228672 D22S732</td><td>y-glutamyl transferase</td></tr><tr><td>¢D225</td><td>Leukocytes and endothelial cells</td><td>16-17</td><td>Interferon-induced transmembrane protein 1 is implicated in the control of cell growth. It is a component of a multimeric complex involved in the transduction of antiproliferative and homotypic adhesion signals</td><td>Leu 13, IFITM1, IFI17</td><td>IFN-induced transmembrane proteins</td></tr><tr><td>CD226</td><td>NK cells, platelets, monocytes, and a subset of T cells</td><td>65</td><td>Adhesion glycoprotein; mediates cellular adhesion to other cells bearing an un- identified ligand and cross-linking CD226 with antibodies causes cellular activation</td><td>DNAM-1 (PTA1), DNAX, TLiSA1</td><td>Immunoglobulin</td></tr><tr><td>¢D227</td><td>Human epithelial tumors, such as breast cancer</td><td>122 (non- glycosylated)</td><td>Epithelial mucin containing a variable number of repeats with a length of 20 amino acids, resulting in many different alleles. Direct or indirect interaction with actin cytoskeleton</td><td>PUM (peanut- reactive urinary mucin), MUC.1, mucin 1</td><td>Mucin</td></tr><tr><td>¢D228</td><td>Predominantly in human melanomas</td><td>97</td><td>Tumor-associated antigen (melanoma) identified by monoclonal antibodies 133.2 and 96.5, involved in cellular iron uptake</td><td>Melanotransferrin, P97</td><td>Transferrin</td></tr><tr><td>¢D229</td><td>Lymphocytes</td><td>90-120</td><td>May participate in adhesion reactions between T lymphocytes and accessory cells by homophilic interaction</td><td>Ly9</td><td>Immunoglobulin (CD2 subfamily)</td></tr><tr><td>¢D230</td><td>Expressed in both normal and infected cells</td><td>27-30</td><td>The function of PRP is not known. It is encoded in the host genome found in high quantity in the brain of humans and animals infected with neurodegenerative diseases known as transmissible spongiform encephalopathies or prion diseases (Creutzfeld—Jakob disease,</td><td>CJD, PRIP, prion protein (p27-30)</td><td>Prion</td></tr></table>
======================================
<table><tr><td></td><td>Nonlineage molecules</td><td>200</td><td>Receptor for an immunologically active semaphorin (virus-encoded semaphorin protein receptor)</td><td>VESPR, PLXN, PLXN-C1</td><td>Plexin</td></tr><tr><td>CD233</td><td>Erythroid cells</td><td>93</td><td>Band 3 is the major integral glycoprotein of the erythrocyte membrane. It has two functional domains. Its integral domain mediates a 1:1 exchange of inorganic anions across the membrane, whereas its cytoplasmic domain provides binding sites for cytoskeletal proteins, glycolytic enzymes, and hemoglobin. Multifunctional transport protein</td><td>SLC4A1, Diego blood group, D1, AE1, EPB3</td><td>Anion exchanger</td></tr><tr><td>CD234</td><td>Erythroid cells and nonerythroid cells</td><td>35</td><td>Fy-glycoprotein; Duffy blood group antigen; nonspecific receptor for many chemokines such as IL-8, GRO, RANTES, MCP-1, and TARC. It is also the receptor for the human malaria parasites Plasmodium vivax and Plasmodium knowlesi and plays a role in inflammation and in malaria infection</td><td>GPD, CCBP1, DARC (duffy antigen/ receptor for chemokines)</td><td>Family 1 of G protein-coupled receptors, chemo- kine receptors</td></tr><tr><td>CD235a</td><td>Erythroid cells</td><td>31</td><td>Major carbohydrate-rich sialoglycoprotein of human erythrocyte membrane which bears the antigenic determinants for the MN and Ss blood groups. The N-terminal glycosylated segment, which lies outside the erythrocyte membrane, has MN blood group receptors and also binds influenza virus</td><td>Glycophorin A, GPA, MNS</td><td>Glycophorin A</td></tr><tr><td>CD235b</td><td>Erythroid cells</td><td>GYPD is smaller than GYPC (24 kDa vs 32 kDa)</td><td>This protein is a minor sialoglycoprotein in human erythrocyte membranes. Along with GYPA, GYPB is responsible for the MNS blood group system. The Ss blood group antigens are located on glycophorin B</td><td>Glycophorin B, MNS, GPB</td><td>Glycophorin A</td></tr><tr><td>CD236</td><td>Erythroid cells</td><td>24</td><td>Glycophorin C (GPC) and glycophorin D (GPD) are closely related sialoglyco- proteins in the human red blood cell (RBC) membrane. GPD is a ubiquitous shortened isoform of GPC, produced by alternative splicing of the same gene. The Webb and Duch antigens, also known as glycophorin D, result from single point mutations of the</td><td>Glycophorin D, GPD, GYPD</td><td>Type Ill membrane proteins</td></tr><tr><td>CD236R</td><td>Erythroid cells</td><td>32</td><td>glycophorin C gene Glycophorin C (GPC) is associated with the Gerbich (Ge) blood group deficiency. It is a minor red cell-membrane component, representing about 4% of the membrane sialoglycoproteins, but shows very little homology with the major red cell-membrane glycophorins A and B. It plays an important role in regulating the mechanical stability of red cells and is a putative receptor for the merozoites of Plasmodium falciparum</td><td>Glycophorin C, GYPC, GPC</td><td>Type Ill membrane proteins</td></tr><tr><td>CD238</td><td>Erythroid cells</td><td>93</td><td>KELL blood group antigen; homology to a family of zinc metalloglycoproteins with neutral endopeptidase activity, type II transmembrane glycoprotein</td><td>KELL</td><td>Peptidase m13 (zinc metallo- proteinase); also known as the neprilysin subfamily</td></tr></table>
======================================
<table><tr><td>CD240CE</td><td>Erythroid cells</td><td>45.5</td><td>Rhesus blood group, CcEe antigens. May be part of an oligomeric complex which is likely to have a transport or channel function in the erythrocyte membrane. It is highly hydrophobic and deeply buried within the phospholipid bilayer</td><td>RHCE, RH30A, RHPI, Rh4</td><td>Rh</td></tr><tr><td>¢D240D</td><td>Erythroid cells</td><td>45.5 (product—30)</td><td>Rhesus blood group, D antigen. May be part of an oligomeric complex which is likely to have a transport or channel function in the erythrocyte membrane. Absent in the Caucasian RHD-negative phenotype</td><td>RhD, Rh4, RhPI, Rhll, Rh30D</td><td>Rh</td></tr><tr><td>C0241</td><td>Erythroid cells</td><td>50</td><td>Rhesus blood group-associated glycoprotein RH50, component of the RH antigen multisubunit complex; required for transport and assembly of the Rh membrane complex to the red blood cell surface. Highly homologous to RH, 30 kDa components. Defects in RhAg are a cause of a form of chronic hemolytic anemia associated with stomatocytosis, and spherocytosis, reduced osmotic fragility, and increased cation permeability</td><td>RhAg, RHS50A</td><td>Rh</td></tr><tr><td>CD242</td><td>Erythroid cells</td><td>42</td><td>Intercellular adhesion molecule 4, Landsteiner-Wiener blood group. LW molecules may contribute to the vaso- occlusive events associated with episodes of acute pain in sickle cell disease</td><td>ICAM-4, LW</td><td>Immunoglobulin, intercellular adhesion molecules (ICAMs)</td></tr><tr><td>CD243</td><td>Stem/progenitor cells</td><td>170</td><td>Multidrug resistance protein 1 (P-glycoprotein). P-gp has been shown to utilize ATP to pump hydrophobic drugs out of cells, thus increasing their intracellular concentration and hence their toxicity. The MDR 1 gene is amplified in</td><td>MDR-1, p-170</td><td>ABC superfamily of ATP-binding transport proteins</td></tr><tr><td>CD244</td><td>NK cells</td><td>66</td><td>multidrug-resistant cell lines 2B4 is a cell-surface glycoprotein related to CD2 and implicated in the regulation of natural killer and T-lymphocyte function. It appears that the primary function of 2B4 is to modulate other receptor—ligand interactions to enhance leukocyte activation</td><td>2B4, NK cell activation inducing ligand (NAIL)</td><td>Immunoglobulin, SLAM</td></tr><tr><td>CD245</td><td>T cells</td><td>220-240</td><td>Cyclin E/Cdk2 interacting protein p220. NPAT is involved in a key S phase event and links cyclical cyclin E/Cdk2 kinase activity to replication-dependent histone gene transcription. NPAT gene may be essential for cell maintenance and may be amember of the housekeeping genes</td><td>NPAT</td><td></td></tr><tr><td>CD246</td><td>Expressed in the small intestine, testis, and brain but not in normal lymphoid cells</td><td>177 kDa; after glycosylation, produces a 200 kDa mature glycoprotein</td><td>Anaplastic (CD30* large cell) lymphoma kinase; plays an important role in brain development, involved in anaplastic nodal non-Hodgkin lymphoma or Hodgkin's disease with translocation t(2;5) (p23;q35) or inv2(23;q35). Oncogenesis via the kinase function is activated by oligomerization of NPM1-ALK mediated by the NPM1 part</td><td>ALK</td><td>Insulin receptor family of tyrosine- protein kinases</td></tr><tr><td>CD247</td><td>T cells, NK cells</td><td></td><td>T-cell receptor ¢; has a probable role in assembly and expression of the TCR complex as well as signal transduction</td><td>Cchain, CD3Z</td><td>Immunoglobulin</td></tr></table>
======================================
<table><tr><td></td><td>Adipocytes, smooth muscle</td><td></td><td>Cell adhesion</td><td>CD164L1, endosialin</td><td>C-type lectin, EGF</td></tr><tr><td>cD249</td><td>Pericytes and podocytes in the kidney</td><td>109</td><td>Aminopeptidase</td><td>ENPEP, APA, gp160, EAP</td><td>Peptidase M1</td></tr><tr><td>CD252</td><td>Activated B cells, dendritic cells</td><td>21</td><td>T-cell activation</td><td>TNFSF4, GP34, OX4OL, TXGP1, CD134L, OX-40L, OX40L</td><td>TNF</td></tr><tr><td>CD253</td><td>B cells, dendritic cells, NK cells, monocytes, macrophages</td><td>33</td><td>Induction of apoptosis</td><td>TNFSF10, TL2, APOZL, TRAIL, Apo-2L</td><td>TNF</td></tr><tr><td>CD254</td><td>Osteoblasts, T cells</td><td>35</td><td>Osteoclast and dendritic-cell development and function</td><td>TNFSF11, RANKL, ODF, OPGL, sOdf, CD254, OPTB2, TRANCE, hRANKL2</td><td>TNF</td></tr><tr><td>CD256</td><td>Dendritic cells, monocytes, CD33* myeloid cells</td><td>27</td><td>B-cell activation</td><td>TNFSF13, APRIL, TALL2, TRDL-1, UNQ383/PRO715</td><td>TNF</td></tr><tr><td>CD257</td><td>DCs, monocytes, CD33* myeloid cells</td><td>31</td><td>B-cell activation</td><td>TNFSF13B, BAFF, BLYS, TALL-1, TALL1, THANK, TNFSF20, ZTNF4, ABAFF</td><td>TNF</td></tr><tr><td>CD258</td><td>B cells, NK cells</td><td>26</td><td>Apoptosis, lymphocyte adhesion</td><td>TNFSF14, LTg, TR2, HVEML, LIGHT, LTBR</td><td>TNF</td></tr><tr><td>CD261</td><td>B cells, CD8* T cells</td><td>50</td><td>TRAIL receptor, induces apoptosis</td><td>TNFRSF10A, APO2, DR4, MGC9365, TRAILR-1, TRAILR1</td><td>TNF receptor</td></tr><tr><td>CD262</td><td>B cells, CD33* myeloid cells</td><td>48</td><td>TRAIL receptor, induces apoptosis</td><td>TNFRSF10B, DRS, KILLER, KILLER/ DRS, TRAIL-R2, TRAILR2, TRICK2, TRICK2A, TRICK2B, TRICKB, ZTNFRO</td><td>TNF receptor</td></tr><tr><td>CD263</td><td>Variety of cell types</td><td>27</td><td>Inhibits TRAIL-induced apoptosis</td><td>TNFRSF10C, DCR1, LIT, TRAILR3, TRID</td><td>TNF receptor</td></tr><tr><td>CD264</td><td>Variety of cell types</td><td>42</td><td>Inhibits TRAIL-induced apoptosis</td><td>TNFRSF10D, DCR2, TRAILR4, TRUNDD</td><td>TNF receptor</td></tr><tr><td>CD265</td><td>Osteoclasts, dendritic cells</td><td>66</td><td>Receptor for RANKL</td><td>TNFRSF11A, EOF, FEO, ODFR, OFE, PDB2, RANK, TRANCER</td><td>TNF receptor</td></tr><tr><td>CD266</td><td>NK cells, CD33* myeloid cells, monocytes</td><td>4</td><td>Receptor for TWEAK</td><td>TNFRSF12A, FN14, TWEAKR, TWEAK</td><td>TNF receptor</td></tr><tr><td>CD267</td><td>B cells</td><td>32</td><td>APRIL and BAFF signal through it, B-cell activation</td><td>TNEFRSF13B, CVID, TACI, CD267, FLJ39942, MGC39952, MGC133214, TNFRSF14B</td><td>TNF receptor</td></tr><tr><td>CD268</td><td>B cells</td><td></td><td>BAFF receptor</td><td>TNFRSF13C, BAFFR, CD268, BAFF-R, MGC138235</td><td>TNF receptor</td></tr><tr><td>CD269</td><td>B cells, dendritic cells</td><td></td><td>APRIL and BAFF signal through it, B-cell activation</td><td>TNFRSF17, BCM, BCMA</td><td>TNF receptor</td></tr></table>
======================================
<table><tr><td></td><td>Dendritic cells</td><td>31</td><td>Ligand for PD-1</td><td>PDCD1LG2, B7DC, Btdc, PDL2, PD-L2, PDCD1L2, bA574F11.2</td><td>Immunoglobulin</td></tr><tr><td>¢D274</td><td>Antigen-presenting cells</td><td>33</td><td>Binds PD-1</td><td>PDL1, B7-H, B7H1, PD-L1, PDCD1L1</td><td>Immunoglobulin</td></tr><tr><td>cD275</td><td>Antigen-presenting cells</td><td>33</td><td>Binds ICOS, multiple functions in immune system</td><td>ICOS-L, B7-H2, B7H2, B7RP-1, B7RP1, GL50, ICOSLG, KIAAQ653, LICOS</td><td>Immunoglobulin</td></tr><tr><td>CD276</td><td>Antigen-presenting cells</td><td>57</td><td>Blunts T-cell activity</td><td>B7H3</td><td>Immunoglobulin</td></tr><tr><td>¢D277</td><td>T cells, NK cells</td><td>58</td><td>Blunts T-cell activity</td><td>BTN3A1, BTFS, BI3.1</td><td>Immunoglobulin</td></tr><tr><td>CD278</td><td>T cells, B cells, ILC2s, some ILC3s</td><td>23</td><td>Receptor for ICOSL, multiple functions in immune system</td><td>ICOS, AILIM, MGC39850</td><td></td></tr><tr><td>cD279</td><td>T cells, B cells</td><td>32</td><td>Inhibitory molecule on multiple immune cells</td><td>PD1, PDCD1, SLEB2, hPD-|</td><td>Immunoglobulin</td></tr><tr><td>CD280</td><td>Variety of cell types</td><td>166</td><td>Mannose receptor, binds extracellular matrix</td><td>MRC2, UPARAP, ENDO180, KIAAQ709</td><td>C-type lectin, fibronectin type II</td></tr><tr><td>¢D281</td><td>Many different immune cells</td><td>90</td><td>Binds bacterial lipoproteins, dimerizes with TLR2</td><td>TLR1, TIL, rsc786, KIAA0012, DKFZp54710610, DKFZp56410682</td><td>Toll-like receptor</td></tr><tr><td>CD282</td><td>Dendritic cells, monocytes, CD33* myeloid cells, B cells</td><td>89</td><td>Binds numerous microbial molecules</td><td>TLR2, TIL4</td><td>Toll-like receptor</td></tr><tr><td>CD283</td><td>Dendritic cells, NK cells, T cells, B cells</td><td>104</td><td>Binds dsRNA and polyl:C</td><td>TLR3</td><td>Toll-like receptor</td></tr><tr><td>CD284</td><td>Macrophages, monocytes, dendritic cells, epithelial cells</td><td>96</td><td>Binds LPS</td><td>TLR4, TOLL, hToll</td><td>Toll-like receptor</td></tr><tr><td>CD286</td><td>B cells, monocytes, NK cells</td><td>92</td><td>Binds bacterial lipoproteins, dimerizes with TLR2</td><td>TLRG</td><td>Toll-like receptor</td></tr><tr><td>CD288</td><td>Monocytes, NK cells, T cells, macro- phages</td><td>120</td><td>Binds ssRNA</td><td>TLR8</td><td>Toll-like receptor</td></tr><tr><td>¢D289</td><td>Dendritic cells, B cells, macrophages, neutrophils, NK cells, microglia</td><td>116</td><td>Binds CpG DNA</td><td>TLR</td><td>Toll-like receptor</td></tr><tr><td>cD290</td><td>B cells, dendritic cells</td><td>95</td><td>Ligand unknown</td><td>TLRIO</td><td>Toll-like receptor</td></tr><tr><td>¢D292</td><td>Variety of cell types, skeletal muscle</td><td>60</td><td>Receptor for BMPs</td><td>BMPR1A, ALK3, ACVRLK3</td><td>Type | trans- membrane</td></tr><tr><td>CDw293</td><td></td><td></td><td></td><td>BMPR1B</td><td></td></tr><tr><td>¢D294</td><td>NK cells</td><td>43</td><td>Activated by prostaglandin D2</td><td>GPR44, CRTH2</td><td>GPCR class A receptor</td></tr><tr><td>¢D295</td><td>Mesenchymal stem cells</td><td>132</td><td>Receptor for leptin</td><td>LEPR, OBR</td><td>Immunoglobulin, fibronectin type III, IL-6R</td></tr><tr><td>CD296</td><td>Cardiomyocytes</td><td>36</td><td>ADP ribosyltransferase activity</td><td>ART1, ART2, RT6</td><td></td></tr></table>
======================================
<table><tr><td>CD300A</td><td>B cells, T cells, NK cells, monocytes, CD33* myeloid cells</td><td>33</td><td>Inhibitory receptor on T, B, and NK cells</td><td>CMRF-35-H9, CMRF35H, CMRF35H3, IRC1, IRC2, IRp60</td><td>Immunoglobulin</td></tr><tr><td>CD300C</td><td>CD33* myeloid cells, monocytes</td><td>24</td><td>Activating receptor on multiple cell types</td><td>| CMRF-35A, CMRF35A, CMRF35A1, LIR</td><td>Immunoglobulin</td></tr><tr><td>CD301</td><td>Dendritic cells, monocytes, CD33* myeloid cells</td><td>35</td><td>Macrophage adhesion and migration</td><td>CLEC10A, HML, HML2, CLECSF13, CLECSF14</td><td>C-type lectin</td></tr><tr><td>CD302</td><td>Dendritic cells, monocytes, CD33* myeloid cells</td><td>26</td><td>Macrophage adhesion and migration</td><td>DCL-1, BIMLEC, KIAA0022</td><td>C-type lectin</td></tr><tr><td>CD303</td><td>Plasmacytoid DC</td><td>25</td><td>Involved in plasmacytoid dendritic cell function</td><td>CLECA4C, BDCA2, CLECSF11, DLEC, HECL, PRO34150, CLECSF7</td><td>C-type lectin</td></tr><tr><td>CD304</td><td>Treg Cells, plasmacytoid DCs</td><td>103</td><td>Cell migration and survival, preferentially |} expressed on thymic compared with induced T,., cells</td><td>Neuropilin-1, NRP1, NRP, VEGF165R</td><td></td></tr><tr><td>CD305</td><td>Variety of hematopoietic cells</td><td>31</td><td>Inhibitory receptor on multiple immune cells</td><td>LAIR-1</td><td>Immunoglobulin</td></tr><tr><td>CD306</td><td>NK cells</td><td>16</td><td>Unknown</td><td>LAIR2</td><td>Immunoglobulin</td></tr><tr><td>CD307a</td><td>B cells</td><td>47</td><td>B-cell signaling and function</td><td>FCRH1, IFGP1, IRTAS, FCRL1</td><td>Immunoglobulin</td></tr><tr><td>CD307b</td><td>B cells</td><td>56</td><td>B-cell signaling and function</td><td>FCRH2, IFGP4, IRTA4, SPAP1, SPAP1A, SPAP1B, SPAPIC, FCRL2</td><td>Immunoglobulin</td></tr><tr><td>CD307¢</td><td>B cells, NK cells</td><td>81</td><td>B-cell signaling and function</td><td>FCRH3, IFGP3, IRTA3, SPAP2, FCRL3</td><td>Immunoglobulin</td></tr><tr><td>CD307d</td><td>Memory B cells</td><td>57</td><td>B-cell signaling and function</td><td>FCRH4, IGFP2, IRTA1, FCRL4</td><td>Immunoglobulin</td></tr><tr><td>CD307e</td><td>B cells, dendritic cells</td><td>106</td><td>B-cell signaling and function</td><td>CD307, FCRH5, IRTA2, BXMAS1, PRO820</td><td>Immunoglobulin</td></tr><tr><td>CD309</td><td>Endothelial cells</td><td>151</td><td>VEGF signaling, hematopoiesis</td><td>KDR, FLK1, VEGFR, | VEGFR2</td><td>Immunoglobulin, type Ill tyrosine kinase</td></tr><tr><td>CD312</td><td>Dendritic cells, NK cells, monocytes, CD33* myeloid cells</td><td>90</td><td>GPCR involved in neutrophil activation</td><td>EMR2</td><td>EGF, GPCR class B</td></tr><tr><td>CD314</td><td>T cells, NK cells</td><td>25</td><td>NK- and T-cell activation</td><td>KLRK1, KLR, NKG2D, NKG2-D, D1282489E</td><td>C-type lectin</td></tr><tr><td>CD315</td><td>Smooth muscle</td><td>99</td><td>Interacts with CD316</td><td>PTGFRN, FPRP, EWI-F, CD9P-1, SMAP-6, FLJ11001, KIAA1436</td><td>Immunoglobulin</td></tr><tr><td>CD316</td><td>Keratinocytes</td><td>65</td><td>Modulates integrin function</td><td>IGSF8, EWI2, PGRL, | CD81P3</td><td>Immunoglobulin</td></tr><tr><td>CD317</td><td>Variety of hematopoietic cells</td><td>20</td><td>IFN-induced antiviral protein</td><td>BST2</td><td></td></tr></table>
======================================
<table><tr><td></td><td>Endothelial cells</td><td>33</td><td>Immune-cell migration across endothelium</td><td>JAMZ, C210rf43, VE-JAM, VEJAM</td><td>Immunoglobulin</td></tr><tr><td></td><td>Endothelial cells</td><td></td><td>Cell adhesion, epithelial development</td><td>E-Cadherin, CDH1, Arc-1, CDHE, ECAD, LCAM, UVO</td><td>Cadherin</td></tr><tr><td>CD325</td><td>Neurons, smooth muscles, cardiomyocytes</td><td>100</td><td>Cell adhesion, neural development</td><td>N-Cadherin, CDH2, CDHN, NCAD</td><td>Cadherin</td></tr><tr><td>CD326</td><td>Epithelial cells</td><td>35</td><td>Cell signaling and migration, promotes proliferation</td><td>Ep-CAM, TACSTD1, C017-1A, EGP, EGP40, GA733-2, KSA, M4S1, MIC18, MK-1, TROP1, hEGP-2</td><td></td></tr><tr><td>CD327</td><td>Neurons</td><td>50</td><td>Sialic acid binding on multiple immune cells</td><td>CD33L, CD33L1, OBBP1, SIGLEC-6</td><td>Immunoglobulin, sialic acid binding- type lectin</td></tr><tr><td>CD328</td><td>NK cells, CD33* myeloid cells, monocytes</td><td>51</td><td>Sialic acid binding on multiple immune cells</td><td>p75, 0A79, AIRM1, CDw328, SIGLEC-7, p75/AIRM1</td><td>Immunoglobulin , sialic acid binding- type lectin</td></tr><tr><td>CD329</td><td>CD33* myeloid cells, monocytes</td><td>50</td><td>Sialic acid binding on multiple immune cells</td><td>CDw329, OBBP-LIKE, SIGLEC9</td><td>Immunoglobulin , sialic acid binding- type lectin</td></tr><tr><td>CD331</td><td>Variety of cell types</td><td>92</td><td>Cell proliferation and survival, skeletal development</td><td>FGFR1, H2, H3, H4, H5, CEK, FLG, FLT2, KAL2, BFGFR, C-FGR, N-SAM</td><td>Immunoglobulin, FGFR, tyrosine kinase</td></tr><tr><td>CD332</td><td>Variety of cell types</td><td>92</td><td>Cell proliferation and survival, craniofacial development</td><td>FGFR2, BEK, JWS, CEK3, CFD1, ECT1, KGFR, TK14, TK25,</td><td>Immunoglobulin, FGFR, tyrosine kinase</td></tr><tr><td>CD333</td><td>Variety of cell types</td><td>87</td><td>Cell proliferation and survival, skeletal development</td><td>BFR-1, K-SAM FGFR3, ACH, CEK2, JTK4, HSFGFR3EX</td><td>Immunoglobulin, FGFR, tyrosine kinase</td></tr><tr><td>CD334</td><td>Variety of cell types</td><td>88</td><td>Cell proliferation and survival, bile acid synthesis</td><td>FGFR4, TKF, JTK2, MGC20292</td><td>Immunoglobulin, FGFR, tyrosine kinase</td></tr><tr><td>CD335</td><td>NK cells, some ILCs</td><td>34</td><td>Nk-cell function</td><td>NKp46, LY94, NKP46, NCR1</td><td>Immunoglobulin</td></tr><tr><td>CD336</td><td>NK cells</td><td>30</td><td>Nk-cell function</td><td>Nkp44, LY95, NKP44, NCR2</td><td>Immunoglobulin</td></tr><tr><td>CD337</td><td>NK cells</td><td>22</td><td>Nk-cell function</td><td>NKp30, 1C7, LY117, NCR3</td><td>Immunoglobulin</td></tr><tr><td>CD338</td><td>Erythroid cells</td><td>72</td><td>ABC transporter, role in stem cells</td><td>ABCG2, MRX, MXR, ABCP BCRP, BMDP, MXR1, ABC15, BCRP1, CDw338, EST157481, MGC102821</td><td>ATP binding cassette transporters</td></tr><tr><td>CD339</td><td>Variety of cell types</td><td>134</td><td>Notch receptor ligand</td><td>JAG1, AGS, AHD, AWS, HJ1, JAGL1</td><td>EGF</td></tr><tr><td>CD340</td><td>Variety of cell types, certain aggressive breast cancers</td><td>134</td><td>EGF receptor, promotes proliferation</td><td>HER2, ERBB2, NEU, NGL, TKR1, HER-2, c-erb B2, HER-2/neu</td><td>ERBB, tyrosine kinase</td></tr><tr><td>CD344</td><td>Adipocytes</td><td>60</td><td>Wnt and Norrin signaling</td><td>EVR1, FEVR, F2-4,</td><td>GPCR class F</td></tr></table>
======================================
<table><tr><td></td><td>B cells, T cells, NKT cells, NK cells</td><td></td><td>T-, B-, and NKT-cell development and function</td><td>SLAMF6, KALI, NTBA, KALIb, Ly108, NTB-A, SF2000</td><td>Immunoglobulin</td></tr><tr><td>CD353</td><td>Variety of cell types</td><td>32</td><td>B-cell development</td><td>SLAMF8, BLAME, SBBI42</td><td>Immunoglobulin</td></tr><tr><td>CD354</td><td>CD33* myeloid cells, monocytes</td><td>26</td><td>Amplifies inflammation in myeloid cells</td><td>TREM-1</td><td>Immunoglobulin</td></tr><tr><td>CD355</td><td>T cells, NK cells</td><td>45</td><td>TCR signaling, cytokine production</td><td>CRTAM</td><td>Immunoglobulin</td></tr><tr><td>CD357</td><td>Activated T cells</td><td>26</td><td>Modulates T,. suppressive function</td><td>TNFRSF18, AITR, GITR, GITR-D, TNFRSF18</td><td>TNF receptor</td></tr><tr><td>CD358</td><td>Dendritic cells</td><td>72</td><td>Induces apoptosis</td><td>TNFRSF21, DRG, BM-018, TNFRSF21</td><td>TNF receptor</td></tr><tr><td>CD360</td><td>B cells</td><td>59</td><td>Receptor for IL-21, numerous immune functions</td><td>IL21R, NILR</td><td>Type | cytokine receptor, fibro- nectin type Ill</td></tr><tr><td>CD361</td><td>Variety of hematopoietic cells</td><td>49</td><td>Unknown</td><td>EVDB, D17S376, EVI2B</td><td></td></tr><tr><td>CD362</td><td>Endothelial cells, fibroblasts, neurons, and B cells</td><td>22</td><td>Cell organization, interaction with extracellular matrix</td><td>HSPG, HSPG1, SYND2, SDC2</td><td>Syndecan proteoglycan</td></tr><tr><td>CD363</td><td>Variety of cell types, including effector lymphocytes</td><td>43</td><td>Sphingosine-1-phosphate receptor 1, immune-cell survival, motility, and egression from lymph nodes</td><td>EDG1, S1P1, ECGF1, EDG-1, CHEDG1</td><td>GPCR class A receptor</td></tr><tr><td>CD364</td><td>Treg Cells</td><td></td><td>Unknown</td><td>MSMBBP, PI16</td><td></td></tr><tr><td>CD365</td><td>T cells</td><td></td><td>T-cell activation</td><td>HAVCR, TIM-1</td><td>Immunoglobulin</td></tr><tr><td>CD366</td><td>T cells</td><td></td><td>Induces apoptosis</td><td>HAVCR2, TIM-3</td><td>Immunoglobulin</td></tr><tr><td>CD367</td><td>Dendritic cells</td><td></td><td>HIV receptor, important in cross-priming CD8 T-cell and DC interactions</td><td>DCIR, CLEC4A</td><td>C-type lectin</td></tr><tr><td>CD368</td><td>Monocytes, macrophages</td><td></td><td>Receptor for endocytosis</td><td>MCL, CLEC-6, CLECAD, CLECSF8</td><td>C-type lectin</td></tr><tr><td>CD369</td><td>Neutrophils, dendritic cells, monocytes, macrophages, B cells</td><td></td><td>Pattern recognition receptor important for antifungal immunity, recognizes glucans and carbohydrates in fungal walls</td><td>DECTIN-1, CLECSF12, CLEC7A</td><td>C-type lectin</td></tr><tr><td>CD370</td><td>Dendritic cells, NK cells</td><td></td><td>Important for cross-priming of CD8 T cells for antiviral immunity</td><td>DNGR1, CLEC9A</td><td>C-type lectin</td></tr><tr><td>CD371</td><td>Dendritic cells</td><td></td><td>Unknown</td><td>MICL, CLL-1, CLEC12A</td><td>C-type lectin</td></tr></table>
======================================
<table><tr><td rowspan="3">Colony- stimulating factors</td><td>G-CSF (CSF-3)</td><td>174, monomer*</td><td>G-CSFR</td><td>Fibroblasts and monocytes</td><td>Stimulates neutrophil development and differentiation</td><td>G-CSF, G-CSFR: defective neutrophil production and Mobilization</td></tr><tr><td></td><td>GM-CSF (granulocyte- macrophage colony- stimulating factor) (CSF-2)</td><td>127, monomer</td><td>(D116, Be</td><td>Macrophages, T cells</td><td>Stimulates growth and differentiation of myelomonocytic lineage cells, particularly dendritic cells</td><td>| GM-CSF, GM-CSFR: pulmonary alveolar proteinosis</td></tr><tr><td></td><td>M-CSF (CSF-1)</td><td>a: 224 B: 492 y: 406 active forms are homo- or heterodimeric</td><td>CSF-1R (c-fms)</td><td>T cells, bone marrow stromal cells, osteoblasts</td><td>Stimulates growth of cells of monocytic lineage</td><td>Osteopetrosis</td></tr><tr><td rowspan="3">Interferons</td><td>IFN-o (at least 12 distinct | proteins)</td><td>166, monomer</td><td>(D118, IFNAR2 |</td><td>Leukocytes, dendritic cells, plasmacytoid dendritic cells, conventional dendritic cells</td><td>Antiviral, increased MHC class | expression</td><td>CD118: impaired antiviral activity</td></tr><tr><td></td><td>IFN-B</td><td>166, monomer</td><td>(D118, IFNAR2 |</td><td>Fibroblasts</td><td>Antiviral, increased MHC class | expression</td><td>IFN-B: increased susceptibility to certain viruses</td></tr><tr><td></td><td>IFN-y</td><td>143, homodimer</td><td>(D119, IFNGR2 |</td><td>T cells, natural killer cells, neutrophils, ILC1s, intraepithelial lymphocytes</td><td>Macrophage activation, increased expression of MHC molecules and antigen processing components, Ig class switching, supresses T,17 and 1,2</td><td>IFN-y, CD119: decreased resistance to bacterial infection and tumors</td></tr><tr><td rowspan="11">Interleukins</td><td>ILta</td><td>159, monomer 153, monomer</td><td>CD121a(IL-1Rl) and CD121b (IL-1RIl) CD121a(IL-1Rl)</td><td>| Macrophages, epithelial | cells | Macrophages, epithelial |</td><td>Fever, T-cell activation, macrophage activation Fever, T-cell activation, macrophage</td><td>IL-1RI: decreased IL-6 production IL-1B: impaired acute-G21</td></tr><tr><td></td><td>IL-1B,</td><td></td><td>and CD121b (IL-1RIl)</td><td>cells</td><td>activation</td><td>phase response</td></tr><tr><td></td><td>IL-1 RA</td><td>152, monomer</td><td>CD121a</td><td>Monocytes, macrophages, neutrophils, hepatocytes |</td><td>Binds to but doesn’t trigger IL-1 receptor, acts as a natural antagonist | of IL-1 function</td><td>IL-1RA: reduced body mass, increased sensitivity to endotoxins (septic shock)</td></tr><tr><td></td><td>IL-2 (T-cell growth factor)</td><td>133, monomer</td><td>CD25a, CD122B, (D132 (yc)</td><td>| T cells</td><td>Tyeg maintenance and function, T-cell | proliferation and differentiation</td><td>IL-2: deregulated T-cell proliferation, colitis IL-2Ra: incomplete T-cell development autoimmunity IL-2RB: increased T-cell autoimmunity IL-2Ryc: severe combined immunodeficiency</td></tr><tr><td></td><td>IL-3 (multicolony CSF)</td><td>133, monomer</td><td>CD123, Be</td><td>cells, and stromal cells T cells, thymic epithelial |</td><td>Synergistic action in early hematopoiesis</td><td>IL-3: impaired eosinophil development. Bone marrow unresponsive to IL-5, GM-CSF</td></tr><tr><td></td><td>IL-4 (BCGF-1, BSF-1)</td><td>129, monomer</td><td>(D124, CD132 (ye)</td><td>T cells, mast cells, ILC2s</td><td>B-cell activation, IgE switch, induces differentiation into T,,2 cells</td><td>IL-4: decreased IgE synthesis</td></tr><tr><td></td><td>IL-5 (BCGF-2)</td><td>115, homodimer</td><td>(D125, Be</td><td>T cells, mast cells, ILC2s</td><td>Eosinophil growth, differentiation</td><td>IL-5: decreased IgE, IgG1 synthesis (in mice); decreased levels of IL-9, IL-10, and eosinophils</td></tr><tr><td></td><td>IL-6 (IFN-B502, BSF-2, BCDF)</td><td>184, monomer</td><td>(D126, CD130</td><td>Tcells, B cells, macrophages, endothelial cells</td><td>T- and B-cell growth and 
======================================
differentiation, acute phase protein production, fever</td><td>IL-6: decreased acute phase reaction, reduced IgA production</td></tr><tr><td></td><td>IL?</td><td>152, monomer*</td><td>D127, cD132 (yc)</td><td>Non-T cells, stromal cells</td><td>Growth of pre-B cells and pre-T cells, and ILCs</td><td>IL-7: early thymic and lymphocyte expansion severely impaired</td></tr><tr><td></td><td>IL-9</td><td>125, monomer*</td><td>IL-9R, CD132 (yc)</td><td>Tcells</td><td>Mast-cell enhancing activity, stimulates T,,2 and ILC2 cells</td><td>Defects in mast-cell expansion</td></tr><tr><td></td><td>IL-10 (cytokine synthesis inhibitory factor) I-11</td><td>160, homodimer 178, monomer</td><td>IL-10Ra, IL-10RBc (CRF2-4, IL-10R2) IL-11R, CD130</td><td>Macrophages, dendritic cells, T cells, and B cells Stromal fibroblasts</td><td>Potent suppressant of macrophage functions Synergistic action with IL-3 and IL-4</td><td>IL-10 and IL20RBc-: reduced growth, anemia, chronic enterocolitis IL-11R: defective</td></tr></table>
======================================
<table><tr><td rowspan="11">leukins</td><td>IL-13 (p600)</td><td>132, monomer</td><td>IL-13R, CD132 (yc) (may also include CD24)</td><td>Tcells, ILC2s</td><td>B-cell growth and differentiation, inhibits macrophage inflammatory cytokine production and T,,1 cells, induces allergy/asthma</td><td>IL-13: defective regulation of isotype specific responses</td></tr><tr><td></td><td>L-15 (T-cell growth factor)</td><td>14, monomer</td><td>IL15Ra, CD12 (IL-2Rp) CD132 (yc)</td><td>Many non-T cells</td><td>IL-2-like, stimulates growth of intestinal epithelium, T cells, and NK cells, enhances CD8 memory T-cell survival</td><td>IL-15: reduced numbers of NK cells and memory phenotype CD8* T cells IL-15Ra: lymphopenia</td></tr><tr><td></td><td>IL-16</td><td>130, homotetramer</td><td>CD4</td><td>T cells, mast cells, eosinophils</td><td>Chemoattractant for CD4 T cells, monocytes, and eosinophils, anti- apoptotic for IL-2-stimulated T cells</td><td></td></tr><tr><td></td><td>IL-17A (mCTLA-8)</td><td>150, homodimer</td><td>IL-17AR (CD217)</td><td>1,17, CD8T cells, NK cells y:6 T cells, neutrophils, ILC3s</td><td>Induces cytokine and antimicrobial peptide production by epithelia, endothelia, and fibroblasts, proinflammatory</td><td>IL-17R: reduced neutrophil migration into infected sites</td></tr><tr><td></td><td>IL-17F (ML-1)</td><td>134, homodimer</td><td>IL-17AR (CD217)</td><td>1,17, CD8T cells, NK cells y:6 T cells, neutrophils, ILC3s</td><td>Induces cytokine production by epithelia, endothelia, and fibroblasts, proinflamatory</td><td></td></tr><tr><td></td><td>IL-18 (IGIF, interferon-a. inducing factor)</td><td>157, monomer</td><td>IL-1Rrp (IL-1R related protein)</td><td>Activated macrophages and Kupffer cells</td><td>Induces IFN-y production by T cells and NK cells, promotes T,,1 induction</td><td>Defective NK activity and Ty responses</td></tr><tr><td></td><td>IL-19</td><td>153, monomer</td><td>IL20Ra + IL-T0RBc</td><td>Monocytes</td><td>Induces IL-6 and TNF-a expression by monocytes</td><td></td></tr><tr><td></td><td>IL-20</td><td>152</td><td>IL-20Ro. + IL-10RBc; IL-22Rac + IL-10RBc</td><td>T,1 cells, monocytes, epithelial cells</td><td>Promotes T,,2 cells, stimulates keratinocyte proliferation and TNF-a. production</td><td></td></tr><tr><td></td><td>IL-21</td><td>133</td><td>IL-21R, + CD132(yc)</td><td>T,,2 cells, T cells, primarily T,,, cells</td><td>Germinal center maintenance induces proliferation of B, T, and NK cells</td><td>Increased IgE production</td></tr><tr><td></td><td>IL-22 (IL-TIF)</td><td>146</td><td>IL-22Rac +IL-10RBc</td><td>NK cells, T,17 cells, 7,22 cells, ILC3s, neutrophils, y:6 T cells</td><td>Induces production of antimicrobial peptides; induces liver acute-phase proteins, pro-inflammatory agents; epithelial barrier</td><td>Increased susceptibility to mucosal infections</td></tr><tr><td></td><td>IL-23</td><td>170 (p19) and 306 (p40c), heterodimer</td><td>IL-12RB1 +IL-23R</td><td>Dendritic cells, macrophages.</td><td>Induces proliferation of T,,17 memory T cells, increased IFN-y production</td><td>Defective inflammation</td></tr><tr><td></td><td>IL-24 (MDA-7)</td><td>157</td><td>IL-22Rac +IL-10R| IL-20Ra, +IL-10R|</td><td>Monocytes, T cells</td><td>Inhibits tumor growth, wound healing</td><td></td></tr><tr><td></td><td>IL-25 (IL-17E)</td><td>145</td><td>IL-17BR (IL-17Rh1)</td><td>T,,2 cells, mast cells, epithelial cells</td><td>Promotes 1,,2 cytokine production</td><td>Defective 1,2 response</td></tr><tr><td></td><td>IL-26 (AK155)</td><td>150</td><td>IL20Ra +IL-10RBc</td><td>T cells (T,,17), NK cells</td><td>Pro-inflammatory, stimulates epithelium</td><td></td></tr><tr><td></td><td>IL-27</td><td>142 (p28) and 229 (EBI3), heterodimer</td><td>WSX-1 +(CD130c</td><td>Monocytes, macrophages, dendritic cells</td><td>Induces IL-12R on T cells via T-bet induction, induces IL-10</td><td>EBI3: reduced NKT cells. WSX-1: overreaction to Toxoplasma gondii infection and death from inflammation</td></tr><tr><td></td><td>IL-28A,B (IFN
======================================
-B502,3)</td><td>175</td><td>IL-28Rac + IL-T0RBc</td><td>Dendritic cells</td><td>Antiviral</td><td></td></tr><tr><td></td><td>IL-29 (IFN-A1)</td><td>181</td><td>IL-28Rac +IL-10RBc</td><td>Dendritic cells</td><td>Antiviral</td><td></td></tr><tr><td></td><td>IL-30 (p28, IL27A, IL-27p28)</td><td>243</td><td>see IL-27</td><td></td><td></td><td></td></tr><tr><td></td><td>IL-31</td><td>164</td><td>IL31A + OSMR</td><td>T,2</td><td>Pro-inflammatory, skin lesions</td><td>IL-31A: elevated OSM responsiveness</td></tr><tr><td></td><td>IL-32 (NK4, TAIF)</td><td>188</td><td>Unknown</td><td>Natural killer cells,</td><td>Induces TNF-a.</td><td></td></tr></table>
======================================
<table><tr><td rowspan="7">Tterleukins NF</td><td>IL-36a, B, A</td><td>(20 kDa) 155-169</td><td>IL-1Rrp2, Acp</td><td>Keratinocytes, monocytes</td><td>Pro-inflammatory stimulant of macrophages and dendritic cells</td><td></td></tr><tr><td></td><td>IL-36 Ra</td><td></td><td>IL-1Rp2, Acp</td><td></td><td>Antagonist of IL-36</td><td></td></tr><tr><td></td><td>IL-37</td><td>(17-24 kDa) homodimer |</td><td>IL-18Ra?</td><td>Monocytes, dendritic cells, epithelial cells, breast tumor cells</td><td>BUTTE dendritic cell/monocyte production of IL-1, -6, -12 etc. cytokines, synergizes with TGFs</td><td>siRNA knockdown: increases pro-inflammatory cytokines</td></tr><tr><td></td><td>TSLP</td><td>140 monomer</td><td>IL-7Ra,, TSLPR</td><td>Epithelial cells, especially lung and skin</td><td>Stimulates hematopoietic cells | and dendritic cells to induce T,,2 responses</td><td>TSLP: resistance to induction of allergies and asthmatic reactions</td></tr><tr><td></td><td>LIF (leukemia inhibitory factor)</td><td>179, monomer</td><td>LIFR, CD130</td><td>Bone marrow stroma, fibroblasts</td><td>Maintains embryonic stem cells, like | IL-6, IL-11, OSM</td><td>LIFR: die at or soon after birth; decreased hematopoietic stem cells</td></tr><tr><td></td><td>OSM (OM, oncostatin M)</td><td>196, monomer</td><td>OSMR or LIFR, (D130</td><td>T cells, macrophages</td><td>Stimulates Kaposi's sarcoma cells, inhibits melanoma growth</td><td>OSMR: defective liver regeneration</td></tr><tr><td></td><td>TNF-a. (cachectin)</td><td>157, trimers</td><td>p55 (CD120a), p75 (CD120b)</td><td>Macrophages, NK cells, T cells</td><td>| Promotes inflammation, endothelial activation</td><td>p55: resistance to septic shock, susceptibility to Listeria, STNFaR: periodic febrile attacks</td></tr><tr><td></td><td>LT-a. (lymphotoxin-a)</td><td>171, trimers</td><td>p55 (CD120a), p75 (CD120b)</td><td>T cells, B cells</td><td>Killing, endothelial activation, and lymph node development</td><td>LT-a: absent lymph nodes, decreased antibody, increased IgM</td></tr><tr><td></td><td>Lp</td><td>Transmembrane, trimerizes with LT-o.</td><td>LTBR or HVEM</td><td>T cells, B cells, ILC3s</td><td>Lymph node development</td><td>Defective development of peripheral lymph nodes, Peyer's patches, and spleen</td></tr><tr><td></td><td>CD40 ligand (CD40L)</td><td>Trimers</td><td>CD40</td><td>T cells, mast cells</td><td>B-cell activation, class switching</td><td>CD4OL: poor antibody response, no class switching, diminished T-cell priming (hyper-IgM</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>syndrome)</td></tr><tr><td></td><td>Fas ligand (FasL)</td><td>Trimers</td><td>CD95 (Fas)</td><td>T cells, stroma (?)</td><td>Apoptosis, Ca’*-independent cytotoxicity</td><td>Fas, FasL: mutant forms lead to lymphoproliferation, and autoimmunity</td></tr><tr><td></td><td>CD27 ligand (CD27L)</td><td>Trimers (?)</td><td>CD27</td><td>T cells</td><td>Stimulates T-cell proliferation</td><td></td></tr><tr><td></td><td>CD30 ligand (CD30L)</td><td>Trimers (?)</td><td>CD30</td><td>T cells</td><td>Stimulates T- and B-cell proliferation |</td><td>CD30: increased thymic size, alloreactivity</td></tr><tr><td></td><td>4-1BBL</td><td>Trimers (?)</td><td>4-1BB</td><td>Tells</td><td>Co-stimulates T and B cells</td><td></td></tr><tr><td></td><td>Trail (APO-2L)</td><td>281, trimers</td><td>DR4, DR5 DCR1, | DCR2 and OPG</td><td>T cells, monocytes</td><td>Apoptosis of activated T cells and ‘tumor cells, and virally infected cells</td><td>Tumor-prone phenotype</td></tr><tr><td></td><td>OPG-L (RANK-L)</td><td>316, trimers</td><td>RANK/OPG</td><td>Osteoblasts, T cells</td><td>Stimulates osteoclasts and bone resorption</td><td>OPG-L: Pee inits runted, toothless OPG: osteoporosis</td></tr><tr><td></td><td>APRIL</td><td>86</td><td>TAC1 or BCMA</td><td>Activated T cells</td><td>B-cell proliferation</td><td>Impaired IgA-class switching</td></tr><tr><td></td><td>LIGHT</td><td>240</td><td>HVEM, LIBR</td><td>T cells</td><td>Dendritic 
======================================
cell activation</td><td>Defective CD8* T-cell expansion</td></tr><tr><td></td><td>TWEAK</td><td>102</td><td>TWEAKR (Fn14)</td><td>| Macrophages, EBV transformed cells</td><td>Angiogenesis</td><td></td></tr><tr><td></td><td>BAFF (CD257, BlyS)</td><td>153</td><td>tale BCMA or</td><td>B cells</td><td>B-cell proliferation</td><td>BAFF: B-cell dysfunction</td></tr><tr><td rowspan="2">Inassigned</td><td>TGF-B1</td><td>112, homo- and heterotrimers</td><td>TGF-BR</td><td>Chondrocytes, monocytes, T cells</td><td>Generation of iT,,. cells and T,17 cells, induces switch to IgA production</td><td>TGF-B: lethal inflammation</td></tr><tr><td></td><td>MIF</td><td>115, monomer</td><td>MIF-R</td><td>T cells, pituitary cells</td><td>Inhibits macrophage migration, stimulates macrophage activation,</td><td>MIF: resistance to septic shock, hyporesponsive to</td></tr></table>
======================================
<table><thead><th>CXCL ('ELR+)</th><th></th><th></th><th></th><th></th></thead><tr><td>1</td><td>GROa</td><td>4</td><td>Neutrophil, fibroblast</td><td>CXCR2</td></tr><tr><td>2</td><td>GROB</td><td>4</td><td>Neutrophil, fibroblast</td><td>CXCR2</td></tr><tr><td>3</td><td>GROy</td><td>4</td><td>Neutrophil, fibroblast</td><td>CXCR2</td></tr><tr><td>5</td><td>ENA-78</td><td>4</td><td>Neutrophil, endothelial cell</td><td>CXCR2&gt;&gt;1</td></tr><tr><td>6 7</td><td>GCP-2 NAP-2</td><td>4 4</td><td>Neutrophil, endothelial cell Fibroblast, neutrophil, endothelial cell</td><td>CXCR2&gt;1 CXCR1, CXCR2</td></tr><tr><td></td><td>(PBP/CTAP-III/ B-B44TG)</td><td></td><td></td><td></td></tr><tr><td>8</td><td>IL-8</td><td>4</td><td>Neutrophil, basophil, CD8 cell subset, endothelial cell</td><td>CXCR1, CXCR2</td></tr><tr><td>14</td><td>BRAK/bolekine</td><td>5</td><td>T cell, monocyte, B cell</td><td>Unknown</td></tr><tr><td>15</td><td>Lungkine/WECHE</td><td>5</td><td>Neutrophil, epithelial cell, endothelial cell</td><td>Unknown</td></tr><tr><td>("ELR-) 4</td><td>PF4</td><td>4</td><td>Fibroblast, endothelial cell</td><td>CXCR3B</td></tr><tr><td></td><td></td><td></td><td></td><td>(alternative splice)</td></tr><tr><td>9</td><td>Mig</td><td>4</td><td>Activated T cell (T,,1 &gt; 7,2), natural killer (NK) cell, B cell, endothelial cell, plasmacytoid dendritic cell</td><td>CXCR3A and B</td></tr><tr><td>10</td><td>IP-10</td><td>4</td><td>Activated T cell (T,,1 &gt; 1,2), NK cell, B cell, endothelial cell</td><td>CXCR3A and B</td></tr><tr><td>11</td><td>I-TAC</td><td>4</td><td>Activated T cell (T,,1 &gt; T,,2), NK cell, B cell, endothelial cell</td><td>CXCR3A and B, CXCR7</td></tr><tr><td>12</td><td>SDF-10/B</td><td>10</td><td>CD34* bone marrow cell, thymocytes, monocytes/macrophages, naive activated T cell, B cell, plasma cell, neutrophil, immature dendritic cells, mature dendritic cells, plasmacytoid dendritic cells</td><td>CXCR4, CXCR7</td></tr><tr><td>13</td><td>BLC/BCA-1</td><td>4</td><td>Naive B cells, activated CD4 cells, immature dendritic cells, mature dendritic cells</td><td>CKCR5&gt;&gt;CXCR3</td></tr><tr><td></td><td></td><td></td><td>T</td><td>|</td></tr><tr><td>16</td><td>sexckine</td><td>7</td><td>Activated T cell, natural killer T (NKT) cell, endothelial cells</td><td>CXCR6</td></tr><tr><td colspan="5">CCL</td></tr><tr><td>1</td><td>1-309</td><td>7</td><td>Neutrophil (TCA-3 only), T cell (T,,2 &gt; T,,1) monocyte</td><td>CCR8</td></tr><tr><td>2</td><td>MCP-1</td><td>7</td><td>T cell (T,2 &gt; T41) monocyte, basophil, immature dendritic cells, NK cells</td><td>CCR2</td></tr><tr><td>3</td><td>MIP-10/LD78</td><td>7</td><td>Monocyte/macrophage, T cell (T,1 &gt; 142), NK cell, basophil, immature dendritic cell, eosinophil, neutrophil, astrocyte, fibroblast, osteoclast</td><td>CCR1,5</td></tr><tr><td>4</td><td>MIP-1B,</td><td>7</td><td>Monocyte/macrophage, T cell (T,1 &gt; 142), NK cell, basophil, immature dendritic cell, eosinophil, B cell</td><td>CCR5&gt;&gt;1</td></tr><tr><td>5</td><td>RANTES</td><td>17</td><td>Monocyte/macrophage, T cell (memory T cell &gt; T cell; Ty1 &gt; 7,2), NK cell, basophil, eosinophil, immature dendritic cell</td><td>| CCR1, 3, 5</td></tr><tr><td>6</td><td>C10/MRP-1</td><td>11 (mouse only)</td><td>| Monocyte, B cell, CD4 T cell, NK cell</td><td>CCR 1</td></tr><tr><td>7</td><td>MCP-3</td><td>7</td><td>T 42 &gt;Ty1 T cell, monocyte, eosinophil, basophil, immature dendritic cell, NK cell</td><td>CCR1, 2, 3,5</td></tr><tr><td>8</td><td>MCP-2</td><td>7</td><td>T,2&gt;T,1 T cell, monocyte, eosinophil, basophil, immature dendritic cell, NK cell</td><td>CCR1, 2,5</td></tr><tr><td>9</td><td>MRP-2/MIP-1y.</td><td>11 (mouse only)</td><td>| T cell, monocyte, adipocyte</td><td>CCRI1</td></tr><tr><td>1</td><td>Eotaxin</td><td>7</td><td>Eosinophil, basophil, mast cell, T,2 cell</td><td>CCR3&gt;&gt;CCR5</td></tr><tr><td>12</td><td>MCP-5</td><td>11 (mouse only)</td><td>| Eosinophil, monocyte, T cell, B cell</td><td>CCR2</td></tr><
======================================
tr><td>13</td><td>MCcpP-4</td><td>7</td><td>1,42 &gt;T,1 T cell, monocyte, eosinophil, basophil, dendritic cell</td><td>CCR2, 3</td></tr></table>
======================================
<table><tr><td>15</td><td>MIP-5/HCC-2</td><td>7</td><td>T cells, monocytes, eosinophils, dendritic cells</td><td>CCR1, 3</td></tr><tr><td>16</td><td>HCC-4/LEC</td><td>7</td><td>Monocytes, T cells, natural killer cells, immature dendritic cells</td><td>CCR1, 2,5, 8</td></tr><tr><td>V7</td><td>TARC</td><td>16</td><td>T cells (T,,2 &gt; T,1), immature dendritic cells, thymocytes, regulatory T cells</td><td>CCR4&gt;&gt;8</td></tr><tr><td>18</td><td>DC-CK1/PARC</td><td>7</td><td>Naive T cells &gt; activated T cells, immature dendritic cells, mantle zone B cells</td><td>PITPNM3</td></tr><tr><td>19</td><td>MIP-3B/ELC</td><td>9</td><td>Naive T cells, mature dendritic cells, B cells</td><td>CCR7</td></tr><tr><td>20</td><td>MIP-3a/LARC</td><td>2</td><td>T cells (memory T cells, T,,17 cells), blood mononuclear cells, immature dendritic cells, activated B cells, NKT cells, GALT development</td><td>CCR6</td></tr><tr><td>21</td><td>6Ckine/SLC</td><td>9</td><td>Naive T cells, B cells, thymocytes, NK cells, mature dendritic cells</td><td>CCR7</td></tr><tr><td>22</td><td>MDC</td><td>16</td><td>Immature dendritic cells, NK cells, T cells (7,2 &gt; T,1), thymocytes, endothelial cells, monocytes, regulatory T cells</td><td>| CCR4</td></tr><tr><td>23</td><td>MPIF-1/CK-B\8</td><td>7</td><td>Monocytes, T cells, resting neutrophils</td><td>CCR1, FPRL-1</td></tr><tr><td>24</td><td>Eotaxin-2/MPIF-2</td><td>7</td><td>Eosinophils, basophils, T cells</td><td>CCR3</td></tr><tr><td>25</td><td>TECK</td><td>19</td><td>Macrophages, thymocytes, dendritic cells, intraepithelial lymphocytes, IgA plasma cells, mucosal memory T cells</td><td>CCRO</td></tr><tr><td>26</td><td>Eotaxin-3</td><td>7</td><td>Eosinophils, basophils, fibroblasts</td><td>CCR3</td></tr><tr><td>27</td><td>CTACK</td><td>9</td><td>Skin homing memory T cells, B cells</td><td>CCR10</td></tr><tr><td>28</td><td>MEC</td><td>5</td><td>T cells, eosinophils, IgA* B cells</td><td>CCR10&gt;3</td></tr><tr><td colspan="5">C and CX3C</td></tr><tr><td>XCL1</td><td>Lymphotactin</td><td>1</td><td>T cells, natural killer cells, CD8a + dendritic cells</td><td>XCR1</td></tr><tr><td>XCL2</td><td>SCM-1B</td><td>1</td><td>T cells, natural killer cells, CD8a + dendritic cells</td><td>XCR1</td></tr><tr><td>CX3CL 1</td><td>Fractalkine</td><td>16</td><td>Activated T cells, monocytes, neutrophil, natural killer cells, immature dendritic</td><td>CX3CR1</td></tr></table>
======================================
<table><tr><td>Chemerin and resolvin E1</td><td>Macrophages, immature dendritic cells, mast cells, plasmacytoid dendritic cells, adipocytes, fibroblasts, endothelial cells, oral epithelial cells</td><td>CMKLR1/chem23</td></tr><tr><td>CCLS5, CCL19 and chemerin</td><td>All hematopoietic cells, microglia, astrocytes, lung epithelial cells</td><td>CCRL2/CRAM</td></tr><tr><td>Inflammatory CC chemokines</td><td>Lymphatic endothelial cells</td><td>D6</td></tr><tr><td>Various CXC and CC chemokines</td><td>Red blood cells, Purkinje cells, blood endothelial cells, kidney epithelial cells</td><td>Duffy/DARC</td></tr><tr><td>CCL19, CCL21, CCL25</td><td>Thymic epithelial cells, lymph node stromal cells, keratinocytes</td><td>CCXCKR</td></tr></table>